Gene	"Gene synonym"	Ensembl	"Gene description"	Uniprot	Chromosome	Position	"Protein class"	"Biological process"	"Molecular function"	"Disease involvement"	Evidence	"HPA evidence"	"UniProt evidence"	"NeXtProt evidence"	"RNA tissue specificity"	"RNA tissue distribution"	"RNA tissue specificity score"	"RNA tissue specific nTPM"	"RNA single cell type specificity"	"RNA single cell type distribution"	"RNA single cell type specificity score"	"RNA single cell type specific nTPM"	"RNA cancer specificity"	"RNA cancer distribution"	"RNA cancer specificity score"	"RNA cancer specific FPKM"	"RNA brain regional specificity"	"RNA brain regional distribution"	"RNA brain regional specificity score"	"RNA brain regional specific nTPM"	"RNA blood cell specificity"	"RNA blood cell distribution"	"RNA blood cell specificity score"	"RNA blood cell specific nTPM"	"RNA blood lineage specificity"	"RNA blood lineage distribution"	"RNA blood lineage specificity score"	"RNA blood lineage specific nTPM"	"RNA cell line specificity"	"RNA cell line distribution"	"RNA cell line specificity score"	"RNA cell line specific nTPM"	"RNA mouse brain regional specificity"	"RNA mouse brain regional distribution"	"RNA mouse brain regional specificity score"	"RNA mouse brain regional specific nTPM"	"RNA pig brain regional specificity"	"RNA pig brain regional distribution"	"RNA pig brain regional specificity score"	"RNA pig brain regional specific nTPM"	Antibody	"Reliability (IH)"	"Reliability (Mouse Brain)"	"Reliability (IF)"	"Subcellular location"	"Secretome location"	"CCD Protein"	"CCD Transcript"	"Blood concentration - Conc. blood IM [pg/L]"	"Blood concentration - Conc. blood MS [pg/L]"	"Blood expression cluster"	"Tissue expression cluster"	"Cell line expression cluster"	"Single cell expression cluster"	"Subcellular main location"	"Subcellular additional location"	"Antibody RRID"	"Pathology prognostics - Breast cancer"	"Pathology prognostics - Cervical cancer"	"Pathology prognostics - Colorectal cancer"	"Pathology prognostics - Endometrial cancer"	"Pathology prognostics - Glioma"	"Pathology prognostics - Head and neck cancer"	"Pathology prognostics - Liver cancer"	"Pathology prognostics - Lung cancer"	"Pathology prognostics - Melanoma"	"Pathology prognostics - Ovarian cancer"	"Pathology prognostics - Pancreatic cancer"	"Pathology prognostics - Prostate cancer"	"Pathology prognostics - Renal cancer"	"Pathology prognostics - Stomach cancer"	"Pathology prognostics - Testis cancer"	"Pathology prognostics - Thyroid cancer"	"Pathology prognostics - Urothelial cancer"	"Tissue RNA - adipose tissue [nTPM]"	"Tissue RNA - adrenal gland [nTPM]"	"Tissue RNA - amygdala [nTPM]"	"Tissue RNA - appendix [nTPM]"	"Tissue RNA - basal ganglia [nTPM]"	"Tissue RNA - bone marrow [nTPM]"	"Tissue RNA - breast [nTPM]"	"Tissue RNA - cerebellum [nTPM]"	"Tissue RNA - cerebral cortex [nTPM]"	"Tissue RNA - cervix [nTPM]"	"Tissue RNA - choroid plexus [nTPM]"	"Tissue RNA - colon [nTPM]"	"Tissue RNA - duodenum [nTPM]"	"Tissue RNA - endometrium 1 [nTPM]"	"Tissue RNA - epididymis [nTPM]"	"Tissue RNA - esophagus [nTPM]"	"Tissue RNA - fallopian tube [nTPM]"	"Tissue RNA - gallbladder [nTPM]"	"Tissue RNA - heart muscle [nTPM]"	"Tissue RNA - hippocampal formation [nTPM]"	"Tissue RNA - hypothalamus [nTPM]"	"Tissue RNA - kidney [nTPM]"	"Tissue RNA - liver [nTPM]"	"Tissue RNA - lung [nTPM]"	"Tissue RNA - lymph node [nTPM]"	"Tissue RNA - medulla oblongata [nTPM]"	"Tissue RNA - midbrain [nTPM]"	"Tissue RNA - ovary [nTPM]"	"Tissue RNA - pancreas [nTPM]"	"Tissue RNA - parathyroid gland [nTPM]"	"Tissue RNA - pituitary gland [nTPM]"	"Tissue RNA - placenta [nTPM]"	"Tissue RNA - pons [nTPM]"	"Tissue RNA - prostate [nTPM]"	"Tissue RNA - rectum [nTPM]"	"Tissue RNA - retina [nTPM]"	"Tissue RNA - salivary gland [nTPM]"	"Tissue RNA - seminal vesicle [nTPM]"	"Tissue RNA - skeletal muscle [nTPM]"	"Tissue RNA - skin 1 [nTPM]"	"Tissue RNA - small intestine [nTPM]"	"Tissue RNA - smooth muscle [nTPM]"	"Tissue RNA - spinal cord [nTPM]"	"Tissue RNA - spleen [nTPM]"	"Tissue RNA - stomach 1 [nTPM]"	"Tissue RNA - testis [nTPM]"	"Tissue RNA - thalamus [nTPM]"	"Tissue RNA - thymus [nTPM]"	"Tissue RNA - thyroid gland [nTPM]"	"Tissue RNA - tongue [nTPM]"	"Tissue RNA - tonsil [nTPM]"	"Tissue RNA - urinary bladder [nTPM]"	"Tissue RNA - vagina [nTPM]"	"Tissue RNA - white matter [nTPM]"	"Cell RNA - A-431 [nTPM]"	"Cell RNA - A549 [nTPM]"	"Cell RNA - AF22 [nTPM]"	"Cell RNA - AN3-CA [nTPM]"	"Cell RNA - ASC diff [nTPM]"	"Cell RNA - ASC TERT1 [nTPM]"	"Cell RNA - BEWO [nTPM]"	"Cell RNA - BJ [nTPM]"	"Cell RNA - BJ hTERT+ [nTPM]"	"Cell RNA - BJ hTERT+ SV40 Large T+ [nTPM]"	"Cell RNA - BJ hTERT+ SV40 Large T+ RasG12V [nTPM]"	"Cell RNA - CACO-2 [nTPM]"	"Cell RNA - CAPAN-2 [nTPM]"	"Cell RNA - Daudi [nTPM]"	"Cell RNA - EFO-21 [nTPM]"	"Cell RNA - fHDF/TERT166 [nTPM]"	"Cell RNA - GAMG [nTPM]"	"Cell RNA - HaCaT [nTPM]"	"Cell RNA - HAP1 [nTPM]"	"Cell RNA - HBEC3-KT [nTPM]"	"Cell RNA - HBF TERT88 [nTPM]"	"Cell RNA - HDLM-2 [nTPM]"	"Cell RNA - HEK 293 [nTPM]"	"Cell RNA - HEL [nTPM]"	"Cell RNA - HeLa [nTPM]"	"Cell RNA - Hep G2 [nTPM]"	"Cell RNA - HHSteC [nTPM]"	"Cell RNA - HL-60 [nTPM]"	"Cell RNA - HMC-1 [nTPM]"	"Cell RNA - HSkMC [nTPM]"	"Cell RNA - hTCEpi [nTPM]"	"Cell RNA - hTEC/SVTERT24-B [nTPM]"	"Cell RNA - hTERT-HME1 [nTPM]"	"Cell RNA - hTERT-RPE1 [nTPM]"	"Cell RNA - HUVEC TERT2 [nTPM]"	"Cell RNA - JURKAT [nTPM]"	"Cell RNA - K-562 [nTPM]"	"Cell RNA - Karpas-707 [nTPM]"	"Cell RNA - LHCN-M2 [nTPM]"	"Cell RNA - MCF7 [nTPM]"	"Cell RNA - MOLT-4 [nTPM]"	"Cell RNA - NB-4 [nTPM]"	"Cell RNA - NTERA-2 [nTPM]"	"Cell RNA - OE19 [nTPM]"	"Cell RNA - PC-3 [nTPM]"	"Cell RNA - REH [nTPM]"	"Cell RNA - RH-30 [nTPM]"	"Cell RNA - RPMI-8226 [nTPM]"	"Cell RNA - RPTEC TERT1 [nTPM]"	"Cell RNA - RT4 [nTPM]"	"Cell RNA - SCLC-21H [nTPM]"	"Cell RNA - SH-SY5Y [nTPM]"	"Cell RNA - SiHa [nTPM]"	"Cell RNA - SK-BR-3 [nTPM]"	"Cell RNA - SK-MEL-30 [nTPM]"	"Cell RNA - SuSa [nTPM]"	"Cell RNA - T-47d [nTPM]"	"Cell RNA - THP-1 [nTPM]"	"Cell RNA - TIME [nTPM]"	"Cell RNA - U-138 MG [nTPM]"	"Cell RNA - U-2 OS [nTPM]"	"Cell RNA - U-2197 [nTPM]"	"Cell RNA - U-251 MG [nTPM]"	"Cell RNA - U-266/70 [nTPM]"	"Cell RNA - U-266/84 [nTPM]"	"Cell RNA - U-698 [nTPM]"	"Cell RNA - U-87 MG [nTPM]"	"Cell RNA - U-937 [nTPM]"	"Cell RNA - WM-115 [nTPM]"	"Blood RNA - basophil [nTPM]"	"Blood RNA - classical monocyte [nTPM]"	"Blood RNA - eosinophil [nTPM]"	"Blood RNA - gdT-cell [nTPM]"	"Blood RNA - intermediate monocyte [nTPM]"	"Blood RNA - MAIT T-cell [nTPM]"	"Blood RNA - memory B-cell [nTPM]"	"Blood RNA - memory CD4 T-cell [nTPM]"	"Blood RNA - memory CD8 T-cell [nTPM]"	"Blood RNA - myeloid DC [nTPM]"	"Blood RNA - naive B-cell [nTPM]"	"Blood RNA - naive CD4 T-cell [nTPM]"	"Blood RNA - naive CD8 T-cell [nTPM]"	"Blood RNA - neutrophil [nTPM]"	"Blood RNA - NK-cell [nTPM]"	"Blood RNA - non-classical monocyte [nTPM]"	"Blood RNA - plasmacytoid DC [nTPM]"	"Blood RNA - T-reg [nTPM]"	"Blood RNA - total PBMC [nTPM]"	"Brain RNA - amygdala [nTPM]"	"Brain RNA - basal ganglia [nTPM]"	"Brain RNA - cerebellum [nTPM]"	"Brain RNA - cerebral cortex [nTPM]"	"Brain RNA - hippocampal formation [nTPM]"	"Brain RNA - hypothalamus [nTPM]"	"Brain RNA - medulla oblongata [nTPM]"	"Brain RNA - midbrain [nTPM]"	"Brain RNA - pons [nTPM]"	"Brain RNA - spinal cord [nTPM]"	"Brain RNA - thalamus [nTPM]"	"Brain RNA - white matter [nTPM]"	"Single Cell Type RNA - Adipocytes [nTPM]"	"Single Cell Type RNA - Alveolar cells type 1 [nTPM]"	"Single Cell Type RNA - Alveolar cells type 2 [nTPM]"	"Single Cell Type RNA - Astrocytes [nTPM]"	"Single Cell Type RNA - B-cells [nTPM]"	"Single Cell Type RNA - Basal keratinocytes [nTPM]"	"Single Cell Type RNA - Basal prostatic cells [nTPM]"	"Single Cell Type RNA - Basal respiratory cells [nTPM]"	"Single Cell Type RNA - Basal squamous epithelial cells [nTPM]"	"Single Cell Type RNA - Bipolar cells [nTPM]"	"Single Cell Type RNA - Breast glandular cells [nTPM]"	"Single Cell Type RNA - Breast myoepithelial cells [nTPM]"	"Single Cell Type RNA - Cardiomyocytes [nTPM]"	"Single Cell Type RNA - Cholangiocytes [nTPM]"	"Single Cell Type RNA - Club cells [nTPM]"	"Single Cell Type RNA - Collecting duct cells [nTPM]"	"Single Cell Type RNA - Cone photoreceptor cells [nTPM]"	"Single Cell Type RNA - Cytotrophoblasts [nTPM]"	"Single Cell Type RNA - dendritic cells [nTPM]"	"Single Cell Type RNA - Distal enterocytes [nTPM]"	"Single Cell Type RNA - Distal tubular cells [nTPM]"	"Single Cell Type RNA - Ductal cells [nTPM]"	"Single Cell Type RNA - Early spermatids [nTPM]"	"Single Cell Type RNA - Endometrial ciliated cells [nTPM]"	"Single Cell Type RNA - Endometrial stromal cells [nTPM]"	"Single Cell Type RNA - Endothelial cells [nTPM]"	"Single Cell Type RNA - Enteroendocrine cells [nTPM]"	"Single Cell Type RNA - Erythroid cells [nTPM]"	"Single Cell Type RNA - Excitatory neurons [nTPM]"	"Single Cell Type RNA - Exocrine glandular cells [nTPM]"	"Single Cell Type RNA - Extravillous trophoblasts [nTPM]"	"Single Cell Type RNA - Fibroblasts [nTPM]"	"Single Cell Type RNA - Gastric mucus-secreting cells [nTPM]"	"Single Cell Type RNA - Glandular and luminal cells [nTPM]"	"Single Cell Type RNA - granulocytes [nTPM]"	"Single Cell Type RNA - Granulosa cells [nTPM]"	"Single Cell Type RNA - Hepatic stellate cells [nTPM]"	"Single Cell Type RNA - Hepatocytes [nTPM]"	"Single Cell Type RNA - Hofbauer cells [nTPM]"	"Single Cell Type RNA - Horizontal cells [nTPM]"	"Single Cell Type RNA - Inhibitory neurons [nTPM]"	"Single Cell Type RNA - Intestinal goblet cells [nTPM]"	"Single Cell Type RNA - Ionocytes [nTPM]"	"Single Cell Type RNA - Kupffer cells [nTPM]"	"Single Cell Type RNA - Langerhans cells [nTPM]"	"Single Cell Type RNA - Late spermatids [nTPM]"	"Single Cell Type RNA - Leydig cells [nTPM]"	"Single Cell Type RNA - Macrophages [nTPM]"	"Single Cell Type RNA - Melanocytes [nTPM]"	"Single Cell Type RNA - Microglial cells [nTPM]"	"Single Cell Type RNA - monocytes [nTPM]"	"Single Cell Type RNA - Muller glia cells [nTPM]"	"Single Cell Type RNA - NK-cells [nTPM]"	"Single Cell Type RNA - Oligodendrocyte precursor cells [nTPM]"	"Single Cell Type RNA - Oligodendrocytes [nTPM]"	"Single Cell Type RNA - Pancreatic endocrine cells [nTPM]"	"Single Cell Type RNA - Paneth cells [nTPM]"	"Single Cell Type RNA - Peritubular cells [nTPM]"	"Single Cell Type RNA - Plasma cells [nTPM]"	"Single Cell Type RNA - Prostatic glandular cells [nTPM]"	"Single Cell Type RNA - Proximal enterocytes [nTPM]"	"Single Cell Type RNA - Proximal tubular cells [nTPM]"	"Single Cell Type RNA - Respiratory ciliated cells [nTPM]"	"Single Cell Type RNA - Rod photoreceptor cells [nTPM]"	"Single Cell Type RNA - Sertoli cells [nTPM]"	"Single Cell Type RNA - Skeletal myocytes [nTPM]"	"Single Cell Type RNA - Smooth muscle cells [nTPM]"	"Single Cell Type RNA - Spermatocytes [nTPM]"	"Single Cell Type RNA - Spermatogonia [nTPM]"	"Single Cell Type RNA - Squamous epithelial cells [nTPM]"	"Single Cell Type RNA - Suprabasal keratinocytes [nTPM]"	"Single Cell Type RNA - Syncytiotrophoblasts [nTPM]"	"Single Cell Type RNA - T-cells [nTPM]"	"Single Cell Type RNA - Theca cells [nTPM]"	"Single Cell Type RNA - Undifferentiated cells [nTPM]"	"Single Cell Type RNA - Urothelial cells [nTPM]"
ACO1	"IREB1, IREBP, IRP1"	ENSG00000122729	"Aconitase 1"	P21399	9	32384603-32454769	"Cancer-related genes, Citric acid cycle related proteins, Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Tricarboxylic acid cycle"	"Lyase, RNA-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 134.5"	"Cell type enhanced"	"Detected in all"		"Hepatocytes: 194.4;Proximal tubular cells: 183.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"ASC diff: 194.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019371, HPA024157"	Enhanced		Supported	Mitochondria,Cytosol		NA	NA		10000000	"Cluster 38: Basophils - Unknown function"	"Cluster 81: Kidney & Liver - Metabolism"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	"Mitochondria, Cytosol"		"HPA019371: AB_1844519, HPA024157: AB_1844520"	"unprognostic (2.11e-1)"	"unprognostic (5.61e-2)"	"unprognostic (8.38e-2)"	"unprognostic (9.12e-2)"	"unprognostic (2.63e-1)"	"unprognostic (3.12e-2)"	"unprognostic (4.25e-3)"	"unprognostic (2.61e-2)"	"unprognostic (1.37e-1)"	"unprognostic (1.19e-1)"	"unprognostic (2.55e-1)"	"unprognostic (3.08e-1)"	"prognostic favorable (5.73e-5)"	"unprognostic (2.54e-1)"	"unprognostic (6.58e-2)"	"unprognostic (1.65e-1)"	"unprognostic (3.23e-2)"	96.6	50.5	15.2	16.1	15.4	3.5	50.1	14.6	15.3	19.8	19.1	23.7	48.6	19.2	30.2	15.4	14.6	15.6	36.3	14.0	16.2	89.2	134.5	20.3	8.8	15.8	15.8	17.4	37.6	22.8	13.1	16.1	14.9	21.9	20.6	12.9	16.6	19.1	25.1	12.0	35.8	22.9	15.3	9.3	28.7	17.6	16.9	13.6	34.5	37.8	7.1	24.4	13.7	14.1	37.5	33.7	25.7	40.7	194.5	104.8	11.6	69.3	169.1	31.2	24.5	36.0	11.4	7.4	21.6	73.1	84.9	5.1	51.3	66.3	62.3	23.8	13.8	54.7	33.4	39.3	97.4	5.1	21.2	91.7	20.1	80.4	56.1	95.6	81.7	28.4	20.0	15.7	89.9	9.9	29.5	26.4	26.9	23.3	35.5	22.8	38.0	7.8	118.9	34.1	3.3	10.5	71.9	2.8	7.6	27.1	16.7	13.5	89.2	112.5	38.2	38.2	18.2	7.8	15.5	14.7	78.7	18.2	10.2	33.2	11.3	3.3	9.2	11.3	8.0	5.6	6.2	6.9	9.3	5.0	8.1	8.2	1.2	6.7	10.0	4.3	3.9	8.4	15.2	15.4	14.6	15.3	14.0	16.2	15.8	15.8	14.9	15.3	16.9	14.1	16.3	3.2	25.7	43.8	6.7	4.5	7.9	11.9	9.1	21.4	17.8	7.4	45.5	38.6	11.7	23.9	22.9	50.8	6.2	26.4	19.6	19.0	8.7	10.0	30.7	18.7	4.9	11.6	24.6	41.0	22.1	29.7	39.3	13.9	2.5	17.1	15.7	194.4	15.1	33.7	46.5	27.7	10.2	14.8	6.7	6.9	23.6	15.6	7.2	20.6	8.6	25.7	8.2	22.1	24.1	19.4	23.7	23.3	7.2	10.1	56.1	183.4	10.7	14.3	19.7	30.5	22.2	9.8	19.4	10.3	5.4	53.5	7.5	22.2	34.6	8.7
ACOT2	"Mte1, ZAP128"	ENSG00000119673	"Acyl-CoA thioesterase 2"	P49753	14	73567620-73575658	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Fatty acid metabolism, Lipid metabolism"	"Hydrolase, Serine esterase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 118.9"	"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 50.0;Exocrine glandular cells: 33.2;Proximal tubular cells: 36.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Hep G2: 62.4"									"HPA043705, HPA060170"	Enhanced		Approved	Mitochondria		NA	NA			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 59: Non-specific - Transcription"	Mitochondria		"HPA043705: AB_2678626, HPA060170: AB_2732642"	"unprognostic (4.44e-3)"	"unprognostic (1.68e-2)"	"unprognostic (3.17e-1)"	"unprognostic (8.66e-2)"	"unprognostic (1.78e-1)"	"unprognostic (1.55e-1)"	"unprognostic (2.78e-2)"	"unprognostic (6.61e-2)"	"unprognostic (4.10e-2)"	"unprognostic (9.21e-2)"	"unprognostic (6.42e-2)"	"unprognostic (1.64e-1)"	"prognostic favorable (2.28e-6)"	"unprognostic (1.66e-3)"	"unprognostic (1.04e-1)"	"unprognostic (1.52e-1)"	"unprognostic (4.35e-1)"	92.3	47.7	10.0	7.0	10.3	5.6	48.9	9.2	12.4	17.1	12.2	42.2	24.7	42.9	10.7	10.9	24.1	6.1	94.5	10.1	9.5	49.4	118.9	17.3	4.7	8.8	9.4	11.7	12.8	22.4	8.3	4.4	8.2	17.8	11.1	4.1	17.8	11.1	114.0	13.1	24.5	22.8	9.2	11.4	22.5	12.0	13.0	3.7	14.5	50.0	3.3	31.2	13.3	9.0	22.8	25.0	4.9	22.1	21.3	7.9	1.0	13.7	31.5	21.9	28.6	18.1	12.6	0.1	9.7	7.0	10.3	12.7	0.0	1.2	11.4	33.1	31.6	16.0	7.6	62.4	14.5	0.1	43.3	19.5	0.0	7.6	0.1	21.0	9.5	0.0	0.0	0.1	18.7	7.4	2.5	18.2	7.5	2.3	37.8	37.2	21.9	0.3	8.0	9.5	21.6	27.3	33.1	24.3	29.6	2.1	51.1	12.7	17.0	17.9	47.2	11.8	13.0	0.0	0.1	9.5	15.8	0.1	18.2	3.5	5.9	3.1	22.1	7.0	15.8	15.0	20.2	16.6	21.9	12.4	17.8	19.9	0.2	15.3	6.5	13.6	31.3	13.6	10.0	10.3	9.2	12.4	10.1	9.5	8.8	9.4	8.2	9.2	13.0	9.0	4.3	0.0	6.4	3.3	6.6	1.7	1.0	5.9	16.5	1.1	5.2	4.2	50.0	7.2	3.0	7.3	10.4	6.1	3.0	20.1	13.7	20.9	1.5	1.4	1.9	4.0	15.7	8.4	2.9	33.2	3.2	7.0	11.7	2.1	13.4	1.9	4.2	27.7	14.9	1.7	3.1	15.5	10.2	3.8	1.6	1.1	5.9	5.6	5.4	1.0	18.5	5.5	7.2	3.0	1.7	21.8	8.6	8.2	7.9	0.4	27.5	36.5	3.3	4.9	6.6	1.4	9.8	0.3	4.8	8.5	0.4	8.2	5.8	1.7	18.8	0.4
ACTR1A	"ARP1, Arp1A"	ENSG00000138107	"Actin related protein 1A"	P61163	10	102461881-102502712	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB037193, HPA047443"	Approved		Approved	Microtubules		NA	NA		560000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 1: Pancreatic cells - Digestion"	Microtubules		"CAB037193: AB_258253, HPA047443: AB_2680049"	"unprognostic (9.64e-3)"	"unprognostic (1.92e-2)"	"unprognostic (8.34e-2)"	"unprognostic (4.05e-2)"	"unprognostic (2.57e-1)"	"unprognostic (3.48e-1)"	"unprognostic (2.20e-3)"	"unprognostic (2.41e-1)"	"unprognostic (1.86e-2)"	"unprognostic (1.01e-1)"	"unprognostic (1.66e-2)"	"unprognostic (7.77e-2)"	"unprognostic (3.41e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.40e-1)"	"unprognostic (3.10e-1)"	"unprognostic (4.13e-1)"	59.4	58.8	98.3	39.4	100.6	36.8	51.5	101.9	108.4	50.9	78.4	90.0	37.8	61.8	37.5	61.6	47.4	36.1	93.0	101.9	108.0	49.0	40.4	58.5	33.7	116.3	105.9	36.9	41.9	56.5	54.7	45.3	116.9	53.0	41.7	41.9	46.4	51.9	174.3	65.1	49.1	69.0	97.4	48.7	56.2	40.4	104.0	56.8	41.2	127.0	42.2	74.8	51.2	104.4	80.5	95.8	113.5	117.1	138.0	109.2	45.5	100.3	177.3	154.4	142.4	52.7	63.3	54.4	75.2	149.5	76.2	78.3	109.9	123.7	106.5	70.7	75.8	72.9	53.4	77.9	99.6	56.9	65.0	112.4	89.6	141.2	100.7	155.7	201.6	88.7	60.5	53.5	154.6	67.1	103.5	97.9	45.4	62.5	86.2	78.5	146.0	35.0	125.2	43.9	40.5	88.8	60.1	35.4	75.1	98.3	130.0	38.9	147.0	74.7	71.5	83.6	102.1	54.0	58.8	63.3	78.7	98.3	45.9	32.2	40.7	44.3	31.1	51.8	25.5	18.8	22.0	30.4	40.6	17.6	18.0	20.7	31.2	23.9	57.0	20.8	33.6	39.2	98.3	100.6	101.9	108.4	101.9	108.0	116.3	105.9	116.9	97.4	104.0	104.4	40.0	57.7	41.0	10.1	23.4	33.8	24.0	42.3	13.1	26.6	22.1	17.1	51.6	14.3	34.8	27.6	16.7	54.9	23.8	52.4	54.8	75.5	53.0	15.3	21.0	45.2	39.6	45.9	14.9	77.5	63.3	36.9	23.4	19.3	32.3	27.3	34.6	24.1	73.9	26.9	15.5	24.4	46.8	37.6	38.2	53.9	33.2	44.5	51.6	5.6	70.3	31.5	38.1	10.1	15.3	92.0	36.8	36.1	30.0	26.7	40.9	45.6	26.5	24.5	46.0	17.1	48.5	61.9	14.0	27.3	32.4	104.7	28.2	32.9	24.2	26.6
ADD1		ENSG00000087274	"Adducin 1"	P35611	4	2843857-2930076	"Plasma proteins, Predicted intracellular proteins"		"Actin-binding, Calmodulin-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Cone photoreceptor cells: 402.4;Rod photoreceptor cells: 624.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009794, HPA035873, HPA035874"	Enhanced		Enhanced	"Nucleoplasm,Plasma membrane"		NA	NA		360000	"Cluster 19: B-cells - Humoral immune response"	"Cluster 54: Non-specific - Microtubule organization"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 46: Photoreceptor cells - Phototransduction"	"Plasma membrane"	Nucleoplasm	"CAB009794: AB_633663, HPA035873: AB_2674836, HPA035874: AB_2674837"	"unprognostic (1.79e-1)"	"unprognostic (1.37e-1)"	"unprognostic (1.66e-2)"	"unprognostic (5.40e-3)"	"unprognostic (1.90e-1)"	"unprognostic (2.66e-2)"	"unprognostic (5.07e-3)"	"unprognostic (1.68e-2)"	"unprognostic (3.52e-1)"	"unprognostic (2.50e-1)"	"prognostic favorable (3.94e-4)"	"unprognostic (5.22e-2)"	"prognostic favorable (1.29e-7)"	"unprognostic (2.61e-2)"	"unprognostic (1.12e-1)"	"unprognostic (7.38e-2)"	"unprognostic (4.03e-3)"	104.4	70.0	96.4	60.7	119.7	65.9	89.1	86.7	117.7	96.5	46.4	127.9	65.5	121.4	57.9	71.9	96.3	69.0	111.2	99.2	90.9	74.1	53.7	93.5	65.3	91.5	100.4	129.5	56.4	67.5	70.1	66.0	92.3	86.1	62.7	269.1	61.9	107.3	166.3	69.4	92.3	110.2	76.0	88.9	84.3	53.2	113.2	76.0	71.7	115.0	62.1	115.3	82.9	116.2	74.7	61.2	142.0	73.8	205.8	152.6	53.2	123.2	146.9	125.6	105.3	90.5	91.8	38.7	63.0	212.3	146.6	46.6	107.5	103.4	104.3	49.9	49.4	109.5	50.4	87.9	100.4	65.8	74.7	151.6	95.2	110.4	44.0	130.1	158.5	71.9	116.0	90.8	145.1	43.7	203.7	91.6	80.0	67.9	85.7	89.1	78.6	45.7	91.2	162.2	84.8	110.0	88.9	35.8	76.9	107.0	84.2	61.7	193.4	102.1	52.4	84.7	103.0	72.5	63.3	48.9	98.2	80.4	100.9	20.1	7.6	35.5	19.1	7.3	17.6	23.8	10.6	16.3	12.0	31.2	9.8	11.8	10.5	27.2	11.4	25.4	14.8	16.0	96.4	119.7	86.7	117.7	99.2	90.9	91.5	100.4	92.3	76.0	113.2	116.2	89.3	70.5	45.4	141.3	66.5	26.9	29.8	33.0	27.9	99.5	41.2	41.5	78.0	40.0	46.3	60.7	402.4	35.5	84.0	51.3	15.6	37.3	48.5	43.9	61.2	89.4	57.7	57.9	85.7	45.8	32.5	72.9	39.8	58.1	37.3	53.0	84.3	41.8	41.8	111.0	83.2	39.3	28.5	51.6	42.2	35.9	77.6	47.4	35.6	72.1	58.3	233.8	120.5	68.9	178.6	53.2	39.4	121.9	49.7	35.8	48.6	44.6	40.4	624.3	98.6	58.4	73.1	45.3	33.2	30.5	36.7	36.5	55.6	80.7	45.1	33.0
ADH5	"ADH-3, ADHX, FDH, GSNOR"	ENSG00000197894	"Alcohol dehydrogenase 5 (class III), chi polypeptide"	P11766	4	99070978-99088801	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA044578, HPA061919"	Approved					NA	NA		5300000	"Cluster 48: NK-cells - Unknown function"	"Cluster 85: Liver - Metabolism"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 39: Non-specific - Basic cellular processes"			"HPA044578: AB_2679002, HPA061919: AB_2684638"	"unprognostic (1.05e-1)"	"unprognostic (1.63e-2)"	"unprognostic (1.14e-3)"	"prognostic favorable (9.90e-5)"	"unprognostic (2.63e-1)"	"unprognostic (1.58e-2)"	"unprognostic (1.11e-1)"	"unprognostic (9.48e-2)"	"prognostic unfavorable (3.54e-4)"	"unprognostic (1.47e-1)"	"unprognostic (1.02e-2)"	"unprognostic (1.22e-1)"	"prognostic favorable (4.58e-10)"	"unprognostic (1.79e-3)"	"unprognostic (9.05e-2)"	"unprognostic (1.15e-2)"	"unprognostic (1.13e-1)"	141.5	71.3	48.3	52.5	48.2	28.5	111.9	48.0	56.0	92.7	55.8	158.8	94.2	134.8	142.2	114.4	95.9	69.3	124.3	45.9	54.6	175.4	264.1	73.5	51.3	47.6	48.5	118.4	49.4	50.1	41.4	60.9	47.9	116.2	100.8	36.0	65.4	124.6	80.9	54.8	94.3	118.0	49.7	51.6	91.3	52.2	48.6	83.3	79.2	75.8	55.5	158.9	73.9	51.4	84.0	66.9	194.8	110.0	344.7	316.0	116.6	136.6	237.6	143.8	125.2	77.1	96.7	96.5	77.5	197.8	92.8	69.8	135.0	188.7	137.7	69.9	56.6	67.1	83.3	306.7	332.2	118.4	51.9	287.3	143.1	108.3	84.7	151.0	112.8	99.8	125.8	53.3	192.3	94.9	160.4	105.4	156.7	20.6	79.8	115.4	108.9	50.9	230.2	96.0	74.0	97.0	82.7	96.6	155.9	141.8	78.2	82.2	85.4	130.5	82.9	86.4	95.2	55.9	74.4	135.4	134.2	77.4	135.7	21.8	21.2	35.8	32.6	18.9	29.5	26.0	35.3	30.4	23.8	26.2	34.0	31.9	3.0	51.3	14.1	20.5	49.5	32.8	48.3	48.2	48.0	56.0	45.9	54.6	47.6	48.5	47.9	49.7	48.6	51.4	69.0	105.8	78.2	22.9	48.1	39.6	85.9	257.5	109.3	31.8	32.1	74.3	127.4	78.6	94.3	55.2	10.4	290.1	51.8	80.4	197.6	94.8	24.0	146.9	159.1	56.3	79.7	45.8	14.3	83.8	277.2	131.2	37.8	113.0	26.6	83.3	47.2	188.0	118.1	38.7	12.0	101.8	87.5	48.6	27.1	22.0	187.4	43.4	53.4	15.9	63.2	152.4	77.2	27.6	13.9	78.4	86.0	255.1	41.5	34.9	95.2	316.0	56.8	46.5	111.7	55.6	127.7	30.5	48.5	74.9	23.0	83.0	58.5	147.0	104.8	68.1
AKTIP	"FLJ13258, FTS"	ENSG00000166971	"AKT interacting protein"	Q9H8T0	16	53491040-53504411	"Plasma proteins, Predicted intracellular proteins"	"Apoptosis, Protein transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 168.3;Late spermatids: 325.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041794, HPA046300"	Approved					NA	NA			"Cluster 20: T-cells - T-cell receptor"	"Cluster 54: Non-specific - Microtubule organization"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 31: Spermatids - Spermatogenesis"			"HPA041794: AB_2677677, HPA046300: AB_2679619"	"unprognostic (2.08e-2)"	"unprognostic (5.92e-2)"	"unprognostic (2.50e-2)"	"unprognostic (5.44e-2)"	"unprognostic (2.62e-2)"	"unprognostic (9.90e-2)"	"unprognostic (1.72e-2)"	"unprognostic (3.41e-3)"	"unprognostic (2.45e-1)"	"unprognostic (2.60e-2)"	"unprognostic (1.50e-3)"	"unprognostic (7.66e-2)"	"prognostic favorable (1.18e-14)"	"unprognostic (2.39e-3)"	"unprognostic (1.86e-1)"	"unprognostic (2.67e-1)"	"unprognostic (1.31e-1)"	29.3	20.5	46.9	15.7	48.9	32.1	24.7	47.8	55.7	24.5	42.0	30.2	15.5	22.3	31.6	33.2	21.4	17.4	55.3	50.9	47.2	37.1	31.8	24.4	22.5	51.5	46.9	30.4	17.3	44.9	29.0	30.2	52.8	24.7	17.8	76.9	20.5	31.0	134.9	26.9	20.0	25.7	47.6	15.5	21.2	44.0	47.5	13.2	31.7	81.4	24.2	25.1	26.1	48.9	40.2	25.7	17.2	22.7	22.8	17.2	50.5	24.7	18.6	21.5	5.3	35.0	20.6	6.6	14.9	25.4	16.2	34.0	14.9	20.0	28.8	9.7	23.6	1.9	13.6	28.1	29.6	9.2	17.1	14.6	55.1	21.4	18.4	31.2	37.1	13.4	3.6	14.1	19.2	31.2	8.0	13.7	11.9	19.2	24.6	9.6	28.5	30.3	28.4	33.2	13.5	16.8	14.9	52.4	22.4	22.9	46.7	5.7	35.2	23.1	25.1	15.2	24.4	20.6	19.6	13.5	24.9	8.1	15.0	22.3	4.5	11.0	32.4	3.4	19.5	9.1	31.1	33.9	2.0	13.7	47.7	39.3	29.3	27.1	3.4	3.0	46.4	19.1	46.9	48.9	47.8	55.7	50.9	47.2	51.5	46.9	52.8	47.6	47.5	48.9	41.9	25.6	15.4	11.8	9.3	7.0	15.1	29.0	5.7	28.4	17.9	11.9	32.2	17.2	25.4	23.9	16.7	80.3	13.6	15.0	82.2	29.8	168.3	11.2	7.1	22.2	6.0	3.6	19.4	20.5	44.3	16.4	8.2	12.9	3.8	9.6	26.0	26.3	13.3	21.9	20.2	6.5	44.7	7.0	5.6	325.9	14.0	6.2	23.2	7.5	8.0	58.8	28.8	8.5	21.5	20.6	6.0	38.4	12.2	15.0	36.2	38.2	22.0	27.3	6.6	22.1	22.2	16.1	40.4	11.2	12.8	77.3	28.7	8.4	11.5	19.0
ANXA6	ANX6	ENSG00000197043	"Annexin A6"	P08133	5	151100706-151157785	"Plasma proteins, Predicted intracellular proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Granulosa cells: 343.8;monocytes: 445.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"ASC diff: 861.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002462, CAB005077, HPA009650, HPA009977"	Enhanced		Approved	Cytosol		NA	NA		1800000	"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 40: Granulosa cells - Unknown function"	Cytosol		"CAB005077: AB_630873, HPA002462: AB_1078166, HPA009650: AB_1844867, HPA009977: "	"unprognostic (1.74e-1)"	"unprognostic (5.85e-2)"	"unprognostic (1.03e-1)"	"unprognostic (5.81e-2)"	"unprognostic (2.44e-1)"	"unprognostic (9.41e-2)"	"unprognostic (1.17e-1)"	"unprognostic (1.75e-1)"	"unprognostic (9.63e-2)"	"unprognostic (1.60e-2)"	"unprognostic (1.08e-3)"	"unprognostic (2.49e-2)"	"prognostic unfavorable (1.31e-5)"	"unprognostic (6.29e-2)"	"unprognostic (1.74e-1)"	"unprognostic (1.28e-3)"	"unprognostic (1.38e-3)"	292.9	135.4	98.1	164.2	104.1	109.7	188.3	94.0	150.6	148.9	151.8	196.0	44.5	181.5	105.0	94.7	149.9	108.7	188.7	102.5	123.1	82.6	214.4	131.6	161.8	144.2	109.4	181.7	78.3	29.6	161.9	141.1	146.2	124.9	78.2	133.6	70.3	208.6	331.3	62.7	119.9	300.1	92.3	150.9	111.4	52.5	127.4	160.8	86.7	371.5	176.4	206.5	107.4	104.8	3.0	30.4	212.8	317.1	861.2	417.8	55.1	397.4	526.4	323.5	477.6	106.7	15.6	26.9	138.5	578.6	268.1	0.5	165.9	200.2	300.3	110.5	52.1	15.3	62.1	204.7	295.0	97.6	94.7	508.6	1.5	282.3	42.0	476.9	420.6	197.5	22.0	396.1	737.6	100.4	181.8	151.7	56.2	1.2	92.4	120.4	592.9	31.0	42.2	0.3	12.2	49.3	39.9	282.7	175.6	308.4	488.3	201.1	326.8	296.6	84.2	19.4	107.1	205.4	289.5	4.5	154.5	459.7	46.2	89.7	89.4	82.9	290.4	54.7	190.4	175.4	213.4	263.3	118.3	179.0	145.8	181.6	17.6	261.9	25.0	30.2	190.9	331.7	98.1	104.1	94.0	150.6	102.5	123.1	144.2	109.4	146.2	92.3	127.4	104.8	90.3	16.0	17.3	19.2	146.8	11.0	11.5	2.2	1.8	16.5	30.7	24.0	59.5	12.8	1.1	23.9	6.2	64.3	110.3	0.3	25.4	6.5	56.9	1.8	38.5	45.6	21.4	36.4	36.5	17.8	33.7	105.9	9.2	1.7	57.5	343.8	57.1	147.1	85.4	15.2	36.3	2.4	0.0	41.0	77.8	46.8	123.3	41.2	55.2	10.3	445.2	45.6	187.4	18.6	5.6	12.1	1.2	211.4	120.3	7.3	1.0	48.4	4.7	125.8	230.1	55.3	150.6	2.5	1.5	0.6	8.1	177.2	143.4	149.4	2.5	1.5
APBB1	"Fe65, RIR"	ENSG00000166313	"Amyloid beta precursor protein binding family B member 1"	O00213	11	6395124-6419414	"Plasma proteins, Predicted intracellular proteins"	"Apoptosis, DNA damage, Transcription, Transcription regulation"	"Activator, Chromatin regulator, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 152.9"	"Cell type enhanced"	"Detected in many"		"Oligodendrocytes: 102.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"naive CD4 T-cell: 85.6"	"Lineage enriched"	"Detected in all"	5	"T-cells: 85.6"	"Cell line enhanced"	"Detected in many"		"SCLC-21H: 68.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038521, HPA038522"	Approved		Supported	"Plasma membrane"		NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 70: Brain - Nervous system development"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 58: T-cells - T-cell receptor"	"Plasma membrane"		"HPA038521: AB_2676058, HPA038522: AB_2676059"	"unprognostic (4.76e-2)"	"unprognostic (1.98e-1)"	"unprognostic (4.46e-3)"	"unprognostic (1.97e-2)"	"unprognostic (6.84e-2)"	"unprognostic (1.75e-1)"	"prognostic unfavorable (2.44e-4)"	"unprognostic (7.30e-2)"	"unprognostic (3.22e-3)"	"unprognostic (2.36e-1)"	"prognostic favorable (1.86e-5)"	"unprognostic (2.21e-1)"	"prognostic favorable (7.44e-13)"	"unprognostic (1.32e-2)"	"unprognostic (2.71e-2)"	"unprognostic (1.91e-1)"	"unprognostic (1.09e-2)"	18.1	23.8	101.7	11.9	119.4	2.7	18.0	116.6	121.1	39.5	65.1	43.3	7.0	43.5	4.3	14.9	38.3	11.4	42.0	123.3	105.3	21.5	3.8	22.5	13.9	123.9	106.0	39.2	16.3	21.4	61.3	8.6	135.0	23.7	4.7	23.3	13.4	25.9	42.3	12.2	19.2	33.2	109.4	13.8	19.4	12.7	112.1	28.9	19.1	54.0	11.1	31.2	23.5	152.9	0.0	14.9	50.6	22.8	26.7	27.4	0.2	24.6	41.7	41.2	51.4	26.4	10.3	0.0	3.6	44.3	36.9	0.5	44.4	7.5	19.4	27.8	33.7	0.3	9.3	0.9	19.3	0.2	9.9	24.8	1.9	19.4	2.9	35.3	51.7	1.2	1.1	0.7	15.3	0.5	0.5	0.1	18.3	0.8	15.5	0.2	2.0	0.2	1.7	0.2	68.1	37.6	3.6	3.0	15.9	15.2	2.1	3.4	22.8	4.2	24.8	27.5	5.0	13.8	6.8	2.0	21.1	0.0	14.3	8.4	1.7	0.3	23.2	1.5	25.2	6.7	32.5	30.2	1.7	16.2	85.6	51.7	1.6	16.5	0.6	0.3	48.7	29.9	101.7	119.4	116.6	121.1	123.3	105.3	123.9	106.0	135.0	109.4	112.1	152.9	9.6	19.2	5.4	22.9	7.5	5.0	12.1	3.6	12.0	45.8	6.6	5.7	50.5	11.5	5.4	5.5	22.9	0.4	4.6	1.1	25.4	18.2	5.6	7.6	9.5	13.9	19.3	4.0	47.1	4.2	0.7	15.2	4.6	2.3	1.3	10.8	15.7	3.3	1.2	40.4	44.8	1.2	0.0	1.9	4.0	13.1	9.6	1.8	8.8	7.5	3.2	24.7	9.2	49.3	102.3	8.0	1.7	19.2	1.4	8.3	0.4	21.6	17.3	20.1	6.6	10.0	17.3	6.9	13.7	3.2	2.8	0.8	20.1	7.0	1.3	5.4
ARHGAP1	"CDC42GAP, p50rhoGAP, RhoGAP"	ENSG00000175220	"Rho GTPase activating protein 1"	Q07960	11	46677080-46700619	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Oligodendrocytes: 92.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004689, HPA008285"	Approved	Approved	Approved	Vesicles		NA	NA		11000000	"Cluster 51: Monocytes - Innate immune response"	"Cluster 46: Fibroblasts - ECM organization"	"Cluster 18: U-2197 - ECM organization"	"Cluster 48: Smooth muscle cells - ECM organization"	Vesicles		"HPA004689: AB_1078194, HPA008285: AB_1078195"	"unprognostic (1.06e-1)"	"unprognostic (2.73e-1)"	"unprognostic (2.05e-3)"	"unprognostic (5.19e-2)"	"unprognostic (2.48e-2)"	"unprognostic (9.07e-2)"	"prognostic unfavorable (2.14e-4)"	"unprognostic (1.34e-3)"	"unprognostic (1.24e-1)"	"unprognostic (7.96e-2)"	"unprognostic (1.35e-2)"	"unprognostic (4.94e-1)"	"unprognostic (4.79e-2)"	"unprognostic (4.13e-2)"	"unprognostic (3.49e-2)"	"unprognostic (2.55e-1)"	"unprognostic (9.24e-2)"	84.5	49.2	40.9	38.0	48.3	33.4	61.8	33.4	46.1	71.3	31.2	62.8	25.7	93.7	21.5	75.0	68.4	50.7	112.3	39.1	41.0	41.5	46.2	38.4	30.7	45.7	43.2	46.4	36.5	24.7	36.8	39.0	39.0	64.9	32.6	9.6	46.1	62.6	30.0	65.3	46.7	80.6	38.0	58.4	49.0	15.8	49.8	23.2	44.6	20.5	34.6	107.9	63.4	57.4	23.0	56.7	27.9	39.8	135.4	99.6	32.9	50.3	50.7	45.3	41.2	34.2	29.5	33.1	26.7	102.3	40.7	55.8	22.4	76.0	33.5	23.3	24.6	36.8	27.7	40.4	44.5	31.3	52.3	131.9	46.7	34.5	42.9	46.8	39.1	27.1	24.3	30.3	55.9	82.6	21.2	30.9	72.1	78.5	29.4	25.0	39.9	49.3	42.3	85.2	10.0	31.6	45.8	69.8	19.1	40.1	88.0	35.4	49.1	82.1	25.5	98.7	51.0	32.0	38.2	24.8	77.4	52.0	39.3	27.6	33.0	33.1	26.7	56.9	19.3	14.3	20.8	22.8	32.3	14.7	17.9	20.8	37.3	23.7	72.0	34.1	27.4	24.9	40.9	48.3	33.4	46.1	39.1	41.0	45.7	43.2	39.0	38.0	49.8	57.4	25.2	19.2	18.7	16.6	18.3	8.5	13.4	24.6	10.8	11.9	22.3	24.6	50.2	10.0	18.1	29.5	27.1	25.1	35.2	35.2	3.9	22.2	0.4	17.9	26.9	19.6	19.4	15.3	13.0	27.9	31.0	29.2	31.6	27.6	19.6	21.3	25.7	32.1	30.4	16.8	15.3	36.0	14.2	30.7	8.4	1.7	23.6	19.1	8.8	11.2	28.2	11.0	36.0	23.1	92.3	27.3	19.2	35.3	10.1	11.4	22.4	13.3	10.9	14.2	59.2	28.0	55.9	3.1	3.5	24.7	13.1	16.6	19.9	9.4	21.5	18.7
BCL2L2	"BCL-W, KIAA0271, PPP1R51"	ENSG00000129473	"BCL2 like 2"	Q92843	14	23298790-23311751	"Cancer-related genes, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	Apoptosis		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"CAB040539, HPA048740"	Approved		Uncertain	Nucleoplasm		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 45: Intestine - Brush border"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 29: Early spermatids - Spermatogenesis"	Nucleoplasm		"CAB040539: , HPA048740: "	"unprognostic (8.23e-3)"	"unprognostic (9.85e-2)"	"unprognostic (1.71e-2)"	"unprognostic (6.08e-2)"	"unprognostic (2.04e-1)"	"unprognostic (1.64e-1)"	"unprognostic (3.47e-3)"	"unprognostic (1.53e-2)"	"unprognostic (1.78e-1)"	"unprognostic (2.91e-3)"	"unprognostic (1.50e-3)"	"unprognostic (2.60e-1)"	"prognostic favorable (1.99e-6)"	"unprognostic (2.44e-1)"	"unprognostic (2.00e-1)"	"unprognostic (6.60e-2)"	"unprognostic (5.38e-2)"	48.5	36.6	102.4	26.0	95.3	13.9	35.6	83.7	112.4	30.2	61.8	86.9	28.5	43.0	30.5	46.8	35.4	24.7	37.3	89.8	88.8	35.0	20.9	34.6	13.9	94.8	94.0	31.8	53.3	52.9	38.1	23.8	91.7	47.4	31.8	51.9	52.2	45.5	24.2	46.5	34.3	41.5	101.0	20.5	54.2	25.1	108.3	10.7	38.5	19.9	16.4	55.6	34.9	92.4	24.1	23.0	25.6	19.0	43.4	39.2	19.3	43.9	28.5	21.8	24.9	16.3	42.6	16.8	14.2	26.6	27.4	43.9	15.9	28.1	29.4	8.9	12.7	18.4	44.4	30.3	26.6	20.7	30.0	30.3	54.0	17.6	27.1	30.6	18.6	2.9	17.3	18.0	27.8	17.8	1.6	14.5	8.0	33.4	41.3	12.8	28.1	8.2	19.7	45.5	31.7	18.0	20.8	31.3	31.2	15.6	20.6	15.5	37.1	35.1	24.8	27.6	23.1	22.0	12.7	2.2	21.6	16.0	43.5	0.0	0.4	0.0	0.0	0.3	0.0	0.2	0.0	0.0	0.3	0.1	0.0	0.0	0.1	0.0	0.2	0.2	0.0	0.3	102.4	95.3	83.7	112.4	89.8	88.8	94.8	94.0	91.7	101.0	108.3	92.4	9.2	9.6	13.1	0.0	2.6	8.7	9.5	12.7	5.7	20.0	11.0	8.0	28.9	4.3	13.6	5.5	25.0	5.3	3.5	16.8	13.7	8.0	20.1	11.1	10.4	10.8	18.6	2.1	0.0	18.3	4.0	10.4	9.7	12.1	5.7	12.0	11.4	7.2	5.5	20.2	0.0	16.8	6.1	8.4	4.0	6.1	11.1	5.5	7.2	0.0	7.5	7.4	2.1	0.0	0.0	25.5	11.0	21.4	4.5	17.2	16.3	9.2	12.2	12.7	6.6	12.6	15.5	0.5	0.9	10.8	11.1	5.6	1.5	8.9	10.5	17.6
BCL7B		ENSG00000106635	"BAF chromatin remodeling complex subunit BCL7B"	Q9BQE9	7	73536356-73557690	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Apoptosis, Differentiation, Wnt signaling pathway"		"Allergen, Williams-Beuren syndrome"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA049943, HPA058069"	Approved		Approved	Nucleoplasm		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 22: Epithelial cell types - Mixed function"	Nucleoplasm		"HPA049943: AB_2680963, HPA058069: AB_2683594"	"unprognostic (2.79e-2)"	"unprognostic (2.87e-1)"	"unprognostic (1.93e-2)"	"unprognostic (1.04e-1)"	"unprognostic (3.54e-3)"	"unprognostic (1.12e-1)"	"unprognostic (2.91e-2)"	"unprognostic (4.84e-2)"	"unprognostic (1.35e-1)"	"unprognostic (2.73e-1)"	"unprognostic (5.37e-2)"	"unprognostic (9.43e-2)"	"prognostic favorable (4.38e-4)"	"unprognostic (4.09e-1)"	"unprognostic (3.55e-1)"	"unprognostic (5.41e-2)"	"unprognostic (1.32e-1)"	35.6	23.8	34.9	18.7	35.0	90.0	18.5	28.1	43.5	16.3	28.3	32.6	21.8	15.5	17.4	27.5	16.6	22.5	49.5	36.5	34.1	21.9	25.1	27.4	24.4	30.6	31.2	9.0	25.6	30.3	20.9	21.7	29.7	17.8	16.4	17.7	16.0	23.5	66.0	11.1	23.6	29.8	28.3	23.0	20.6	20.5	33.4	22.4	22.1	55.8	19.4	33.4	11.4	34.3	67.8	46.9	26.7	47.8	21.5	34.0	27.1	56.1	58.9	58.0	52.9	52.0	73.8	56.7	14.0	58.7	84.7	30.4	19.4	45.7	42.7	73.9	27.5	31.5	28.7	28.0	61.3	54.3	85.3	22.8	45.0	59.5	58.7	23.9	38.4	31.7	50.6	65.0	41.6	79.5	93.0	71.2	46.5	43.0	67.7	49.2	28.6	67.6	46.5	51.8	59.7	57.9	49.6	85.0	62.3	11.3	53.0	73.3	39.6	69.8	44.7	47.9	84.1	37.0	35.9	105.2	68.7	82.8	89.0	13.7	13.3	19.7	11.4	15.8	13.8	11.7	13.1	15.3	13.5	17.6	13.7	11.1	6.5	21.2	20.3	15.9	11.4	8.3	34.9	35.0	28.1	43.5	36.5	34.1	30.6	31.2	29.7	28.3	33.4	34.3	50.4	32.1	20.7	6.8	59.8	64.6	81.9	18.7	39.3	27.5	37.4	32.1	29.5	24.3	17.5	16.5	6.2	72.5	55.9	63.3	54.8	46.7	8.0	35.4	16.8	37.3	34.6	17.9	10.3	45.8	43.6	30.4	21.9	31.6	32.4	21.5	34.2	18.1	51.0	42.1	8.8	40.6	32.6	37.5	46.4	6.7	25.7	48.3	32.0	6.5	41.1	32.4	62.8	6.0	10.0	67.9	58.3	30.5	35.7	61.6	50.4	47.0	15.7	21.8	46.0	52.4	46.7	64.1	71.6	28.7	57.7	101.8	58.3	27.3	37.6	74.1
BLVRA	BLVR	ENSG00000106605	"Biliverdin reductase A"	P53004	7	43758680-43807342	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Hofbauer cells: 259.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019709, HPA042865, HPA054322"	Approved		Supported	Cytosol		NA	NA		1200000	"Cluster 7: Monocytes - Unknown function"	"Cluster 68: Epididymis - Unknown function"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 4: Macrophages - Innate immune response"	Cytosol		"HPA019709: AB_2670239, HPA042865: AB_10797024, HPA054322: AB_2682450"	"unprognostic (2.47e-2)"	"unprognostic (8.38e-3)"	"unprognostic (1.79e-2)"	"unprognostic (2.16e-3)"	"unprognostic (6.45e-3)"	"unprognostic (5.01e-2)"	"unprognostic (1.63e-2)"	"prognostic favorable (8.65e-4)"	"unprognostic (1.42e-1)"	"unprognostic (1.75e-2)"	"unprognostic (2.93e-1)"	"unprognostic (9.27e-2)"	"unprognostic (1.15e-2)"	"unprognostic (5.63e-3)"	"unprognostic (3.18e-1)"	"unprognostic (2.13e-3)"	"unprognostic (4.56e-2)"	53.2	28.0	31.4	39.7	33.4	65.6	49.9	32.0	40.1	44.3	31.4	61.4	12.5	38.5	129.9	67.5	40.9	33.4	52.7	32.3	34.7	41.3	14.6	62.7	58.6	34.1	33.6	46.6	23.5	54.9	26.2	28.9	34.2	38.4	19.8	25.4	36.5	46.0	59.7	33.4	27.7	54.1	33.1	82.0	35.3	13.1	34.0	43.0	31.3	69.3	52.6	43.5	40.4	32.0	48.6	92.2	26.2	110.5	55.0	72.7	1.3	32.3	99.3	54.0	65.4	22.2	28.3	0.3	60.6	51.5	190.7	62.1	82.1	81.7	46.2	227.3	56.8	104.1	86.6	138.1	139.5	11.8	37.5	49.9	135.7	57.2	37.8	108.5	92.7	51.1	70.2	55.7	41.4	52.5	37.0	6.3	35.9	11.0	104.7	80.4	45.6	261.4	121.1	26.6	34.0	104.4	65.9	65.1	55.2	46.2	146.7	77.7	57.0	49.3	53.9	21.8	56.0	74.7	63.2	0.2	80.8	46.9	78.4	51.1	291.9	169.2	39.1	374.9	36.7	26.9	75.7	64.9	135.4	17.0	39.7	31.0	26.5	22.4	368.4	20.1	82.2	208.5	31.4	33.4	32.0	40.1	32.3	34.7	34.1	33.6	34.2	33.1	34.0	32.0	22.0	60.9	85.0	7.5	10.7	29.1	64.2	102.4	34.1	18.0	29.6	36.1	59.4	17.2	75.7	35.0	2.1	9.7	9.3	0.3	56.7	52.6	0.7	31.6	20.2	27.3	0.0	74.7	8.4	35.1	8.1	39.7	8.2	41.4	111.5	17.2	24.3	1.9	259.1	8.4	11.5	0.4	59.0	136.5	53.7	1.6	37.0	80.4	46.2	2.8	147.3	36.6	13.4	7.5	4.3	25.2	1.2	29.0	16.6	87.9	7.1	110.5	69.6	13.0	46.0	23.0	50.6	3.0	14.2	52.9	34.4	5.2	23.4	4.9	0.6	48.7
BNC2	"BSN2, FLJ20043"	ENSG00000173068	"Basonuclin 2"	Q6ZN30	9	16409503-16870843	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"		"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"endometrium 1: 26.9;ovary: 31.7;smooth muscle: 31.7"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 46.7;Leydig cells: 90.1;Microglial cells: 230.5;Peritubular cells: 67.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	5	"gdT-cell: 2.5"	"Lineage enriched"	"Detected in single"	5	"T-cells: 2.5"	"Cell line enhanced"	"Detected in many"		"HSkMC: 31.9;Karpas-707: 40.4;RPMI-8226: 28.0"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"HPA018525, HPA059419"	Approved		Supported	Nucleoplasm		NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 50: Fibroblasts - ECM organization"	Nucleoplasm		"HPA018525: AB_1845402, HPA059419: AB_2732637"	"unprognostic (2.68e-1)"	"unprognostic (2.89e-1)"	"unprognostic (3.64e-2)"	"unprognostic (1.14e-2)"	"unprognostic (1.56e-2)"	"unprognostic (5.07e-2)"	"unprognostic (2.81e-2)"	"unprognostic (2.50e-1)"	"unprognostic (1.94e-2)"	"unprognostic (6.05e-2)"	"unprognostic (5.99e-2)"	"unprognostic (3.87e-1)"	"unprognostic (1.15e-1)"	"unprognostic (1.36e-2)"	"unprognostic (1.62e-1)"	"unprognostic (6.74e-2)"	"unprognostic (1.14e-3)"	5.6	1.0	1.4	3.7	2.5	0.7	3.3	2.3	4.4	12.1	8.2	10.1	1.3	26.9	2.1	4.6	18.4	7.2	2.9	2.6	2.7	6.4	0.3	3.1	0.8	4.7	6.0	31.7	0.5	2.9	1.7	3.4	3.9	3.7	3.0	0.8	1.3	4.8	3.5	3.4	3.3	31.7	3.5	0.7	3.0	6.9	4.7	2.5	2.1	1.9	1.1	6.3	5.8	4.9	0.3	1.7	1.2	0.1	17.5	21.1	2.7	11.4	19.5	7.8	6.4	0.1	0.0	0.0	3.7	7.8	5.8	0.1	5.1	0.0	7.9	0.2	2.0	0.1	5.3	0.0	13.4	0.1	0.5	31.9	0.0	16.6	0.1	13.7	18.0	0.0	0.0	40.4	11.1	0.0	0.0	2.8	6.6	0.1	10.2	0.0	12.5	28.0	6.0	0.3	0.2	1.0	0.1	0.1	18.6	8.3	0.1	0.0	17.7	18.6	13.5	15.1	20.9	0.2	0.0	0.1	7.6	2.5	2.5	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.5	0.0	0.0	0.0	1.5	1.4	2.5	2.3	4.4	2.6	2.7	4.7	6.0	3.9	3.5	4.7	4.9	5.5	0.0	2.2	46.7	0.0	10.1	0.6	0.0	33.6	8.2	0.2	0.4	4.8	0.0	0.6	0.0	0.0	3.2	10.7	0.1	0.0	1.0	7.2	2.2	9.1	10.5	0.0	0.0	1.6	0.4	1.2	38.6	3.1	2.0	22.2	25.1	10.4	0.3	7.3	0.0	1.9	1.1	6.1	1.6	2.3	4.5	90.1	4.2	10.6	230.5	0.1	2.6	30.9	1.0	1.6	0.1	0.0	67.7	3.9	0.7	5.7	35.5	0.7	0.3	6.6	31.5	5.1	0.9	13.5	5.7	5.5	1.2	3.1	36.5	1.8	0.1
C20orf194	DKFZp434N061	ENSG00000088854	"Chromosome 20 open reading frame 194"	Q5TEA3	20	3249306-3407669	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 226.9;Cone photoreceptor cells: 202.3;Excitatory neurons: 205.6;Inhibitory neurons: 163.1;Oligodendrocyte precursor cells: 135.7;Oligodendrocytes: 191.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA052103, HPA067418"	Approved		Approved	"Nucleoli fibrillar center,Cytosol"		No	No			"Cluster 41: Basophils - Cellular respiration"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Nucleoli fibrillar center, Cytosol"		"HPA052103: AB_2681727, HPA067418: AB_2685835"	"unprognostic (9.77e-2)"	"unprognostic (8.39e-2)"	"unprognostic (5.03e-3)"	"unprognostic (1.83e-1)"	"unprognostic (1.18e-1)"	"unprognostic (4.26e-2)"	"unprognostic (1.66e-2)"	"unprognostic (7.64e-2)"	"unprognostic (6.41e-2)"	"unprognostic (1.68e-1)"	"prognostic favorable (1.68e-4)"	"unprognostic (2.97e-1)"	"prognostic favorable (7.68e-4)"	"unprognostic (9.58e-3)"	"unprognostic (3.70e-1)"	"unprognostic (2.00e-1)"	"unprognostic (7.52e-2)"	11.8	9.5	19.7	5.2	22.4	3.6	8.7	18.5	20.1	10.1	6.8	14.4	4.1	10.4	5.4	8.4	9.8	8.3	15.3	19.5	21.4	11.2	2.6	10.0	4.5	21.5	22.9	12.3	6.3	4.2	8.8	9.1	21.1	8.6	4.3	16.4	5.8	11.6	32.3	5.6	6.6	12.9	19.6	7.3	9.7	10.4	21.8	3.8	9.6	11.6	2.9	12.6	8.9	26.0	4.0	3.6	9.7	4.7	19.7	21.6	1.1	9.2	10.3	6.0	7.5	0.0	4.3	0.0	2.5	12.3	7.7	4.7	3.7	9.1	8.2	0.9	1.8	1.1	1.4	10.0	9.2	1.2	0.5	17.7	6.9	7.9	6.8	8.6	12.2	3.5	2.0	0.0	8.9	1.8	2.5	6.5	2.9	2.2	2.3	2.9	8.8	0.1	7.8	8.1	1.9	5.7	4.1	7.2	12.0	8.3	6.8	11.3	13.7	7.5	3.2	4.7	4.5	0.1	0.0	0.0	2.4	1.2	5.8	0.4	0.8	0.0	0.5	0.4	0.2	0.2	0.3	0.4	0.9	0.4	0.1	0.3	0.0	0.0	0.4	1.0	0.4	0.2	19.7	22.4	18.5	20.1	19.5	21.4	21.5	22.9	21.1	19.6	21.8	26.0	23.6	28.9	9.2	226.9	3.7	6.9	6.7	10.8	8.6	35.1	10.1	10.8	28.5	15.7	10.3	12.9	202.3	1.8	8.9	0.1	1.9	9.1	31.8	10.6	15.9	20.1	0.0	4.0	205.6	4.7	5.4	13.4	19.4	12.1	14.0	53.3	25.7	2.3	19.6	30.3	163.1	0.5	4.1	34.0	25.5	8.9	19.9	22.4	8.8	89.9	14.1	10.0	3.1	135.7	191.2	9.4	14.8	13.5	1.5	5.4	7.4	8.4	21.8	13.9	13.1	18.4	22.2	28.5	25.0	7.2	5.7	1.8	7.8	16.4	1.4	5.2
CALU		ENSG00000128595	Calumenin	O43852	7	128739292-128773400	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Extravillous trophoblasts: 504.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"fHDF/TERT166: 2467.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA006018	Supported		Supported	"Endoplasmic reticulum"	"Intracellular and membrane"	NA	NA		21000000	"Cluster 27: Non-specific - Gene expression"	"Cluster 46: Fibroblasts - ECM organization"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 38: Extravillous trophoblasts - Unknown function"	"Endoplasmic reticulum"		"HPA006018: AB_1845934"	"unprognostic (7.22e-3)"	"unprognostic (1.16e-3)"	"unprognostic (3.16e-1)"	"unprognostic (8.86e-2)"	"unprognostic (1.27e-1)"	"unprognostic (9.52e-3)"	"prognostic unfavorable (1.80e-4)"	"unprognostic (1.05e-3)"	"unprognostic (1.95e-1)"	"unprognostic (1.38e-1)"	"unprognostic (2.75e-3)"	"unprognostic (2.31e-1)"	"prognostic unfavorable (1.30e-11)"	"unprognostic (3.80e-3)"	"unprognostic (1.66e-1)"	"unprognostic (1.45e-1)"	"prognostic unfavorable (4.60e-5)"	115.8	56.6	20.6	137.9	22.7	22.8	66.2	22.8	28.5	133.5	54.7	97.5	37.6	113.6	61.1	60.4	57.1	92.7	236.9	24.5	23.5	45.1	74.2	68.5	38.8	24.1	22.2	54.8	52.6	85.0	28.8	211.8	24.2	113.0	81.3	19.6	67.7	150.1	82.1	29.9	40.0	328.4	22.3	47.5	62.5	39.8	33.2	31.0	77.1	117.1	45.2	160.1	48.2	26.6	257.8	207.4	486.6	152.7	1348.5	1229.5	270.9	1821.7	1378.1	577.5	770.7	238.6	388.3	100.0	351.5	2467.8	850.4	144.9	258.2	318.2	826.5	80.6	138.2	136.6	283.7	295.0	657.1	187.2	254.3	930.5	223.6	868.3	370.6	904.4	537.3	116.4	237.9	172.8	1131.8	141.0	130.2	95.5	305.2	247.0	197.3	122.9	333.3	164.5	243.5	132.7	44.3	238.2	595.4	481.5	753.1	932.2	106.2	145.6	799.8	1706.6	234.2	1350.8	754.6	306.8	385.7	224.8	1478.6	223.6	1857.2	21.7	38.8	23.5	28.3	41.4	27.9	23.7	19.5	22.0	33.4	16.6	17.1	20.0	4.5	26.2	35.7	32.9	23.4	31.2	20.6	22.7	22.8	28.5	24.5	23.5	24.1	22.2	24.2	22.3	33.2	26.6	67.3	22.4	38.5	25.5	29.9	81.3	68.1	82.0	31.3	28.2	51.7	42.7	247.0	25.8	62.7	25.8	18.8	116.8	25.0	14.4	17.6	69.5	11.4	37.5	186.3	104.0	19.7	42.3	37.7	60.5	504.7	198.8	37.2	72.8	59.6	62.6	113.2	54.2	136.9	28.6	47.0	55.9	22.4	58.9	70.7	9.3	100.3	44.6	120.9	27.2	26.3	32.4	21.6	31.2	32.2	71.5	11.4	118.8	140.9	110.6	12.6	17.7	57.2	12.8	59.2	64.9	162.8	27.1	41.9	30.9	76.9	243.0	30.9	69.7	26.1	90.5
CDC42BPA	"FLJ23347, KIAA0451, MRCK, MRCKA, PK428"	ENSG00000143776	"CDC42 binding protein kinase alpha"	Q5VT25	1	226989865-227318474	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 320.3;Excitatory neurons: 447.6;Inhibitory neurons: 479.0;Oligodendrocyte precursor cells: 444.3;Oligodendrocytes: 671.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB070414, HPA071252"	Approved		Approved	"Intermediate filaments"		NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 78: Testis - Spermatogenesis"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	"Intermediate filaments"		"CAB070414: AB_11156796, HPA071252: AB_2686374"	"unprognostic (3.67e-3)"	"unprognostic (1.45e-1)"	"unprognostic (1.10e-1)"	"unprognostic (2.78e-2)"	"unprognostic (3.04e-1)"	"unprognostic (5.90e-2)"	"unprognostic (7.89e-2)"	"unprognostic (2.27e-1)"	"unprognostic (1.46e-1)"	"unprognostic (3.93e-1)"	"unprognostic (4.88e-2)"	"unprognostic (2.87e-2)"	"unprognostic (7.73e-3)"	"unprognostic (1.35e-1)"	"unprognostic (1.70e-1)"	"unprognostic (9.79e-2)"	"unprognostic (1.21e-2)"	15.6	12.5	26.3	5.5	32.4	3.5	12.2	33.5	30.0	15.8	12.2	21.2	14.7	15.0	7.7	10.1	12.6	13.7	16.4	24.9	25.2	17.3	14.7	12.3	2.0	25.7	26.8	14.0	13.1	19.7	14.6	12.7	27.0	15.8	10.3	23.7	7.6	14.9	11.4	6.3	12.9	14.5	19.8	6.6	22.4	24.4	29.7	2.2	8.1	13.6	1.8	23.0	11.3	37.0	22.6	21.1	21.9	10.4	21.5	26.4	7.7	25.4	35.7	17.2	17.9	17.1	50.1	0.1	26.6	42.4	13.0	10.3	16.3	14.2	20.9	0.1	13.2	17.4	25.5	6.7	24.3	14.1	7.5	18.6	17.9	27.8	27.8	21.3	58.0	13.6	45.1	0.1	28.2	6.2	0.4	2.5	18.0	29.3	20.0	0.0	37.0	0.1	27.7	43.1	15.7	22.9	43.0	17.8	24.8	13.4	23.1	0.8	59.0	31.3	16.2	36.1	33.9	0.1	0.1	0.1	41.4	0.0	42.7	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	26.3	32.4	33.5	30.0	24.9	25.2	25.7	26.8	27.0	19.8	29.7	37.0	82.6	41.7	35.7	320.3	0.8	11.7	26.0	15.9	12.0	97.7	14.0	12.8	59.9	30.0	38.9	44.1	118.9	5.9	1.8	49.3	13.7	26.0	128.0	18.7	45.1	68.4	26.4	45.6	447.6	41.1	7.3	44.4	92.8	25.7	7.0	21.5	47.8	28.9	3.7	223.8	479.0	30.5	22.4	4.4	9.9	132.3	44.1	6.4	16.0	180.8	5.9	33.4	0.0	444.3	671.8	65.1	74.0	85.4	1.8	30.1	50.7	41.3	24.8	66.9	78.9	64.0	68.4	45.6	57.7	8.0	8.0	1.4	1.3	23.4	34.4	43.1
CDR2	"CDR62, Yo"	ENSG00000140743	"Cerebellar degeneration related protein 2"	Q01850	16	22345936-22437165	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Rod photoreceptor cells: 70.2;Spermatocytes: 50.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"granulocytes: 8.4;NK-cells: 2.5;T-cells: 6.5"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA018151, HPA023870"	Uncertain		Approved	Nucleoplasm		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 77: Retina - Visual perception"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 46: Photoreceptor cells - Phototransduction"	Nucleoplasm		"HPA018151: AB_1846457, HPA023870: AB_1846459"	"unprognostic (7.89e-2)"	"unprognostic (1.55e-1)"	"unprognostic (5.23e-2)"	"unprognostic (3.09e-1)"	"unprognostic (6.59e-2)"	"unprognostic (1.27e-2)"	"unprognostic (5.76e-2)"	"unprognostic (2.75e-1)"	"unprognostic (2.55e-1)"	"unprognostic (1.06e-1)"	"unprognostic (9.86e-2)"	"unprognostic (3.04e-1)"	"unprognostic (2.04e-2)"	"unprognostic (3.34e-3)"	"unprognostic (1.38e-2)"	"unprognostic (5.78e-2)"	"unprognostic (1.67e-3)"	19.1	12.0	9.5	19.0	17.7	23.9	14.6	13.6	10.9	18.8	32.0	22.5	28.6	17.8	10.3	12.1	15.9	22.2	14.3	9.8	9.5	25.0	22.9	21.6	25.4	8.6	7.6	14.9	13.9	13.2	21.8	15.0	8.5	20.7	19.3	74.0	15.7	23.1	5.9	10.6	22.1	27.2	5.0	18.7	17.5	62.0	10.5	28.2	49.0	5.6	19.3	29.2	14.0	8.3	38.9	26.8	22.8	24.2	55.2	47.4	23.9	36.4	57.0	36.7	48.4	35.3	25.9	33.3	19.3	62.4	22.2	36.5	49.2	20.8	43.0	26.2	25.1	25.3	29.4	111.0	63.4	27.6	49.6	35.6	18.8	36.2	40.3	46.3	46.2	42.6	25.1	53.3	35.4	28.0	27.8	20.0	32.4	32.3	22.0	40.1	29.4	49.5	45.7	24.8	17.5	12.5	24.8	51.9	36.4	25.7	15.4	13.7	31.9	36.2	22.9	34.5	32.9	27.6	49.7	46.9	23.8	27.1	31.7	8.4	0.8	1.2	1.6	0.7	3.6	0.9	5.3	3.4	0.9	0.6	4.1	3.5	0.7	2.5	0.9	1.1	6.5	1.7	9.5	17.7	13.6	10.9	9.8	9.5	8.6	7.6	8.5	5.0	10.5	8.3	18.2	3.2	5.1	3.6	8.7	34.0	17.3	4.3	15.4	8.9	27.4	9.1	3.5	10.0	7.0	9.2	14.6	1.7	12.7	22.0	1.9	8.7	36.7	6.9	10.0	13.9	6.6	17.2	8.0	7.1	10.8	19.6	19.4	12.0	0.0	9.6	10.0	9.5	9.4	8.4	10.5	16.1	6.1	5.0	11.5	8.8	6.8	7.4	10.6	2.8	4.0	10.1	4.1	3.5	2.2	13.8	12.2	10.9	24.9	19.4	22.4	12.4	4.9	70.2	6.6	9.7	15.8	50.9	16.1	8.7	24.3	1.4	25.8	2.7	7.8	14.8
CDS2		ENSG00000101290	"CDP-diacylglycerol synthase 2"	O95674	20	5126879-5197887	"Enzymes, Metabolic proteins, Plasma proteins, Predicted membrane proteins"	"Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism"	"Nucleotidyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"U-266/84: 160.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA019698	Approved		Approved	"Endoplasmic reticulum"		No	No			"Cluster 38: Basophils - Unknown function"	"Cluster 44: Heart - Cardiac muscle contraction"	"Cluster 16: U-266 - Nucleosome"	"Cluster 48: Smooth muscle cells - ECM organization"	"Endoplasmic reticulum"		"HPA019698: AB_1846464"	"unprognostic (4.59e-2)"	"unprognostic (1.98e-1)"	"unprognostic (2.39e-1)"	"unprognostic (3.37e-2)"	"unprognostic (1.15e-1)"	"unprognostic (1.99e-1)"	"unprognostic (1.44e-1)"	"unprognostic (3.22e-1)"	"unprognostic (1.71e-2)"	"unprognostic (1.48e-1)"	"unprognostic (3.35e-3)"	"unprognostic (1.65e-1)"	"prognostic favorable (3.53e-9)"	"unprognostic (8.89e-2)"	"unprognostic (3.53e-1)"	"unprognostic (1.38e-1)"	"unprognostic (2.44e-1)"	14.3	13.8	30.0	9.1	32.4	13.0	10.6	22.9	28.6	10.5	2.1	13.0	5.2	11.5	8.2	9.2	10.7	8.9	24.8	30.3	34.6	14.6	12.8	13.4	8.8	27.2	36.1	9.3	6.5	17.3	14.4	9.9	37.4	13.4	10.7	31.5	7.6	16.7	9.7	5.9	10.1	18.0	18.8	9.4	10.6	11.7	42.5	13.3	12.5	12.7	12.6	10.8	7.7	21.7	25.4	27.4	28.1	13.7	16.4	14.9	11.7	13.9	28.5	22.7	32.2	17.8	23.8	19.8	6.8	26.4	41.1	36.5	23.1	29.5	23.9	18.4	6.8	23.5	7.9	27.0	15.3	13.9	8.1	12.8	16.1	29.8	11.5	20.3	30.7	26.5	11.6	23.9	21.4	4.6	30.1	5.7	12.1	12.4	7.6	25.0	22.5	9.4	14.5	25.0	11.4	15.5	15.3	26.2	34.6	33.8	16.4	6.7	25.4	15.6	11.6	14.1	14.0	20.8	160.2	15.9	7.4	11.7	8.1	55.3	17.3	21.2	15.2	14.7	16.6	12.1	15.6	17.3	13.8	11.4	12.0	11.8	49.7	12.0	13.4	10.9	19.5	23.7	30.0	32.4	22.9	28.6	30.3	34.6	27.2	36.1	37.4	18.8	42.5	21.7	43.3	19.2	15.7	36.9	36.2	17.6	30.3	33.0	14.2	60.1	17.7	14.4	55.2	18.6	19.6	33.1	95.9	22.2	29.6	15.3	5.9	33.1	71.6	20.1	14.0	42.3	10.7	14.9	39.3	22.7	40.0	17.9	15.3	21.5	21.0	20.5	27.8	21.7	60.8	43.7	52.0	12.4	12.2	36.6	26.1	33.3	16.1	31.5	32.0	21.5	38.7	21.9	28.8	28.6	56.1	31.7	20.3	24.8	48.9	23.1	15.7	13.2	23.5	65.5	19.7	19.7	52.1	26.8	34.7	14.8	15.3	16.3	36.7	13.0	13.1	29.1
CHRDL1	"CHL, MGC1, NRLN1"	ENSG00000101938	"Chordin like 1"	Q9BU40	X	110673856-110795819	"Disease related genes, Human disease related genes, Predicted secreted proteins"	"Differentiation, Neurogenesis, Osteogenesis"	"Developmental protein"	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"seminal vesicle: 224.4"	"Group enriched"	"Detected in many"	4	"Astrocytes: 50.3;Fibroblasts: 83.8;Leydig cells: 41.0;Muller glia cells: 81.6"	"Cancer enhanced"	"Detected in many"		"prostate cancer: 16.7"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	9	"ASC diff: 537.8;ASC TERT1: 724.7;hTERT-RPE1: 341.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000226, HPA000250"	Approved				"Secreted in other tissues"	NA	NA		610000	"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 46: Fibroblasts - ECM organization"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"			"HPA000226: AB_1078522, HPA000250: AB_1078521"	"unprognostic (5.13e-2)"	"unprognostic (6.31e-2)"	"unprognostic (8.50e-3)"	"unprognostic (2.48e-3)"	"unprognostic (1.99e-2)"	"unprognostic (1.72e-2)"	"unprognostic (7.26e-3)"	"unprognostic (1.42e-2)"	"unprognostic (4.89e-2)"	"unprognostic (5.54e-2)"	"unprognostic (3.43e-2)"	"unprognostic (3.56e-1)"	"prognostic unfavorable (2.36e-4)"	"unprognostic (4.75e-3)"	"unprognostic (7.91e-2)"	"unprognostic (5.01e-2)"	"prognostic unfavorable (2.23e-4)"	188.3	7.3	7.1	26.2	14.5	0.9	69.8	8.3	14.1	38.8	6.5	74.8	10.8	148.2	20.2	58.0	53.5	47.9	22.0	9.4	6.2	15.1	1.8	76.3	24.4	4.4	4.5	7.1	12.5	84.9	6.4	21.9	4.0	141.6	35.5	55.6	23.3	224.4	6.1	17.5	22.1	101.3	4.3	16.0	17.9	6.5	5.8	10.9	37.8	34.9	11.7	28.3	20.0	6.3	0.0	0.1	3.3	0.0	537.8	724.7	0.3	7.6	3.3	18.8	16.1	0.0	0.0	0.0	0.0	0.7	0.0	0.0	23.0	0.0	17.6	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	58.7	0.1	1.6	0.0	341.2	0.0	2.0	0.0	0.0	0.1	0.0	1.0	0.3	21.3	0.0	0.0	0.0	0.0	0.1	3.0	0.0	1.7	5.2	0.0	0.0	0.4	1.4	0.0	0.0	0.0	5.8	4.2	60.4	7.8	0.1	0.1	0.0	5.9	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	7.1	14.5	8.3	14.1	9.4	6.2	4.4	4.5	4.0	4.3	5.8	6.3	8.4	0.0	2.7	50.3	0.1	4.8	0.0	0.0	0.6	1.5	0.3	0.4	2.3	0.0	1.8	1.8	0.0	0.1	0.1	0.0	0.0	0.3	0.3	0.0	1.0	13.8	0.0	0.0	4.2	0.0	0.1	83.8	2.0	0.2	1.3	0.3	2.2	0.1	0.2	0.0	9.3	0.0	0.0	0.0	8.1	1.4	41.0	1.1	8.8	1.0	0.0	81.6	0.0	13.6	0.2	0.0	0.0	9.1	1.4	0.3	0.0	4.1	1.5	2.9	0.0	2.7	11.2	0.2	8.2	0.3	4.4	0.1	1.0	0.0	0.0	0.1
CHRDL2	BNF1	ENSG00000054938	"Chordin like 2"	Q6WN34	11	74696429-74731426	"Predicted intracellular proteins, Predicted secreted proteins"	"Chondrogenesis, Differentiation, Osteogenesis"	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"endometrium 1: 145.1;gallbladder: 106.0;lymphoid tissue: 115.8;smooth muscle: 122.1"	"Cell type enhanced"	"Detected in some"		"Breast glandular cells: 194.1;Hepatocytes: 112.2;Skeletal myocytes: 533.4"	"Cancer enhanced"	"Detected in many"		"stomach cancer: 14.6"	"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HeLa: 2.4;PC-3: 1.3;SiHa: 2.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA021771, HPA076522"	Uncertain		Approved	Vesicles	"Secreted to extracellular matrix"	NA	NA		9700000		"Cluster 12: Smooth muscle tissue - Mixed function"	"Cluster 20: HeLa - Mitochondria"	"Cluster 30: Mammary glandular cells - Lactation"	Vesicles		"HPA021771: AB_1846689, HPA076522: "	"unprognostic (2.38e-2)"	"unprognostic (1.80e-1)"	"unprognostic (7.24e-2)"	"unprognostic (3.41e-3)"	"unprognostic (9.45e-2)"	"unprognostic (2.09e-1)"	"unprognostic (4.08e-2)"	"unprognostic (4.33e-2)"	"unprognostic (6.64e-2)"	"unprognostic (2.57e-1)"	"unprognostic (1.86e-1)"	"unprognostic (1.23e-1)"	"unprognostic (7.58e-6)"	"unprognostic (8.39e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.46e-1)"	"prognostic unfavorable (6.08e-4)"	2.7	0.2	0.6	115.8	0.4	0.0	5.1	0.4	0.7	64.7	0.1	88.7	4.1	145.1	0.8	4.1	9.4	106.0	24.4	0.4	0.6	5.2	46.3	2.9	0.4	1.0	0.6	2.5	3.1	0.4	0.4	4.5	0.7	22.6	2.6	0.5	0.5	8.9	6.6	1.2	10.8	122.1	2.3	1.3	57.7	3.4	0.7	0.0	0.9	4.8	2.8	46.3	21.2	0.2	0.0	0.1	0.2	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.2	0.3	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.4	2.4	0.3	0.0	0.5	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	1.3	0.0	0.2	0.0	0.0	0.0	0.0	0.1	2.5	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.1	0.0	0.2	0.2	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.6	0.4	0.4	0.7	0.4	0.6	1.0	0.6	0.7	2.3	0.7	0.2	1.2	0.0	2.6	0.7	0.3	0.3	0.5	0.2	0.0	0.0	194.1	3.8	2.2	15.7	0.1	9.2	0.0	0.0	0.8	0.0	0.0	13.8	31.4	0.6	0.2	2.1	0.0	0.0	0.1	10.3	0.1	5.3	0.0	0.5	0.0	0.2	2.9	112.2	0.1	0.0	0.2	0.0	0.0	2.4	0.0	2.4	0.0	1.1	0.0	1.0	0.0	0.0	0.0	0.5	0.1	4.1	0.0	0.7	0.1	0.9	0.0	0.0	0.0	0.0	0.0	533.4	1.2	0.6	4.3	0.0	0.0	0.1	0.5	0.4	0.0	0.5
CLIC4	"CLIC4L, DKFZP566G223, H1, huH1, P64H1"	ENSG00000169504	"Chloride intracellular channel 4"	Q9Y696	1	24745382-24844321	"Predicted intracellular proteins, Transporters"	"Ion transport, Transport"	"Chloride channel, Ion channel, Voltage-gated channel"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Proximal tubular cells: 346.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"memory B-cell: 13.4;naive B-cell: 11.9"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008019, HPA060804"	Enhanced		Supported	"Plasma membrane,Centrosome"		NA	NA		5800000	"Cluster 23: Antigen presenting cells - Antigen presentation"	"Cluster 46: Fibroblasts - ECM organization"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 48: Smooth muscle cells - ECM organization"	"Plasma membrane, Centrosome"		"HPA008019: AB_1846946, HPA060804: AB_2684370"	"unprognostic (7.35e-3)"	"prognostic unfavorable (8.31e-4)"	"unprognostic (5.54e-2)"	"unprognostic (7.60e-2)"	"unprognostic (2.92e-2)"	"unprognostic (9.48e-2)"	"unprognostic (6.78e-3)"	"unprognostic (1.63e-2)"	"unprognostic (5.50e-2)"	"unprognostic (4.03e-3)"	"unprognostic (1.98e-2)"	"unprognostic (7.01e-2)"	"prognostic favorable (1.48e-5)"	"unprognostic (2.75e-3)"	"unprognostic (2.17e-1)"	"unprognostic (1.22e-2)"	"unprognostic (3.82e-3)"	154.0	58.6	51.8	97.7	70.2	32.3	88.1	61.8	82.7	165.4	39.4	136.3	32.4	201.5	84.6	119.3	103.0	106.5	197.2	50.8	66.5	256.8	72.3	114.6	51.0	73.6	68.0	46.0	49.7	29.3	14.1	120.6	67.0	112.8	66.8	53.1	49.4	152.8	30.7	33.6	54.2	280.4	62.4	43.1	80.0	34.2	88.9	59.6	47.6	53.2	56.4	156.1	73.4	91.4	219.3	25.3	222.7	176.8	299.1	645.6	116.7	561.0	571.4	253.9	304.2	48.3	114.1	129.8	320.1	799.2	77.0	76.8	155.0	151.5	635.7	33.3	64.9	50.0	60.8	88.3	417.3	17.5	6.3	299.3	256.8	363.0	365.1	417.3	427.0	76.0	40.4	138.2	739.0	38.4	34.8	28.5	212.6	50.4	101.8	83.5	247.3	51.5	260.0	58.4	38.9	101.3	144.7	68.4	453.7	228.3	60.0	116.1	601.0	452.2	168.8	199.4	230.1	75.4	111.7	108.6	333.8	151.1	140.5	0.8	5.4	2.5	0.4	4.4	0.0	13.4	0.3	0.2	5.6	11.9	0.1	0.2	1.2	0.0	4.0	1.7	0.0	3.5	51.8	70.2	61.8	82.7	50.8	66.5	73.6	68.0	67.0	62.4	88.9	91.4	178.7	16.0	30.5	24.8	50.8	61.6	50.4	79.8	37.0	3.7	49.9	33.0	172.5	21.5	35.2	14.7	10.4	71.5	2.2	18.1	41.1	39.2	44.9	20.9	103.0	177.1	9.6	40.8	1.5	43.1	211.4	120.5	21.4	53.6	40.0	10.2	88.5	34.4	39.3	1.7	4.2	22.6	20.3	28.2	100.2	27.3	28.6	52.6	129.9	75.9	50.8	13.0	4.1	41.7	196.9	54.7	10.6	87.6	171.2	114.5	0.1	346.1	16.7	26.5	46.0	87.9	162.5	44.0	29.1	29.3	52.0	177.0	8.1	46.5	2.6	49.1
CLU	"APOJ, CLI, CLU1, CLU2, KUB1, SGP-2, SP-40, TRPM-2"	ENSG00000120885	Clusterin	P10909	8	27596917-27614700	"Cancer-related genes, Candidate cardiovascular disease genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Apoptosis, Complement pathway, Immunity, Innate immunity"	Chaperone	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 10230.8;liver: 9779.1"	"Group enriched"	"Detected in all"	4	"Cholangiocytes: 2586.5;Collecting duct cells: 3525.7;Hepatocytes: 4230.2;Muller glia cells: 8522.6"	"Cancer enhanced"	"Detected in all"		"glioma: 1485.6"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in many"	10	"basophil: 767.1"	"Lineage enriched"	"Detected in all"	33	"granulocytes: 767.1"	"Cell line enhanced"	"Detected in all"		"HeLa: 3644.3;SK-BR-3: 3500.4;T-47d: 2562.4;U-2 OS: 2225.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000572, CAB016253, HPA075983"	Enhanced		Supported	Cytosol	"Secreted to blood"	NA	NA	169000000000	29000000000	"Cluster 38: Basophils - Unknown function"	"Cluster 68: Epididymis - Unknown function"	"Cluster 20: HeLa - Mitochondria"	"Cluster 5: Muller glia cells - Visual perception"	Cytosol		"CAB016253: AB_673562, HPA000572: AB_1078539, HPA075983: "	"unprognostic (1.10e-2)"	"unprognostic (1.81e-2)"	"unprognostic (1.14e-3)"	"unprognostic (2.74e-2)"	"unprognostic (5.59e-2)"	"unprognostic (4.13e-2)"	"unprognostic (1.76e-2)"	"unprognostic (2.37e-1)"	"unprognostic (1.46e-1)"	"unprognostic (1.05e-1)"	"unprognostic (2.87e-2)"	"unprognostic (1.41e-1)"	"unprognostic (1.80e-2)"	"unprognostic (2.33e-2)"	"unprognostic (1.72e-1)"	"prognostic favorable (7.66e-5)"	"unprognostic (5.29e-2)"	1438.7	3809.7	6730.2	897.0	6536.5	53.2	1423.8	6992.3	8050.5	1389.4	6057.7	1407.9	323.9	1152.5	9148.8	768.6	3543.7	2863.5	617.7	6660.5	8149.9	1170.5	9779.1	827.8	2309.4	10230.8	8450.9	756.7	2246.3	1689.2	827.2	131.2	8001.8	986.4	276.1	3274.6	1453.0	5466.4	114.1	281.9	662.7	1439.9	8813.6	295.4	1081.6	2709.4	7385.0	388.1	2406.8	267.7	2343.1	1777.4	741.0	9752.3	13.0	1673.1	73.2	86.4	401.4	546.1	230.7	297.8	584.8	77.3	40.1	323.4	265.5	6.6	1159.9	267.1	926.6	561.2	318.4	48.1	50.3	1268.7	306.4	741.8	3644.3	403.7	348.8	19.2	1891.2	923.4	189.1	334.0	95.5	719.5	1028.1	10.6	10.1	842.2	27.5	288.4	5.7	56.5	603.3	505.3	197.6	6.5	276.1	236.3	763.0	1220.2	66.7	41.7	412.3	3500.4	18.1	349.1	2562.4	10.3	153.2	24.0	2225.3	131.8	101.9	108.1	419.0	16.1	1808.8	122.4	10.3	767.1	18.4	8.9	19.8	6.2	7.4	0.7	23.1	21.3	6.2	1.6	2.8	7.0	79.8	9.3	1.1	11.8	6.5	1073.6	6730.2	6536.5	6992.3	8050.5	6660.5	8149.9	10230.8	8450.9	8001.8	8813.6	7385.0	9752.3	255.3	32.1	91.8	720.5	16.1	81.3	944.6	134.1	118.9	74.3	475.3	480.4	86.1	2586.5	514.0	3525.7	77.2	116.3	15.2	23.6	41.1	488.3	311.3	196.9	31.1	442.0	9.5	92.4	73.4	620.7	22.7	614.8	226.8	185.6	803.0	31.4	1037.7	4230.2	12.6	30.3	81.0	30.9	28.5	180.5	88.9	789.3	114.3	244.6	206.3	69.3	25.1	8522.6	11.3	61.3	54.3	174.8	15.0	57.2	11.6	200.5	9.9	459.2	709.1	221.4	13.1	334.4	157.7	189.8	20.3	58.8	55.3	85.6	58.7	288.9	49.3	353.7
COL4A1		ENSG00000187498	"Collagen type IV alpha 1 chain"	P02462	13	110148963-110307157	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted secreted proteins"	Angiogenesis		"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"placenta: 900.3"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 401.4;Endometrial stromal cells: 312.2;Endothelial cells: 385.9;Extravillous trophoblasts: 672.4;Sertoli cells: 506.2;Smooth muscle cells: 415.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"neutrophil: 1.4"	"Lineage enriched"	"Detected in single"	6	"granulocytes: 1.4"	"Cell line enhanced"	"Detected in many"		"ASC diff: 501.6;EFO-21: 915.3;TIME: 331.3"	"Low region specificity"	"Detected in all"							CAB001695	Approved				"Secreted to extracellular matrix"	NA	NA		75000	"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 28: Placenta - Pregnancy"	"Cluster 38: EFO-21 - Unknown function"	"Cluster 48: Smooth muscle cells - ECM organization"			"CAB001695: "	"unprognostic (3.82e-2)"	"prognostic unfavorable (4.67e-4)"	"unprognostic (2.27e-1)"	"unprognostic (1.02e-1)"	"unprognostic (3.28e-1)"	"unprognostic (2.40e-1)"	"unprognostic (1.10e-1)"	"unprognostic (6.51e-3)"	"unprognostic (1.06e-2)"	"unprognostic (9.79e-2)"	"unprognostic (1.73e-2)"	"unprognostic (1.21e-1)"	"prognostic unfavorable (1.30e-7)"	"unprognostic (1.47e-3)"	"unprognostic (1.72e-2)"	"unprognostic (1.58e-1)"	"unprognostic (1.16e-2)"	348.4	33.6	10.8	135.9	5.2	0.4	130.4	3.7	9.0	65.7	8.9	108.5	24.8	105.3	14.8	40.8	64.1	116.8	81.9	12.6	5.2	53.4	22.1	137.0	27.7	9.1	7.0	27.0	36.0	36.3	12.8	900.3	7.5	53.6	30.4	1.8	19.0	85.6	40.1	25.2	43.4	312.7	6.8	76.3	50.1	10.7	13.7	10.7	54.7	47.0	11.1	120.8	38.2	6.9	40.0	15.2	195.9	0.3	501.6	148.9	274.9	246.2	59.5	134.0	65.3	4.2	0.8	0.1	915.3	46.2	59.7	26.8	0.0	55.8	30.3	1.3	29.5	0.2	28.2	0.0	142.8	0.0	0.4	49.7	8.9	132.8	59.4	212.8	207.7	0.1	0.3	0.2	31.1	0.1	0.1	0.8	28.1	0.2	3.6	0.4	58.6	0.1	278.8	0.0	1.4	29.8	0.1	0.4	61.0	192.4	0.1	13.9	331.3	39.9	121.4	1.0	97.4	0.3	1.8	3.9	0.4	0.7	297.0	0.5	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.4	0.2	0.0	0.1	0.0	0.0	10.8	5.2	3.7	9.0	12.6	5.2	9.1	7.0	7.5	6.8	13.7	6.9	401.4	41.7	8.9	5.2	1.9	14.0	9.7	8.5	2.8	1.0	3.5	16.5	41.1	10.0	0.9	23.9	0.0	49.7	0.5	0.1	1.9	22.6	0.7	19.8	312.2	385.9	0.0	0.0	10.5	0.2	672.4	211.8	1.5	48.7	1.3	215.8	134.6	1.3	27.7	0.0	18.9	0.5	0.0	4.4	19.2	2.8	38.5	4.2	30.2	36.5	0.6	2.5	0.0	1.0	0.9	0.6	0.1	109.4	0.5	6.2	0.5	26.7	2.8	0.4	506.2	142.8	415.1	1.2	5.0	0.8	15.2	45.0	4.2	45.9	0.6	2.2
COX7A1	"COX7A, COX7AH"	ENSG00000161281	"Cytochrome c oxidase subunit 7A1"	P24310	19	36150922-36152449	"Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"		Oxidoreductase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	18	"heart muscle: 2260.5;skeletal muscle: 6947.0;tongue: 4960.0"	"Cell type enriched"	"Detected in many"	26	"Cardiomyocytes: 21879.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC diff: 162.5;ASC TERT1: 122.3;BJ: 84.7;BJ hTERT+: 102.7;fHDF/TERT166: 178.6;HHSteC: 91.4;HSkMC: 109.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 54: Cardiomyocytes - Muscle contraction"				"unprognostic (5.48e-2)"	"unprognostic (1.19e-1)"	"unprognostic (6.13e-3)"	"unprognostic (6.46e-3)"	"unprognostic (5.33e-2)"	"unprognostic (3.87e-2)"	"unprognostic (3.77e-2)"	"unprognostic (9.93e-2)"	"unprognostic (1.92e-1)"	"unprognostic (1.41e-1)"	"unprognostic (9.49e-2)"	"unprognostic (1.46e-1)"	"unprognostic (7.84e-3)"	"unprognostic (7.27e-3)"	"unprognostic (9.44e-2)"	"unprognostic (6.23e-2)"	"unprognostic (1.54e-2)"	269.2	91.5	197.5	20.4	198.8	2.1	105.9	195.3	256.5	70.6	197.2	122.8	14.9	54.6	39.3	82.3	57.8	31.9	2260.5	210.0	214.7	86.9	11.9	63.3	12.0	197.7	188.7	46.0	40.6	147.8	105.6	27.4	199.5	86.6	23.7	49.7	88.0	119.1	6947.0	33.8	36.7	85.1	192.1	34.4	46.7	9.7	200.0	85.8	54.8	4960.0	7.3	88.5	50.1	217.9	0.5	5.9	0.6	0.1	162.5	122.3	0.0	84.7	102.7	3.4	0.0	0.0	1.8	1.4	13.0	178.6	0.0	0.7	0.0	0.0	0.8	0.2	1.8	0.4	2.1	0.3	91.4	0.0	0.8	109.0	0.0	0.0	0.0	0.0	11.3	0.0	0.6	0.7	0.0	0.8	0.0	0.7	1.0	0.6	1.2	0.2	0.0	0.4	0.0	1.6	0.0	0.6	0.0	0.0	0.0	0.2	0.6	0.1	20.7	0.0	1.3	0.5	0.4	0.8	1.9	0.7	0.2	0.8	1.2	0.0	0.6	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.4	0.0	0.3	0.1	0.0	0.0	197.5	198.8	195.3	256.5	210.0	214.7	197.7	188.7	199.5	192.1	200.0	217.9	309.7	0.0	5.1	2.3	2.2	26.4	1.0	28.2	2.8	80.6	25.0	89.4	21879.1	18.6	11.0	22.0	45.9	1.0	1.5	0.0	817.8	13.7	17.0	6.0	124.6	360.4	0.0	5.3	5.9	14.1	0.7	602.1	0.5	3.7	45.0	5.5	259.5	7.3	24.0	67.3	4.3	0.0	26.4	10.7	30.5	90.8	224.6	5.2	284.6	3.7	0.0	31.5	0.0	2.0	2.3	6.2	0.0	281.3	1.5	3.5	0.0	183.1	10.7	84.7	184.1	328.4	463.4	2.0	3.8	4.3	19.0	1.9	4.8	17.3	0.1	0.8
CTIF	KIAA0427	ENSG00000134030	"Cap binding complex dependent translation initiation factor"	O43310	18	48539031-48863217	"Predicted intracellular proteins, Transporters"	"Nonsense-mediated mRNA decay, Translation regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 94.7;Excitatory neurons: 76.4;Inhibitory neurons: 80.6;Oligodendrocyte precursor cells: 75.9;Oligodendrocytes: 59.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA016865, HPA024801"	Uncertain		Supported	Cytosol		NA	NA				"Cluster 35: Non-specific - Unknown function"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 52: Non-specific - Transcription"	Cytosol		"HPA016865: AB_1852311, HPA024801: AB_1852312"	"unprognostic (5.84e-2)"	"unprognostic (5.86e-2)"	"unprognostic (2.27e-2)"	"unprognostic (1.23e-2)"	"unprognostic (2.06e-1)"	"unprognostic (2.57e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.44e-1)"	"unprognostic (8.86e-2)"	"unprognostic (1.95e-3)"	"unprognostic (2.77e-3)"	"unprognostic (1.35e-1)"	"prognostic favorable (3.18e-4)"	"unprognostic (1.95e-1)"	"unprognostic (1.99e-1)"	"unprognostic (2.34e-3)"	"unprognostic (7.33e-3)"	35.3	20.0	15.7	3.3	13.9	2.0	24.3	10.7	23.2	14.0	0.0	26.0	2.5	21.5	2.6	11.4	16.3	7.5	24.8	16.0	15.5	11.1	24.8	14.3	1.3	20.7	17.4	28.0	9.8	4.6	12.4	4.3	23.3	13.9	1.6	7.4	11.0	5.4	15.8	14.0	9.9	7.0	9.1	6.7	19.6	7.3	19.0	1.4	10.7	4.3	1.0	26.1	12.6	16.7	3.2	3.4	4.5	5.8	11.3	6.0	2.5	15.9	13.2	12.4	11.2	3.5	1.9	0.0	3.5	22.0	5.2	6.7	3.3	9.0	5.3	0.0	2.7	1.4	7.9	8.4	21.6	2.6	4.5	8.4	14.5	7.8	13.8	8.9	8.9	4.1	4.0	9.8	8.0	1.7	0.9	2.0	2.2	3.4	2.8	1.6	5.2	4.2	3.7	4.3	9.6	9.7	5.6	6.0	4.5	3.8	3.8	3.1	18.1	11.4	10.5	3.4	2.9	3.3	4.2	0.0	10.1	1.6	5.1	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.7	13.9	10.7	23.2	16.0	15.5	20.7	17.4	23.3	9.1	19.0	16.7	7.3	35.3	3.7	94.7	1.9	3.3	2.1	3.5	2.8	25.6	11.2	8.4	16.0	5.7	5.6	7.3	16.7	1.9	0.8	4.6	7.9	5.1	11.1	1.7	7.7	8.5	3.5	0.4	76.4	4.8	2.8	13.1	7.1	3.6	4.5	19.5	7.5	23.0	4.2	11.8	80.6	3.5	4.1	6.4	2.7	19.3	25.1	5.0	3.6	30.0	1.5	3.6	3.1	75.9	59.7	5.7	2.7	50.8	4.8	3.0	5.9	5.8	4.7	8.8	6.6	8.8	9.4	2.3	1.8	3.5	2.3	1.2	0.7	34.7	3.3	3.3
DBN1	D0S117E	ENSG00000113758	"Drebrin 1"	Q16643	5	177456608-177474401	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Differentiation, Neurogenesis"	"Actin-binding, Developmental protein"	"Alzheimer disease, Amyloidosis, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Ductal cells: 87.1;Pancreatic endocrine cells: 64.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Group enriched"	"Detected in many"	7	"dendritic cells: 5.8;granulocytes: 9.4;T-cells: 14.0"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA051452, HPA056940"	Enhanced	Supported	Supported	"Plasma membrane,Actin filaments"		NA	NA		2000000	"Cluster 16: MAIT-cells - Unknown function"	"Cluster 35: Non-specific - Unknown function"	"Cluster 12: NES - Nervous system development"	"Cluster 50: Fibroblasts - ECM organization"	"Plasma membrane, Actin filaments"		"HPA051452: AB_2681489, HPA056940: AB_2683279"	"unprognostic (3.81e-2)"	"unprognostic (6.60e-3)"	"unprognostic (2.88e-2)"	"unprognostic (7.57e-3)"	"unprognostic (9.32e-2)"	"unprognostic (5.68e-2)"	"unprognostic (2.01e-3)"	"unprognostic (4.29e-2)"	"unprognostic (1.73e-2)"	"unprognostic (7.92e-2)"	"unprognostic (2.94e-2)"	"unprognostic (3.64e-1)"	"prognostic favorable (8.28e-4)"	"unprognostic (1.53e-1)"	"unprognostic (4.56e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.76e-3)"	59.4	9.3	44.8	17.6	52.5	6.4	36.5	19.3	71.7	59.7	18.6	67.6	9.5	84.4	10.2	30.9	44.7	24.4	39.7	70.1	45.4	52.0	4.0	24.7	9.0	33.8	25.4	34.8	16.9	17.1	45.8	7.1	32.3	29.7	5.9	5.5	33.1	23.9	27.6	36.6	25.0	28.6	24.0	14.2	47.4	27.0	39.7	14.6	33.4	9.0	4.4	61.0	33.1	35.5	17.4	56.1	182.0	319.1	42.4	66.2	56.5	198.6	50.3	113.4	94.5	193.9	59.0	0.3	139.5	155.1	39.0	27.0	80.9	144.0	53.6	5.2	70.4	111.6	72.9	82.0	149.3	43.0	20.5	87.1	37.1	127.3	38.0	113.3	189.4	131.4	54.0	26.0	84.2	25.1	115.1	63.8	264.1	5.7	123.4	338.1	197.2	34.5	85.3	23.7	213.7	289.8	67.0	28.8	111.5	58.4	78.7	42.6	298.6	126.7	169.3	28.2	94.9	6.3	3.1	177.5	53.2	40.5	80.5	9.4	1.4	1.1	10.3	0.8	14.0	0.3	0.3	7.2	1.8	0.4	0.4	5.2	3.2	0.3	0.8	5.8	0.2	2.2	44.8	52.5	19.3	71.7	70.1	45.4	33.8	25.4	32.3	24.0	39.7	35.5	44.2	3.2	1.5	8.1	1.2	10.3	13.7	24.6	9.1	7.0	7.6	9.1	5.1	2.8	11.1	9.2	4.2	1.0	4.5	1.4	1.9	87.1	16.9	8.4	44.0	43.2	40.7	4.8	15.7	43.4	2.8	56.1	11.7	18.4	10.8	49.4	20.7	0.0	1.7	42.1	13.0	2.4	40.7	1.8	8.9	41.6	50.1	6.1	8.8	2.8	2.4	13.4	1.0	5.0	1.0	64.5	0.6	41.0	4.0	16.9	0.6	6.3	5.2	4.5	19.7	10.8	43.4	6.5	26.7	20.1	7.2	0.8	10.4	8.1	3.9	7.5
DHX35	"C20orf15, DDX35, FLJ22759, KAIA0875"	ENSG00000101452	"DEAH-box helicase 35"	Q9H5Z1	20	38962299-39039723	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	"Helicase, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 23.5;Inhibitory neurons: 21.5;Oligodendrocyte precursor cells: 22.6;Oligodendrocytes: 24.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA054451, HPA062700"	Uncertain		Approved	"Nucleoplasm,Nuclear bodies,Centrosome"		No	No			"Cluster 39: Non-specific - mRNA processing"	"Cluster 12: Smooth muscle tissue - Mixed function"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	"Nuclear bodies"	"Nucleoplasm, Centrosome"	"HPA054451: AB_2682491, HPA062700: AB_2684838"	"unprognostic (8.31e-2)"	"unprognostic (2.34e-2)"	"unprognostic (5.51e-2)"	"prognostic unfavorable (4.25e-5)"	"unprognostic (1.29e-2)"	"unprognostic (8.38e-2)"	"prognostic unfavorable (5.63e-6)"	"unprognostic (9.83e-2)"	"unprognostic (2.21e-1)"	"unprognostic (6.22e-2)"	"unprognostic (4.47e-2)"	"unprognostic (5.67e-2)"	"unprognostic (8.57e-2)"	"unprognostic (1.88e-2)"	"unprognostic (1.66e-1)"	"unprognostic (1.11e-1)"	"unprognostic (3.31e-1)"	6.6	4.2	4.2	4.5	4.9	9.8	6.0	4.4	5.2	10.1	3.1	16.7	6.2	11.2	8.0	8.1	8.5	5.6	10.2	4.5	3.9	6.0	4.8	5.3	6.7	4.1	4.3	7.9	3.7	7.0	3.8	5.2	4.1	8.1	8.6	6.0	5.1	7.2	8.2	6.9	7.9	8.1	3.8	4.8	8.0	6.6	4.2	6.4	5.1	6.3	5.4	11.9	7.0	5.1	10.3	8.4	15.9	6.6	6.0	7.8	11.3	6.0	10.3	13.5	9.9	29.1	9.0	11.4	10.4	11.4	10.4	16.0	11.0	17.5	13.2	2.9	5.2	15.4	14.3	16.7	7.2	18.4	7.7	9.0	11.3	11.7	10.9	8.3	6.1	19.4	16.0	6.5	7.2	8.2	30.0	14.0	9.1	18.5	13.5	14.5	23.2	9.5	5.0	11.8	13.9	11.1	16.4	9.6	15.4	9.9	13.3	14.7	6.0	19.1	10.6	7.8	12.6	6.5	9.2	12.3	10.9	8.2	10.4	0.0	3.0	1.2	2.9	2.7	2.9	2.5	2.4	3.1	4.0	2.9	4.5	2.4	0.6	3.9	2.4	1.4	1.7	2.9	4.2	4.9	4.4	5.2	4.5	3.9	4.1	4.3	4.1	3.8	4.2	5.1	5.4	0.0	3.7	16.0	3.8	0.5	1.4	2.2	7.4	5.1	2.3	3.0	6.7	4.3	4.8	1.8	4.2	3.7	4.1	4.2	1.9	2.4	3.7	2.5	6.6	3.8	5.4	5.5	23.5	1.1	2.4	3.8	7.7	3.2	8.2	6.1	5.7	7.0	5.0	5.0	21.5	6.3	4.1	4.7	4.0	0.8	6.2	3.3	3.6	14.0	3.6	3.3	6.2	22.6	24.8	2.0	5.8	6.4	4.9	2.7	4.6	2.2	4.3	4.7	0.0	4.7	3.9	1.9	9.4	4.5	2.0	3.0	4.5	4.9	5.4	1.1
DIPK1A	"FAM69A, FLJ23493"	ENSG00000154511	"Divergent protein kinase domain 1A"	Q5T7M9	1	92832737-92961522	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in some"	5	"Cytotrophoblasts: 30.6;Syncytiotrophoblasts: 25.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA015718, HPA017281"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 43: B-cells - Humoral immune response"	"Cluster 15: Liver - Metabolism"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 47: Cytotrophoblasts - Unknown function"	Cytosol	Nucleoplasm	"HPA015718: AB_1848405, HPA017281: AB_1848406"	"prognostic favorable (8.96e-4)"	"unprognostic (1.00e-1)"	"unprognostic (6.17e-2)"	"unprognostic (1.50e-3)"	"unprognostic (1.43e-1)"	"unprognostic (3.77e-3)"	"unprognostic (3.63e-3)"	"unprognostic (1.08e-1)"	"unprognostic (1.04e-1)"	"unprognostic (2.10e-1)"	"unprognostic (2.19e-1)"	"unprognostic (5.04e-2)"	"prognostic unfavorable (1.45e-7)"	"unprognostic (1.26e-2)"	"unprognostic (5.99e-2)"	"unprognostic (2.57e-1)"	"unprognostic (1.66e-2)"	18.8	4.2	20.2	14.5	23.3	10.0	9.9	22.3	29.5	7.8	14.6	15.2	11.7	15.7	4.7	12.0	9.5	14.6	6.7	20.4	21.2	7.9	32.8	6.0	14.9	21.7	20.6	7.5	4.5	15.1	3.9	16.9	22.3	11.8	15.9	8.3	7.5	13.8	11.3	7.4	11.0	25.5	23.1	10.6	11.9	8.6	20.9	16.1	8.0	7.5	12.2	14.8	6.2	31.0	11.2	12.6	4.6	11.5	17.6	33.5	5.9	33.9	69.0	18.6	37.8	6.7	2.3	38.3	6.0	62.1	38.0	13.6	0.9	25.3	30.5	15.7	12.2	1.2	9.2	17.1	6.3	3.4	2.1	19.6	19.8	40.8	9.7	31.8	0.3	22.7	13.4	37.7	24.1	4.0	12.4	3.1	8.6	18.4	4.6	11.4	36.2	11.5	2.6	11.2	11.8	9.5	9.7	9.2	12.7	10.6	4.3	1.1	1.3	22.1	17.0	43.0	12.0	57.7	60.2	44.0	10.4	2.2	2.0	0.1	1.8	0.1	19.3	0.9	15.5	43.4	22.3	15.5	8.6	26.9	25.6	22.2	0.5	24.2	0.6	14.1	21.9	12.3	20.2	23.3	22.3	29.5	20.4	21.2	21.7	20.6	22.3	23.1	20.9	31.0	0.6	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.5	0.0	0.0	0.0	0.0	30.6	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	5.5	3.4	0.0	0.0	0.0	0.0	0.0	0.0	4.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.5	0.0	0.0	0.0	0.0	25.3	0.7	0.0	0.0	0.0
DMWD	"D19S593E, DMR-N9, gene59"	ENSG00000185800	"DM1 locus, WD repeat containing"	Q09019	19	45782947-45792845	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 60.5;Late spermatids: 57.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA068172, HPA069843"	Approved		Approved	"Plasma membrane,Actin filaments"		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 35: Non-specific - Unknown function"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 52: Non-specific - Transcription"	"Plasma membrane, Actin filaments"		"HPA068172: AB_2685964, HPA069843: AB_2686212"	"unprognostic (6.49e-2)"	"unprognostic (3.35e-1)"	"unprognostic (1.03e-2)"	"unprognostic (1.65e-3)"	"unprognostic (3.10e-2)"	"unprognostic (2.39e-1)"	"prognostic unfavorable (1.47e-4)"	"unprognostic (5.11e-3)"	"unprognostic (7.61e-2)"	"unprognostic (7.26e-3)"	"unprognostic (1.31e-2)"	"unprognostic (2.16e-1)"	"unprognostic (1.81e-1)"	"unprognostic (1.85e-1)"	"unprognostic (1.97e-1)"	"unprognostic (1.18e-2)"	"unprognostic (4.59e-2)"	24.6	19.1	27.7	12.3	23.4	7.3	23.0	10.5	31.7	29.1	10.8	40.3	9.7	39.6	6.7	18.2	29.4	11.8	43.1	30.0	18.6	18.7	10.2	22.6	11.2	17.5	19.9	29.1	18.1	10.3	29.6	15.0	15.1	25.2	7.4	11.9	17.1	12.2	44.0	15.5	18.3	14.8	8.9	17.0	25.0	36.5	20.2	10.3	23.1	20.1	7.1	30.6	23.2	14.5	31.6	34.3	30.4	21.2	18.1	22.9	23.3	26.9	18.8	23.5	21.2	20.6	17.1	13.2	15.4	30.4	28.8	23.4	16.1	13.4	12.3	38.6	30.0	11.4	37.3	18.2	22.4	1.4	17.6	21.5	16.2	22.0	31.2	26.7	20.3	8.3	28.2	28.9	18.6	25.8	16.0	9.0	13.8	20.6	22.2	16.3	11.0	14.5	14.6	29.7	30.4	33.6	28.9	22.2	19.5	13.4	19.4	7.7	43.3	27.0	26.6	18.1	40.7	41.1	27.4	15.0	28.1	2.1	31.8	0.6	0.2	0.2	1.4	0.6	1.1	0.6	1.2	1.1	0.2	1.4	0.4	0.8	0.6	1.8	0.8	0.2	0.7	0.3	27.7	23.4	10.5	31.7	30.0	18.6	17.5	19.9	15.1	8.9	20.2	14.5	18.8	6.4	4.7	8.1	6.9	8.4	13.9	4.5	2.2	34.5	11.8	9.8	28.5	10.0	4.4	9.2	60.5	7.3	10.6	10.4	5.9	7.3	17.2	12.4	18.9	16.2	26.3	9.3	8.1	10.6	9.6	15.3	6.1	11.2	11.4	23.3	20.0	4.6	2.0	52.2	7.5	7.9	10.2	4.8	11.4	57.7	17.1	2.6	5.4	5.6	0.9	23.3	14.4	10.1	5.8	13.8	7.2	17.0	6.8	11.5	5.6	7.1	8.9	41.2	13.1	24.5	19.0	10.8	15.7	4.6	7.0	5.5	9.0	20.6	8.1	11.5
DNAJC15	"DNAJD1, MCJ"	ENSG00000120675	"DnaJ heat shock protein family (Hsp40) member C15"	Q9Y5T4	13	43023203-43114213	"Disease related genes, Predicted membrane proteins"	"Protein transport, Translocation, Transport"	Chaperone		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 462.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA			"Cluster 23: Antigen presenting cells - Antigen presentation"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 44: Endometrium - Transcription"				"unprognostic (1.12e-1)"	"unprognostic (2.89e-2)"	"unprognostic (1.09e-2)"	"unprognostic (2.97e-2)"	"unprognostic (1.53e-2)"	"unprognostic (3.07e-3)"	"unprognostic (3.91e-2)"	"unprognostic (1.49e-1)"	"unprognostic (1.25e-1)"	"unprognostic (3.23e-1)"	"unprognostic (2.38e-2)"	"unprognostic (3.40e-1)"	"unprognostic (2.50e-1)"	"unprognostic (2.51e-2)"	"unprognostic (2.90e-1)"	"unprognostic (5.92e-3)"	"unprognostic (3.17e-1)"	5.2	7.2	13.1	5.2	13.3	3.8	5.0	13.6	23.0	6.1	9.4	7.7	8.8	3.2	1.5	4.6	3.2	4.0	10.8	12.1	14.8	9.3	7.0	5.3	6.5	14.2	13.5	1.0	4.0	6.8	3.2	5.5	14.3	3.1	6.4	4.8	4.3	8.5	6.9	3.5	8.4	4.5	16.1	4.1	4.7	3.9	15.4	5.8	6.7	6.8	5.9	4.2	2.3	15.5	0.0	0.0	2.6	2.3	9.3	13.9	1.9	10.7	10.4	12.6	6.7	12.8	11.1	8.2	0.0	13.5	6.3	7.8	1.2	9.2	13.3	17.7	0.0	7.8	5.5	9.2	10.7	0.0	5.4	14.0	17.6	6.3	6.0	6.4	10.2	4.8	0.0	1.4	10.4	4.5	0.1	2.0	0.0	9.5	0.0	3.0	2.5	12.2	19.8	4.1	3.3	3.8	0.0	5.8	8.2	4.3	4.2	11.1	10.8	5.1	2.3	8.5	2.8	0.5	1.4	0.0	11.0	0.0	5.0	5.8	4.4	2.3	2.8	4.9	2.6	5.7	3.5	3.3	8.2	4.6	2.7	3.1	0.3	3.9	4.0	5.2	4.9	3.0	13.1	13.3	13.6	23.0	12.1	14.8	14.2	13.5	14.3	16.1	15.4	15.5	82.2	83.3	49.0	16.6	111.2	42.3	23.0	59.2	53.5	25.9	73.2	80.9	166.4	100.1	71.7	132.4	25.0	76.9	58.4	192.9	115.4	271.7	462.8	172.3	77.8	83.1	133.7	98.7	16.6	329.0	291.3	72.5	63.2	289.2	39.2	13.9	71.7	238.5	140.3	30.3	22.4	147.2	63.1	143.8	104.3	124.8	15.2	130.5	88.9	22.5	159.3	50.8	64.9	25.6	17.3	274.7	241.3	12.0	148.1	20.5	263.3	342.9	72.4	26.2	26.3	71.4	92.8	279.4	117.8	90.6	45.6	92.6	70.2	16.2	176.3	38.8
EHD2	PAST2	ENSG00000024422	"EH domain containing 2"	Q9NZN4	19	47713422-47743134	"Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 161.9;Leydig cells: 99.1;Peritubular cells: 107.2;Sertoli cells: 236.7;Smooth muscle cells: 139.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC diff: 312.2;BJ: 238.5;fHDF/TERT166: 258.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA047394, HPA049890, HPA049986, HPA066751"	Approved		Supported	"Plasma membrane"		NA	NA		1500000		"Cluster 89: Fibroblasts - ECM organization"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 48: Smooth muscle cells - ECM organization"	"Plasma membrane"		"HPA047394: AB_2680026, HPA049890: AB_2680936, HPA049986: AB_2680983, HPA066751: AB_2685713"	"unprognostic (1.50e-1)"	"unprognostic (2.11e-2)"	"unprognostic (3.16e-3)"	"unprognostic (1.54e-1)"	"unprognostic (3.33e-2)"	"unprognostic (5.42e-3)"	"unprognostic (3.36e-2)"	"unprognostic (1.33e-2)"	"unprognostic (2.70e-3)"	"prognostic unfavorable (8.75e-4)"	"unprognostic (5.49e-3)"	"unprognostic (9.50e-2)"	"prognostic unfavorable (3.98e-4)"	"unprognostic (6.59e-3)"	"unprognostic (6.48e-2)"	"unprognostic (1.82e-2)"	"unprognostic (3.06e-3)"	195.0	59.9	18.4	32.8	17.6	0.4	133.9	16.5	21.2	110.3	11.9	116.1	14.3	119.9	13.2	53.5	75.4	31.2	85.9	15.9	17.1	24.4	14.4	102.8	9.1	23.3	19.3	68.3	28.2	6.2	12.6	50.3	20.0	62.2	14.7	3.0	34.2	51.1	39.6	54.7	54.5	79.6	17.2	40.3	56.3	11.2	24.1	5.1	49.5	28.2	8.3	112.3	88.8	15.8	62.7	142.7	0.1	1.7	312.2	236.0	0.2	238.5	114.0	86.0	70.0	9.3	31.2	0.0	0.3	258.6	20.3	78.1	1.5	126.5	51.9	0.1	0.8	8.4	78.4	0.7	197.0	0.0	16.6	230.1	109.5	72.5	70.6	113.7	168.4	0.7	26.6	0.2	91.7	11.4	13.3	0.7	1.8	9.2	25.9	1.4	10.0	0.2	69.5	2.9	0.1	0.8	212.5	8.2	6.2	19.1	20.2	4.3	192.6	128.0	27.8	112.5	52.2	0.2	0.2	0.2	119.3	3.3	27.9	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.1	18.4	17.6	16.5	21.2	15.9	17.1	23.3	19.3	20.0	17.2	24.1	15.8	161.9	60.9	20.6	10.7	0.3	20.3	29.4	31.0	12.5	5.5	7.3	10.8	11.6	10.0	22.5	5.5	0.0	1.1	0.8	0.1	0.0	21.2	0.6	3.4	60.5	75.4	0.0	8.6	4.0	14.1	1.6	55.8	5.1	4.5	2.5	24.7	48.9	3.1	1.9	0.0	0.9	0.0	2.0	1.3	8.8	4.3	99.1	1.6	8.8	7.5	0.6	1.8	0.0	3.5	0.3	31.1	0.0	107.2	0.1	28.8	0.0	0.1	5.5	0.8	236.7	24.8	139.4	0.9	3.0	15.8	13.5	1.5	1.5	27.2	0.0	33.4
EML1	"ELP79, EMAP, EMAPL, HuEMAP"	ENSG00000066629	"EMAP like 1"	O00423	14	99737693-99942060	"Disease related genes, Predicted intracellular proteins"			"Disease variant, Epilepsy, Lissencephaly, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 158.4;Excitatory neurons: 57.5;Late spermatids: 61.3;Microglial cells: 69.3;Oligodendrocytes: 61.8;Rod photoreceptor cells: 113.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 67.3;HDLM-2: 89.5;U-2197: 104.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB033137, HPA049105"	Uncertain					NA	NA				"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 18: U-2197 - ECM organization"	"Cluster 9: Photoreceptor cells - Phototransduction"			"CAB033137: AB_2098052, HPA049105: AB_2680633"	"unprognostic (9.86e-3)"	"unprognostic (2.54e-1)"	"unprognostic (8.18e-2)"	"unprognostic (2.77e-2)"	"unprognostic (2.56e-1)"	"unprognostic (4.08e-2)"	"unprognostic (2.68e-2)"	"unprognostic (8.09e-3)"	"unprognostic (7.83e-2)"	"unprognostic (3.06e-3)"	"unprognostic (1.89e-2)"	"unprognostic (9.98e-2)"	"unprognostic (4.09e-3)"	"unprognostic (1.37e-2)"	"unprognostic (1.25e-1)"	"unprognostic (7.81e-3)"	"unprognostic (7.03e-3)"	15.5	6.4	8.6	9.1	25.5	0.3	9.7	7.3	12.7	13.2	15.0	35.5	6.8	16.1	10.8	24.1	15.1	18.6	17.2	8.6	7.9	8.6	5.5	13.2	3.3	9.2	9.0	3.8	8.7	28.3	9.2	27.2	10.7	9.6	14.9	50.1	5.0	16.9	47.5	9.4	10.1	31.0	9.4	3.9	14.9	8.0	8.9	1.3	14.8	34.4	4.4	17.1	10.3	22.8	0.0	44.9	36.8	12.9	20.1	39.5	0.3	35.9	67.3	25.2	8.4	5.1	0.9	0.0	22.2	22.6	30.3	0.2	26.7	3.1	11.5	89.5	13.6	0.0	7.9	0.8	4.8	0.1	0.9	11.6	4.9	31.0	11.7	16.0	44.5	0.7	0.1	0.0	10.4	21.3	0.1	0.1	14.5	0.1	17.2	5.4	13.5	0.2	56.2	0.6	14.1	20.9	11.8	1.8	0.0	24.1	13.7	1.2	42.3	22.8	4.1	104.3	14.9	0.5	0.0	0.3	57.3	0.1	11.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.6	25.5	7.3	12.7	8.6	7.9	9.2	9.0	10.7	9.4	8.9	22.8	22.8	16.0	7.0	17.3	0.3	2.8	1.2	0.4	1.2	9.2	1.0	1.3	15.0	1.5	4.5	3.7	158.4	2.7	0.1	0.1	0.0	4.6	29.1	15.9	14.2	30.1	0.0	0.0	57.5	4.9	0.6	20.6	4.1	4.7	0.0	1.6	40.0	1.3	1.3	1.7	29.9	0.6	0.0	2.5	4.7	61.3	7.2	1.9	7.2	69.3	0.6	8.8	1.0	17.6	61.8	0.8	0.0	6.0	1.2	1.4	0.0	2.5	11.8	113.6	0.0	20.8	8.7	4.8	11.3	0.4	4.0	2.9	0.7	1.2	0.0	0.7
ERC1	"CAST2, ELKS, KIAA1081, MGC12974, RAB6IP2"	ENSG00000082805	"ELKS/RAB6-interacting/CAST family member 1"	Q8IUD2	12	990509-1495933	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"	"Protein transport, Transport"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Excitatory neurons: 292.3;Horizontal cells: 185.1;Inhibitory neurons: 487.0;Microglial cells: 213.6;Oligodendrocyte precursor cells: 230.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019513, HPA019523, HPA024130"	Approved		Supported	"Vesicles,Plasma membrane,Cytosol"		NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 21: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Cytosol	"Vesicles, Plasma membrane"	"HPA019513: AB_1856012, HPA019523: AB_1856013, HPA024130: AB_1856014"	"unprognostic (2.41e-1)"	"unprognostic (4.00e-2)"	"unprognostic (2.14e-1)"	"unprognostic (5.70e-2)"	"unprognostic (2.81e-1)"	"unprognostic (1.32e-1)"	"unprognostic (5.50e-2)"	"unprognostic (8.49e-2)"	"unprognostic (2.53e-1)"	"unprognostic (3.26e-2)"	"unprognostic (1.04e-1)"	"unprognostic (6.79e-2)"	"unprognostic (3.75e-3)"	"unprognostic (4.19e-2)"	"unprognostic (3.01e-1)"	"unprognostic (7.37e-2)"	"prognostic unfavorable (7.01e-4)"	10.4	9.7	12.2	6.8	14.4	7.3	8.0	38.1	12.8	8.9	8.0	11.8	3.5	9.0	4.8	11.8	8.2	7.5	13.9	15.2	18.5	9.2	6.5	7.3	4.8	13.7	14.8	10.5	7.6	15.4	8.1	11.8	13.7	9.5	6.2	7.0	8.4	12.1	9.4	9.4	5.8	12.9	11.9	5.8	7.2	7.5	17.7	7.9	13.4	9.0	5.3	13.4	9.0	12.6	8.2	20.1	10.3	7.1	27.8	22.2	14.2	25.0	20.0	17.0	15.3	17.7	10.0	12.5	3.4	33.2	16.8	13.3	22.1	19.7	23.1	25.9	11.6	30.3	20.1	9.3	21.1	16.1	6.9	18.7	17.0	30.0	55.6	20.7	22.3	7.9	9.6	23.9	12.9	9.2	5.2	3.5	16.8	8.1	9.7	9.9	38.9	3.8	16.9	14.2	6.3	12.3	38.8	9.3	13.9	37.6	9.3	7.0	39.6	29.6	29.0	21.6	24.0	6.4	13.1	18.1	19.2	9.4	12.9	1.5	3.1	2.3	1.7	1.2	2.4	12.7	2.7	2.7	2.7	5.6	3.8	2.7	2.4	1.4	4.8	3.4	2.8	0.7	12.2	14.4	38.1	12.8	15.2	18.5	13.7	14.8	13.7	11.9	17.7	12.6	36.9	25.6	25.1	155.4	21.2	21.0	25.6	9.4	29.0	39.2	13.2	14.1	56.4	17.2	17.4	20.2	47.9	34.1	12.6	12.7	1.9	20.3	34.3	31.2	43.4	34.6	30.0	7.6	292.3	13.4	18.0	32.3	23.9	53.9	14.5	59.2	24.3	17.3	12.4	185.1	487.0	11.9	2.0	12.6	16.5	35.2	24.8	17.0	14.2	213.6	18.4	34.8	6.2	230.7	171.1	18.5	10.3	30.9	39.1	30.8	6.1	4.1	13.2	33.4	19.7	35.5	33.1	18.5	28.8	33.8	27.4	78.7	15.8	18.7	10.3	29.4
EXTL3	"botv, REGR"	ENSG00000012232	"Exostosin like glycosyltransferase 3"	O43909	8	28600469-28755599	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"		"Glycosyltransferase, Transferase"	"Disease variant, Dwarfism, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"neutrophil: 5.7"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB025387	Approved					NA	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 38: Heart - Muscle contraction"	"Cluster 38: EFO-21 - Unknown function"	"Cluster 23: Spermatids - Flagellum & Golgi organization"			"CAB025387: "	"unprognostic (1.35e-1)"	"unprognostic (1.31e-1)"	"unprognostic (5.53e-2)"	"unprognostic (1.19e-3)"	"unprognostic (9.83e-2)"	"unprognostic (2.41e-1)"	"prognostic unfavorable (1.14e-5)"	"unprognostic (4.25e-2)"	"unprognostic (9.29e-3)"	"unprognostic (1.05e-1)"	"unprognostic (5.10e-3)"	"unprognostic (1.19e-3)"	"prognostic favorable (2.47e-5)"	"unprognostic (1.34e-1)"	"unprognostic (1.73e-1)"	"unprognostic (8.91e-2)"	"unprognostic (1.39e-2)"	10.8	16.5	11.3	7.2	12.0	3.8	6.3	7.6	13.7	8.9	5.8	11.1	5.5	13.8	5.4	12.3	11.3	7.9	31.1	14.7	10.4	7.0	6.2	8.6	5.4	10.7	14.3	10.0	11.9	18.9	10.3	13.8	7.2	8.5	5.4	11.2	8.1	11.8	20.8	11.1	6.7	17.9	8.9	8.6	9.0	10.3	23.4	6.4	7.7	22.7	4.8	10.6	7.2	12.7	45.3	33.6	70.1	37.0	18.8	18.5	15.6	33.7	32.6	20.3	16.4	28.9	15.9	12.2	46.6	40.1	28.2	29.7	34.5	55.1	22.4	8.9	18.9	17.2	15.7	14.3	9.8	8.6	46.9	22.2	36.7	15.9	14.6	16.9	44.3	17.4	16.2	15.4	16.5	8.5	15.5	4.7	49.2	13.3	13.6	18.4	31.3	7.1	31.2	29.0	15.2	26.6	14.3	8.6	17.3	22.0	8.4	9.4	34.9	26.6	62.7	25.4	28.9	7.9	17.9	13.5	22.5	10.3	23.7	3.0	1.3	2.0	1.7	0.9	0.8	0.3	0.7	0.9	1.3	0.4	0.5	0.4	5.7	0.5	1.4	1.1	0.3	0.8	11.3	12.0	7.6	13.7	14.7	10.4	10.7	14.3	7.2	8.9	23.4	12.7	6.3	3.2	4.4	10.4	2.4	5.0	2.9	8.7	6.8	17.5	4.8	4.2	26.8	7.2	5.0	1.8	25.0	3.7	7.1	4.9	3.9	9.7	32.0	4.2	7.0	7.3	4.2	1.3	20.0	10.6	16.9	6.5	4.1	5.9	5.7	3.0	8.2	9.0	4.4	8.4	19.0	2.4	2.0	6.6	2.5	10.1	9.9	6.1	5.4	16.9	5.7	6.7	23.7	13.0	16.6	12.3	2.4	14.3	4.2	6.3	2.1	3.5	4.9	16.2	26.3	8.4	9.6	4.3	9.1	4.3	3.0	2.2	4.5	8.6	3.1	3.1
FAM178B	LOC51252	ENSG00000168754	"Family with sequence similarity 178 member B"	Q8IXR5	2	96875882-96986580	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"bone marrow: 18.9;brain: 10.5;epididymis: 5.5;lymphoid tissue: 12.1;testis: 8.2"	"Cell type enriched"	"Detected in many"	4	"Erythroid cells: 88.3"	"Cancer enriched"	"Detected in many"	5	"melanoma: 8.1"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"K-562: 25.7;OE19: 7.0;RPMI-8226: 28.0;WM-115: 27.2"	"Not detected"	"Not detected"			"Region enhanced"	"Detected in some"		"spinal cord: 2.4"	"HPA042516, HPA062110"	Uncertain		Uncertain	"Nuclear speckles,Golgi apparatus"		NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 33: Fibroblasts - ECM organization"	"Nuclear speckles"	"Golgi apparatus"	"HPA042516: AB_10806241, HPA062110: "	"unprognostic (2.47e-2)"	"unprognostic (1.76e-1)"	"unprognostic (1.08e-2)"	"unprognostic (8.04e-4)"	"unprognostic (1.39e-1)"	"unprognostic (1.28e-2)"	"unprognostic (9.02e-4)"	"unprognostic (4.70e-2)"	"unprognostic (8.55e-2)"	"unprognostic (6.49e-3)"	"unprognostic (1.49e-1)"	"unprognostic (5.13e-2)"	"unprognostic (9.82e-11)"	"unprognostic (6.93e-2)"	"unprognostic (1.57e-1)"	"unprognostic (9.63e-3)"	"unprognostic (1.08e-1)"	1.7	0.0	4.9	0.0	8.7	18.9	0.9	6.3	7.3	0.5	2.3	2.2	0.0	1.6	5.5	0.7	1.3	0.1	0.4	4.7	6.8	0.1	0.0	0.4	0.1	7.7	8.0	0.5	0.0	0.0	0.1	0.9	7.4	1.1	0.1	0.1	0.3	0.8	0.2	1.2	0.5	0.4	6.5	12.1	0.3	8.2	7.3	0.1	0.1	0.0	0.0	2.1	0.8	10.5	6.2	0.0	0.0	2.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	25.7	0.0	0.5	2.5	0.0	0.0	0.2	7.0	0.0	0.0	6.7	28.0	0.0	0.0	0.8	0.0	0.0	4.3	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	2.6	0.0	0.0	0.0	27.2	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.5	0.3	0.0	0.0	0.0	0.1	0.0	0.1	4.9	8.7	6.3	7.3	4.7	6.8	7.7	8.0	7.4	6.5	7.3	10.5	0.2	0.0	0.0	1.0	1.2	0.8	0.6	0.4	0.0	0.2	0.5	1.4	0.4	0.0	0.0	0.0	2.1	3.2	0.5	0.1	0.0	0.0	3.6	0.1	0.3	0.2	0.0	88.3	7.2	0.0	7.1	3.0	0.0	0.1	0.0	0.2	0.4	0.0	1.2	1.7	1.1	0.0	10.2	0.0	0.9	7.8	0.9	1.0	3.6	1.0	0.2	2.9	1.0	1.0	20.7	0.2	0.1	0.0	0.1	0.3	0.0	0.0	0.4	0.2	0.0	2.8	1.6	3.2	20.1	0.6	1.7	2.5	0.2	0.3	0.1	0.4
FBXO30	"Fbx30, MGC21674"	ENSG00000118496	"F-box protein 30"	Q8TB52	6	145793502-145814795	"Predicted intracellular proteins"	"Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in many"	6	"basophil: 9.3"	"Lineage enriched"	"Detected in many"	6	"granulocytes: 9.3"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA012583	Approved		Approved	Microtubules		NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 40: Granulosa cells - Unknown function"	Microtubules		"HPA012583: AB_2668686"	"unprognostic (8.69e-2)"	"unprognostic (3.35e-3)"	"unprognostic (2.92e-2)"	"unprognostic (4.29e-2)"	"unprognostic (5.47e-3)"	"unprognostic (8.36e-2)"	"unprognostic (7.61e-7)"	"unprognostic (5.79e-2)"	"unprognostic (1.63e-1)"	"unprognostic (6.32e-2)"	"unprognostic (1.18e-2)"	"unprognostic (9.25e-2)"	"unprognostic (2.35e-1)"	"unprognostic (3.28e-2)"	"unprognostic (5.72e-2)"	"unprognostic (1.68e-1)"	"unprognostic (1.78e-1)"	4.5	4.0	3.8	4.2	5.0	7.2	4.0	4.6	3.9	4.1	2.7	9.7	4.1	6.7	3.1	9.6	3.2	5.6	7.2	3.1	6.0	4.1	3.4	3.2	4.3	4.5	5.5	5.9	3.8	4.0	1.6	4.8	4.7	6.0	4.7	5.3	4.4	6.8	11.5	2.6	3.5	8.0	4.2	3.7	3.7	6.5	5.1	2.9	8.0	9.1	4.1	5.7	2.9	5.3	3.7	6.9	9.7	13.2	9.9	8.8	9.9	10.3	9.6	6.9	6.8	8.7	3.3	17.0	7.8	11.8	12.6	5.7	8.4	7.5	10.4	10.0	5.8	10.8	9.1	8.8	17.8	14.1	10.8	14.6	8.3	8.6	11.4	9.0	10.1	4.1	12.6	11.9	13.6	2.9	6.4	7.5	11.2	2.4	5.1	8.2	21.7	5.9	7.2	3.8	4.3	6.9	12.6	6.5	6.1	9.6	3.0	13.8	13.4	7.1	6.0	9.1	10.4	8.8	7.2	6.8	11.4	6.0	7.7	9.3	1.3	1.6	0.4	1.1	0.3	0.6	0.4	0.8	1.6	1.3	0.6	0.6	1.2	0.5	0.9	0.5	0.3	0.6	3.8	5.0	4.6	3.9	3.1	6.0	4.5	5.5	4.7	4.2	5.1	5.3	11.1	3.2	5.9	7.2	5.4	14.3	5.3	4.2	12.5	8.8	10.5	8.3	22.9	10.0	4.7	3.7	4.2	5.8	5.7	4.9	11.7	4.7	10.9	4.1	13.7	13.8	6.0	36.7	5.3	3.2	3.4	15.4	7.1	6.2	12.0	37.1	11.4	9.7	7.5	26.9	6.4	5.0	2.0	11.9	20.8	4.4	11.1	10.2	7.2	7.5	7.5	12.0	0.0	5.0	7.6	5.1	3.2	10.1	11.1	7.1	4.3	8.2	2.8	8.7	0.0	26.5	18.4	19.7	10.5	12.4	17.3	5.6	6.2	7.2	5.0	5.0
FN1	"CIG, FINC, GFND2, LETS, MSF"	ENSG00000115414	"Fibronectin 1"	P02751	2	215360440-215436073	"Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Acute phase, Angiogenesis, Cell adhesion, Cell shape"	Heparin-binding	"Cancer-related genes, Disease variant, Dwarfism, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 1725.9;placenta: 2928.1"	"Cell type enhanced"	"Detected in many"		"Extravillous trophoblasts: 2583.6;Fibroblasts: 562.6;Hepatocytes: 1012.4;Smooth muscle cells: 450.2"	"Cancer enhanced"	"Detected in all"		"thyroid cancer: 833.9"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC TERT1: 34405.9;HSkMC: 16044.5;hTERT-HME1: 9585.3;hTERT-RPE1: 10587.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB000126, HPA027066"	Enhanced				"Secreted to blood"	NA	NA		47000000000		"Cluster 86: Liver & Placenta - Transport via ER"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 38: Extravillous trophoblasts - Unknown function"			"CAB000126: , HPA027066: AB_10602500"	"unprognostic (8.08e-2)"	"unprognostic (1.09e-3)"	"unprognostic (2.20e-2)"	"unprognostic (3.45e-3)"	"unprognostic (1.82e-2)"	"unprognostic (3.47e-3)"	"unprognostic (3.36e-2)"	"unprognostic (5.91e-3)"	"unprognostic (2.96e-2)"	"unprognostic (2.91e-3)"	"unprognostic (1.41e-2)"	"unprognostic (2.84e-1)"	"prognostic unfavorable (3.44e-8)"	"prognostic unfavorable (8.82e-5)"	"unprognostic (7.88e-2)"	"unprognostic (7.74e-2)"	"prognostic unfavorable (3.33e-4)"	151.1	31.4	37.8	131.9	44.8	0.6	76.5	36.3	51.2	135.9	85.9	444.0	33.8	156.1	61.3	251.6	174.5	187.1	410.9	38.9	41.1	42.9	1725.9	785.7	37.3	37.7	39.8	110.0	26.0	19.3	26.2	2928.1	43.5	105.6	237.2	6.0	67.0	428.9	37.7	52.7	103.4	722.6	36.2	14.3	127.2	25.8	112.1	133.8	40.4	148.4	23.9	361.7	87.1	35.3	12.5	84.2	104.6	22.8	4456.5	34405.9	4.8	1799.2	1200.2	1765.3	1259.9	1059.2	43.7	1.2	9.7	6331.7	47.2	192.7	17.4	4220.9	946.9	1.0	7.4	0.8	24.7	3607.2	3192.2	1.2	6.6	16044.5	29.3	4136.5	9585.3	10587.1	2177.2	1.0	8.2	5.0	3673.9	17.0	2.9	1.5	52.7	2.4	15.2	1.0	2.4	8.0	47.4	13.7	6.0	25.0	213.7	116.4	1219.8	4649.5	19.4	3.2	4161.0	2553.1	269.9	2837.4	355.6	4.4	1.6	1.6	3161.2	1.0	694.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	37.8	44.8	36.3	51.2	38.9	41.1	37.7	39.8	43.5	36.2	112.1	35.3	138.9	67.3	67.8	13.4	2.3	55.1	4.1	227.0	2.2	6.4	4.2	5.2	36.3	30.0	34.0	16.5	0.0	216.6	2.3	3.4	0.0	6.5	1.8	6.5	265.8	215.4	21.0	16.8	9.5	9.8	2583.6	562.6	4.1	5.5	18.9	53.5	227.7	1012.4	365.2	1.7	8.1	10.2	12.2	38.0	73.7	4.6	186.4	85.9	110.3	101.2	1.2	1.9	0.0	11.6	10.7	12.5	1.4	88.4	1.7	17.8	0.0	0.6	23.1	8.7	72.3	401.5	450.2	1.6	7.8	5.0	37.4	205.8	11.3	8.5	23.7	1.7
FYCO1	"FLJ13335, ZFYVE7"	ENSG00000163820	"FYVE and coiled-coil domain autophagy adaptor 1"	Q9BQS8	3	45917899-45995824	"Disease related genes, Human disease related genes, Predicted intracellular proteins"			"Cataract, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 263.3"	"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 89.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035526, HPA057966"	Uncertain		Enhanced	Vesicles		NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 15: RT4 - Unknown function"	"Cluster 54: Cardiomyocytes - Muscle contraction"	Vesicles		"HPA035526: AB_10672867, HPA057966: AB_2683567"	"unprognostic (2.45e-1)"	"unprognostic (6.62e-2)"	"unprognostic (6.97e-3)"	"unprognostic (1.14e-3)"	"unprognostic (7.65e-2)"	"unprognostic (1.23e-2)"	"unprognostic (1.57e-2)"	"unprognostic (4.53e-3)"	"unprognostic (5.85e-2)"	"unprognostic (8.85e-2)"	"unprognostic (2.36e-1)"	"unprognostic (2.98e-1)"	"prognostic favorable (3.33e-11)"	"unprognostic (2.90e-1)"	"unprognostic (1.42e-1)"	"unprognostic (2.89e-2)"	"unprognostic (6.99e-2)"	16.7	13.0	10.5	9.7	12.0	6.5	13.4	9.6	9.4	23.1	11.3	42.0	8.0	25.6	10.3	21.3	15.4	18.7	66.8	8.6	10.3	10.7	10.8	14.7	8.6	15.5	10.8	23.1	12.7	20.3	7.6	8.2	14.8	19.3	10.7	33.0	14.9	22.9	263.3	19.3	14.4	28.2	15.1	10.2	20.4	3.3	11.9	10.5	16.5	104.6	8.2	39.6	16.9	15.1	10.8	10.3	3.0	13.0	27.9	21.8	4.9	10.2	23.7	13.1	14.6	5.6	9.3	7.9	5.6	14.2	12.7	7.9	8.5	17.0	15.7	3.3	9.0	11.4	8.7	6.3	19.0	8.8	7.9	24.3	16.7	21.1	20.5	20.3	26.7	13.4	7.4	11.3	9.5	6.7	9.0	5.5	4.5	8.8	9.8	3.1	8.3	4.4	15.9	37.2	2.2	3.4	6.4	20.0	17.6	4.4	9.7	5.7	20.8	5.0	5.9	17.0	5.7	6.4	4.4	2.7	17.2	11.1	9.6	0.7	0.5	0.3	2.0	0.5	2.7	0.2	1.2	2.1	0.2	0.2	0.5	0.7	0.4	1.5	0.3	1.3	1.2	0.7	10.5	12.0	9.6	9.4	8.6	10.3	15.5	10.8	14.8	15.1	11.9	15.1	9.5	28.9	13.7	12.4	4.8	4.1	4.8	5.6	3.4	11.2	8.5	4.8	89.3	8.6	13.0	16.5	35.5	4.3	8.7	6.8	3.9	8.8	0.1	6.4	8.9	9.3	9.6	6.9	0.8	8.3	2.2	14.0	12.8	11.2	2.5	14.9	11.4	9.2	4.1	0.0	0.8	7.6	2.0	5.8	4.6	1.6	12.8	5.1	10.6	10.3	4.0	20.0	6.2	8.0	21.2	11.0	2.5	17.7	3.0	17.3	8.7	6.2	18.6	37.1	6.6	20.8	12.8	2.3	0.8	8.4	4.1	2.9	12.7	6.1	6.2	7.9
GPC4	K-glypican	ENSG00000076716	"Glypican 4"	O75487	X	133300103-133415489	"Disease related genes, Human disease related genes, Plasma proteins, Predicted membrane proteins"			"Deafness, Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 51.3;Alveolar cells type 2: 29.2;Astrocytes: 54.5;Extravillous trophoblasts: 36.2;Granulosa cells: 30.6;Proximal tubular cells: 30.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AF22: 209.7;HAP1: 121.8;NTERA-2: 110.3;RPTEC TERT1: 276.6;SuSa: 242.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030834, HPA030836"	Approved		Approved	"Nucleoplasm,Plasma membrane"	"Intracellular and membrane"	NA	NA		190000		"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 11: Alveolar cells - Smell perception"	"Plasma membrane"	Nucleoplasm	"HPA030834: , HPA030836: AB_10601327"	"unprognostic (9.60e-2)"	"unprognostic (8.67e-2)"	"unprognostic (2.29e-1)"	"unprognostic (8.21e-2)"	"unprognostic (8.51e-3)"	"unprognostic (5.90e-3)"	"unprognostic (5.68e-2)"	"prognostic favorable (3.51e-4)"	"unprognostic (2.54e-2)"	"unprognostic (1.26e-1)"	"unprognostic (5.87e-3)"	"unprognostic (1.30e-1)"	"prognostic favorable (1.25e-5)"	"unprognostic (1.97e-1)"	"unprognostic (2.89e-1)"	"unprognostic (2.75e-1)"	"unprognostic (2.72e-1)"	9.6	9.8	5.9	4.9	6.4	0.1	5.6	5.0	5.8	12.0	4.6	22.5	10.6	10.8	16.4	7.4	11.2	9.0	7.9	6.3	7.5	20.6	1.8	17.4	2.5	7.2	6.9	12.3	10.8	5.6	16.6	29.0	6.0	8.0	10.9	1.2	13.0	11.4	24.3	3.8	10.8	17.7	6.6	5.7	16.9	7.8	4.9	8.4	5.9	20.0	2.0	10.3	5.2	8.5	0.0	0.0	209.7	8.3	8.9	1.3	26.0	1.6	0.0	0.0	0.0	0.1	0.5	0.3	71.7	1.2	0.0	0.1	121.8	0.1	0.0	0.0	11.5	0.0	0.0	0.0	0.2	0.0	0.0	37.3	0.1	0.0	0.0	0.2	0.0	0.3	0.0	0.0	0.2	6.0	0.1	0.1	110.3	0.0	3.2	0.6	19.2	0.0	276.6	8.4	0.1	1.5	0.8	0.1	0.1	242.0	3.2	3.2	0.0	21.3	24.8	0.0	13.6	0.0	0.0	0.1	0.0	0.0	31.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.9	6.4	5.0	5.8	6.3	7.5	7.2	6.9	6.0	6.6	4.9	8.5	1.7	51.3	29.2	54.5	0.2	1.5	3.7	14.7	14.2	0.0	2.9	2.0	4.4	5.7	8.7	23.9	0.0	0.5	0.2	2.5	3.9	7.0	0.6	5.9	1.7	1.2	2.4	0.0	4.7	12.7	36.2	14.4	6.6	10.0	0.0	30.6	0.0	0.0	2.5	0.0	1.4	11.1	4.1	0.6	3.9	2.1	2.1	2.0	1.8	14.0	1.1	1.0	0.0	4.5	4.3	16.5	4.3	0.4	0.1	1.4	4.6	30.3	12.8	0.1	0.0	6.3	13.6	2.4	23.6	2.3	0.4	3.1	1.0	1.4	11.3	0.6
GPR135	"HUMNPIIY20, PAFR"	ENSG00000181619	"G protein-coupled receptor 135"	Q8IZ08	14	59429022-59465342	"G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in many"	8	"Early spermatids: 150.0;Late spermatids: 215.5"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HeLa: 2.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA045337	Uncertain					NA	NA				"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 20: HeLa - Mitochondria"	"Cluster 31: Spermatids - Spermatogenesis"			"HPA045337: AB_10960528"	"unprognostic (1.55e-1)"	"unprognostic (3.00e-1)"	"unprognostic (6.09e-3)"	"unprognostic (1.14e-1)"	"unprognostic (4.20e-2)"	"unprognostic (8.47e-2)"	"unprognostic (3.22e-1)"	"unprognostic (3.91e-2)"	"unprognostic (4.64e-2)"	"unprognostic (1.09e-1)"	"unprognostic (2.47e-2)"	"unprognostic (1.55e-1)"	"unprognostic (2.75e-5)"	"unprognostic (1.33e-2)"	"unprognostic (1.90e-1)"	"unprognostic (2.71e-2)"	"unprognostic (2.68e-3)"	1.2	1.7	1.3	0.6	1.1	0.2	0.9	3.3	1.5	2.2	3.5	1.5	0.2	2.0	1.1	0.6	3.1	0.8	2.1	0.9	1.7	0.9	0.6	0.9	0.3	1.5	1.5	2.5	0.9	2.5	3.4	0.6	0.8	1.9	0.5	0.8	0.6	2.7	0.8	0.6	0.9	1.2	0.8	0.5	1.0	6.0	1.3	0.2	1.4	0.3	0.3	2.1	1.5	1.2	0.4	0.5	0.8	1.0	0.7	1.0	0.7	0.9	0.5	0.6	0.6	0.2	0.9	0.4	0.6	1.1	0.2	0.5	0.4	0.3	0.8	0.9	0.3	0.3	2.8	0.3	0.6	0.5	0.4	0.6	0.6	0.9	0.4	1.3	0.4	0.4	0.5	0.6	0.8	0.3	0.1	1.2	0.6	0.0	1.8	0.6	0.6	0.4	0.6	0.4	1.1	1.3	2.1	0.3	0.1	0.4	0.4	0.2	1.5	1.5	1.2	0.4	1.0	0.1	0.0	0.3	0.5	0.6	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	1.3	1.1	3.3	1.5	0.9	1.7	1.5	1.5	0.8	0.8	1.3	1.2	1.0	0.0	0.5	9.1	1.1	0.3	0.8	0.4	0.0	5.0	0.5	0.4	2.6	1.5	2.7	3.7	2.1	0.4	0.3	0.0	0.0	0.6	150.0	9.7	4.5	0.7	3.0	0.8	21.3	0.7	0.3	2.4	0.5	0.5	0.0	7.0	1.1	0.2	0.1	1.7	20.6	0.2	0.0	0.0	0.5	215.5	3.1	0.6	0.0	3.7	0.4	4.3	1.0	7.5	13.3	0.5	0.0	3.8	0.4	1.1	0.4	1.1	7.6	2.4	0.0	3.6	2.8	22.7	1.8	0.2	0.1	0.1	0.5	5.4	0.7	0.2
GPR155	"DEP.7, DEPDC3, FLJ31819, PGR22"	ENSG00000163328	"G protein-coupled receptor 155"	Q7Z3F1	2	174431571-174487094	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"choroid plexus: 83.4;stomach 1: 52.6"	"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 125.1;Excitatory neurons: 99.4;Inhibitory neurons: 131.1;Melanocytes: 152.9;Oligodendrocyte precursor cells: 130.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"U-266/70: 14.6;WM-115: 9.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036159, HPA057384"	Approved		Approved	"Nuclear bodies,Cytosol"		NA	NA			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 88: Choroid plexus - Transmembrane transport"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Nuclear bodies, Cytosol"		"HPA036159: AB_10671835, HPA057384: AB_2683424"	"unprognostic (3.91e-2)"	"unprognostic (7.93e-2)"	"unprognostic (3.14e-2)"	"unprognostic (4.11e-4)"	"unprognostic (5.03e-2)"	"unprognostic (2.48e-1)"	"unprognostic (8.49e-2)"	"unprognostic (2.94e-2)"	"unprognostic (2.39e-1)"	"unprognostic (2.14e-1)"	"unprognostic (1.91e-2)"	"unprognostic (2.48e-2)"	"unprognostic (4.82e-2)"	"unprognostic (2.59e-2)"	"unprognostic (9.90e-2)"	"unprognostic (1.82e-2)"	"unprognostic (4.54e-2)"	4.3	9.7	8.7	5.9	16.3	2.3	2.4	6.5	12.1	2.4	83.4	10.2	3.8	1.9	12.3	5.9	1.6	5.7	7.0	12.2	5.3	20.1	7.3	3.0	6.3	5.5	5.3	2.5	18.2	8.9	2.3	4.4	5.2	7.5	3.7	10.0	3.6	8.4	4.7	13.2	4.0	6.1	3.5	5.4	52.6	2.2	7.1	3.0	8.3	4.4	3.6	4.1	2.7	6.1	0.7	0.3	0.8	2.0	4.9	2.7	0.5	3.8	1.3	0.6	2.1	0.3	0.2	2.2	1.2	2.8	1.3	0.2	1.3	1.1	2.1	0.8	1.5	2.3	1.1	0.2	0.9	0.7	1.1	3.9	3.1	1.9	0.6	4.0	1.0	3.0	0.3	5.5	4.2	0.6	1.6	0.8	0.4	2.3	1.5	1.9	5.6	1.0	2.0	1.3	5.9	5.0	1.2	0.8	2.0	2.5	0.3	0.3	2.6	2.7	1.0	3.9	0.5	14.6	2.2	0.3	3.0	0.6	9.9	1.3	2.2	0.1	1.8	4.0	1.6	1.1	3.1	2.9	0.6	1.0	2.5	3.9	7.3	3.6	5.7	0.3	5.5	1.4	8.7	16.3	6.5	12.1	12.2	5.3	5.5	5.3	5.2	3.5	7.1	6.1	18.5	12.8	3.6	31.3	9.8	42.7	4.0	4.0	29.0	34.9	5.8	6.1	26.0	2.8	6.8	11.0	125.1	1.5	12.2	0.6	1.9	1.9	0.7	1.4	24.1	9.8	12.7	15.2	99.4	6.0	1.2	9.7	9.7	0.6	1.3	4.0	16.1	16.1	6.1	50.5	131.1	0.8	2.0	50.4	23.0	1.8	14.9	27.0	152.9	8.4	34.3	16.7	11.3	130.2	21.2	3.5	0.1	32.0	14.3	3.1	0.4	41.7	0.5	25.8	0.0	16.9	9.5	3.3	3.2	7.5	28.6	0.8	25.7	52.4	1.0	1.8
GPR161	RE2	ENSG00000143147	"G protein-coupled receptor 161"	Q8N6U8	1	168079543-168137667	"G-protein coupled receptors, Predicted membrane proteins, Transporters"		"Developmental protein, G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"endometrium 1: 41.5;smooth muscle: 27.6"	"Cell type enriched"	"Detected in many"	8	"Horizontal cells: 158.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"CACO-2: 44.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA015576, HPA072047"	Uncertain		Uncertain	Nucleoplasm,Nucleoli		Yes	No				"Cluster 89: Fibroblasts - ECM organization"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 62: Horizontal cells - Visual perception"	Nucleoplasm	Nucleoli	"HPA015576: AB_1849283, HPA072047: AB_2686484"	"unprognostic (1.45e-1)"	"unprognostic (3.78e-2)"	"unprognostic (2.68e-2)"	"unprognostic (1.58e-3)"	"unprognostic (1.87e-1)"	"unprognostic (6.84e-2)"	"unprognostic (3.24e-3)"	"unprognostic (1.48e-1)"	"unprognostic (1.19e-1)"	"unprognostic (5.04e-2)"	"unprognostic (5.45e-2)"	"unprognostic (1.31e-2)"	"unprognostic (5.57e-6)"	"unprognostic (3.93e-2)"	"unprognostic (1.84e-2)"	"unprognostic (1.03e-2)"	"unprognostic (6.34e-2)"	3.5	1.1	3.8	5.3	2.8	0.2	2.7	3.3	4.0	6.7	1.1	8.4	1.5	41.5	3.6	9.8	10.7	5.6	3.1	3.8	2.4	1.4	0.4	4.2	0.9	3.7	9.4	7.3	11.7	5.4	1.7	2.2	3.8	9.5	3.2	2.1	1.8	11.8	1.0	2.1	3.3	27.6	2.8	2.0	2.9	1.7	4.1	2.0	1.7	1.9	1.3	4.6	5.4	2.7	11.7	7.1	28.0	18.1	6.6	11.7	0.0	11.1	11.9	9.2	9.7	44.9	1.8	0.0	6.0	16.6	17.2	33.9	6.9	10.7	5.3	4.4	8.8	4.2	5.8	0.1	2.8	1.2	2.8	4.2	6.9	7.9	12.7	21.3	18.7	3.6	3.9	0.1	14.2	1.0	1.3	0.2	11.5	19.4	11.0	3.4	12.1	0.0	4.9	3.1	5.7	24.6	12.0	0.4	32.2	10.6	6.3	1.4	25.4	18.9	9.7	25.6	12.7	0.0	0.0	0.0	5.0	0.0	4.9	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	3.8	2.8	3.3	4.0	3.8	2.4	3.7	9.4	3.8	2.8	4.1	2.7	5.8	3.2	1.1	13.7	0.1	2.2	5.7	2.5	5.2	2.2	2.2	4.2	3.6	0.0	1.4	0.0	0.0	0.5	0.0	2.8	0.0	4.1	0.4	1.3	19.4	9.1	0.0	0.0	10.8	8.0	0.4	12.3	1.1	1.8	0.0	15.3	8.9	0.1	0.8	158.2	10.9	1.5	0.0	2.5	6.3	0.9	7.5	2.0	1.8	3.7	1.1	3.2	0.0	9.5	0.4	2.6	2.4	17.0	0.0	10.9	0.0	0.1	1.1	2.1	19.7	8.8	15.1	0.3	3.3	2.7	1.4	0.4	1.0	0.7	2.5	2.7
GSDME	"DFNA5, ICERE-1"	ENSG00000105928	"Gasdermin E"	O60443	7	24698355-24757940	"Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Transporters"	Necrosis		"Deafness, Non-syndromic deafness, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"Cytotrophoblasts: 168.1;Distal tubular cells: 41.1;Extravillous trophoblasts: 26.5;Hofbauer cells: 39.9;Syncytiotrophoblasts: 104.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	4	"memory B-cell: 9.0;myeloid DC: 5.9;naive B-cell: 8.4"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA011326, CAB019306"	Approved		Supported	Cytosol		NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 47: Cytotrophoblasts - Unknown function"	Cytosol		"CAB019306: , HPA011326: AB_1847629"	"unprognostic (1.08e-1)"	"unprognostic (1.77e-2)"	"unprognostic (6.29e-2)"	"unprognostic (6.36e-3)"	"unprognostic (6.70e-2)"	"unprognostic (1.49e-2)"	"prognostic unfavorable (2.49e-5)"	"unprognostic (4.35e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.35e-1)"	"unprognostic (2.23e-1)"	"unprognostic (1.24e-1)"	"unprognostic (1.13e-3)"	"unprognostic (1.48e-3)"	"unprognostic (6.70e-2)"	"unprognostic (1.06e-1)"	"unprognostic (5.90e-2)"	13.5	7.8	16.4	2.9	16.7	0.5	7.6	13.3	18.0	17.3	9.2	6.4	7.7	24.8	15.3	3.6	14.3	8.5	9.7	18.1	15.0	13.3	4.5	4.4	5.8	19.4	18.7	16.9	2.6	7.3	7.0	35.0	16.1	7.5	2.4	6.3	3.1	21.1	7.8	3.0	26.8	15.1	16.5	1.8	3.9	12.9	14.1	5.8	14.5	5.2	3.8	15.0	10.1	26.6	31.4	21.7	9.6	41.2	51.4	28.6	16.4	24.1	63.6	24.5	34.3	22.9	1.1	0.5	20.6	66.4	81.7	20.5	5.8	105.4	42.8	0.1	2.1	0.8	39.3	48.0	43.0	0.1	1.5	31.3	75.3	43.5	103.1	73.0	42.3	13.8	3.0	5.2	55.3	0.4	1.9	0.8	10.2	0.1	15.7	0.2	33.6	0.0	74.5	21.9	0.4	60.0	36.5	0.6	42.3	24.3	2.2	2.8	27.9	23.1	39.7	31.6	29.2	2.4	0.6	15.5	69.8	0.1	5.8	0.0	1.9	0.0	0.0	0.2	0.0	9.0	0.1	0.0	5.9	8.4	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.6	16.4	16.7	13.3	18.0	18.1	15.0	19.4	18.7	16.1	16.5	14.1	26.6	1.0	6.4	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	2.1	3.9	0.0	0.0	0.6	5.5	0.0	168.1	0.0	0.0	41.1	1.9	0.0	0.7	16.9	1.3	0.0	0.0	0.0	0.9	26.5	4.3	0.0	1.0	0.0	4.8	0.0	0.0	39.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.7	0.0	0.0	8.3	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.1	0.0	0.0	8.8	1.5	0.0	0.0	0.0	4.8	0.0	0.0	0.0	0.0	104.7	0.7	0.9	0.0	0.0
HDAC9	"HD7, HDAC, HDAC7B, KIAA0744, MITR"	ENSG00000048052	"Histone deacetylase 9"	Q9UKV0	7	18086949-19002416	"Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Chromatin regulator, Hydrolase, Repressor"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"choroid plexus: 47.5"	"Group enriched"	"Detected in many"	4	"Early spermatids: 244.6;Excitatory neurons: 376.2;Inhibitory neurons: 442.3;Microglial cells: 334.5;Oligodendrocyte precursor cells: 322.7;Oligodendrocytes: 233.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"myeloid DC: 74.1"	"Group enriched"	"Detected in all"	9	"B-cells: 52.6;dendritic cells: 74.1;monocytes: 24.4"	"Cell line enhanced"	"Detected in many"		"HAP1: 163.6;hTERT-HME1: 79.4;SH-SY5Y: 65.7;U-698: 64.5;WM-115: 69.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA028926	Uncertain		Approved	Nucleoplasm		NA	NA			"Cluster 23: Antigen presenting cells - Antigen presentation"	"Cluster 20: Retina & Lymphoid tissues - Unknown function"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Nucleoplasm		"HPA028926: AB_10602327"	"unprognostic (2.06e-2)"	"unprognostic (2.67e-1)"	"unprognostic (2.30e-1)"	"unprognostic (1.17e-1)"	"unprognostic (2.74e-1)"	"unprognostic (5.54e-2)"	"unprognostic (2.20e-2)"	"unprognostic (2.32e-1)"	"unprognostic (2.21e-1)"	"unprognostic (2.45e-1)"	"unprognostic (5.01e-1)"	"unprognostic (7.58e-2)"	"unprognostic (1.29e-1)"	"unprognostic (3.94e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.02e-1)"	"unprognostic (6.87e-3)"	8.2	12.3	5.8	8.8	6.6	5.9	5.1	4.8	7.9	10.1	47.5	5.4	3.4	13.2	6.0	2.9	9.3	6.7	14.3	5.5	3.8	2.8	2.8	5.1	18.9	6.0	6.7	2.4	1.5	1.8	6.5	6.3	6.0	11.0	5.5	25.4	7.1	14.5	16.7	2.2	4.5	13.0	3.8	17.5	8.7	5.6	12.9	6.8	2.9	5.8	18.7	5.2	4.9	7.3	40.2	0.2	6.3	0.1	0.9	8.4	0.2	2.4	23.0	9.5	16.1	0.3	12.7	16.7	41.9	26.0	51.6	5.8	163.6	3.2	24.2	0.2	1.1	0.0	0.2	0.0	0.2	3.5	0.1	3.0	3.1	29.7	79.4	8.4	0.4	2.7	0.0	25.1	13.3	0.0	1.6	3.5	20.3	0.0	3.9	4.7	2.5	10.2	5.2	10.6	11.6	65.7	0.5	0.3	12.7	9.7	0.6	15.2	1.8	34.4	11.1	1.9	22.3	28.8	13.3	64.5	9.0	1.6	69.2	0.3	24.4	0.1	4.2	16.5	4.1	52.6	1.4	2.0	74.1	43.2	0.0	2.1	1.4	5.5	10.3	15.9	5.6	12.9	5.8	6.6	4.8	7.9	5.5	3.8	6.0	6.7	6.0	3.8	12.9	7.3	31.4	6.4	2.8	28.1	46.1	2.4	0.7	6.8	6.2	33.0	1.4	0.8	15.2	0.0	12.9	0.0	16.7	0.1	16.3	15.3	3.9	6.8	244.6	24.2	2.3	16.5	7.2	5.7	376.2	0.7	0.2	5.3	13.7	26.1	1.3	0.0	8.9	1.0	12.9	20.2	442.3	0.7	4.1	51.2	64.2	80.1	1.5	34.8	16.0	334.5	21.0	5.1	11.3	322.7	233.1	10.6	6.7	0.7	46.7	1.6	0.0	0.1	17.5	26.2	6.6	2.3	9.0	34.3	8.7	0.7	2.0	0.1	7.8	0.1	0.3	12.1
HSPG2	"perlecan, PRCAN, SJS1"	ENSG00000142798	"Heparan sulfate proteoglycan 2"	P98160	1	21822244-21937310	"Disease related genes, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	Angiogenesis		"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 366.8;Endothelial cells: 322.9;Granulosa cells: 776.0;Hepatic stellate cells: 600.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"EFO-21: 293.0;HUVEC TERT2: 620.8;TIME: 504.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB009820, HPA018892, CAB020718, HPA072690"	Approved		Approved	"Nucleoplasm,Plasma membrane,Cytosol"	"Secreted to extracellular matrix"	NA	NA		1400000000	"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 46: Fibroblasts - ECM organization"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 40: Granulosa cells - Unknown function"	"Nucleoplasm, Plasma membrane, Cytosol"		"CAB009820: AB_2119229, CAB020718: , HPA018892: AB_1850597, HPA072690: "	"unprognostic (1.61e-1)"	"unprognostic (1.57e-2)"	"unprognostic (4.93e-2)"	"unprognostic (9.60e-2)"	"unprognostic (2.38e-2)"	"unprognostic (8.56e-2)"	"unprognostic (4.55e-1)"	"unprognostic (1.90e-2)"	"unprognostic (9.35e-2)"	"unprognostic (2.19e-3)"	"unprognostic (5.82e-2)"	"unprognostic (2.83e-1)"	"unprognostic (1.21e-3)"	"unprognostic (1.17e-2)"	"unprognostic (4.86e-2)"	"unprognostic (1.46e-2)"	"prognostic unfavorable (2.82e-4)"	140.7	54.7	3.8	36.1	5.2	1.7	96.2	3.7	4.8	65.9	18.8	153.1	18.3	151.9	6.6	44.1	85.0	53.4	156.6	3.6	2.9	37.6	10.6	49.0	14.2	5.6	4.6	31.3	31.7	13.1	11.8	30.3	5.7	60.3	8.6	0.3	45.0	56.5	65.1	41.0	54.9	96.2	4.0	37.4	76.1	9.0	7.6	6.7	69.1	40.8	3.5	110.2	59.7	4.7	44.0	40.7	13.8	45.9	131.0	99.4	51.5	70.2	17.8	21.1	18.7	50.5	86.7	3.3	293.0	112.9	0.8	26.9	3.1	31.9	5.4	0.6	4.3	15.7	46.0	35.7	27.0	0.0	4.1	61.6	9.4	19.9	6.0	28.1	620.8	0.3	21.4	5.7	32.4	11.8	0.0	20.0	11.7	19.6	17.9	6.3	87.8	6.1	35.1	6.5	1.3	4.1	51.4	20.0	28.7	14.0	8.1	7.2	504.3	41.1	51.8	29.7	2.3	0.5	7.3	2.6	9.7	0.1	54.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	3.8	5.2	3.7	4.8	3.6	2.9	5.6	4.6	5.7	4.0	7.6	4.7	366.8	70.5	28.6	3.6	3.9	26.4	13.5	81.1	21.1	0.6	6.2	21.5	5.8	38.6	30.3	92.0	0.0	11.0	3.4	52.9	0.0	76.1	1.4	24.2	47.7	322.9	2.4	22.9	0.8	25.0	89.0	141.3	62.2	39.8	23.4	776.0	600.4	6.6	6.8	3.3	0.8	12.6	16.2	22.1	19.2	5.8	75.2	4.6	60.5	15.9	1.8	1.6	0.0	2.5	4.3	87.5	29.9	69.2	4.6	19.3	19.2	0.9	28.7	0.6	32.9	82.5	69.8	0.3	4.8	10.0	17.8	9.3	5.0	83.3	20.1	11.8
IL17RD	"FLJ35755, IL-17RD, IL17RLM, SEF"	ENSG00000144730	"Interleukin 17 receptor D"	Q8NFM7	3	57089982-57170306	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins"		Receptor	"Disease variant, Hypogonadotropic hypogonadism, Kallmann syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"choroid plexus: 28.0"	"Cell type enhanced"	"Detected in many"		"Breast myoepithelial cells: 14.0;Early spermatids: 17.9;Late spermatids: 23.7;Microglial cells: 15.0;Peritubular cells: 25.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AF22: 25.0;AN3-CA: 67.9;NTERA-2: 39.2;SH-SY5Y: 102.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA039577, HPA043550"	Approved		Supported	"Nucleoplasm,Golgi apparatus"		NA	NA				"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 50: Fibroblasts - ECM organization"	"Golgi apparatus"	Nucleoplasm	"HPA039577: AB_2676580, HPA043550: AB_2678546"	"unprognostic (4.67e-2)"	"unprognostic (1.52e-1)"	"unprognostic (2.31e-1)"	"unprognostic (2.72e-2)"	"unprognostic (1.33e-2)"	"unprognostic (9.62e-2)"	"unprognostic (1.17e-2)"	"unprognostic (1.60e-1)"	"unprognostic (3.72e-1)"	"unprognostic (2.11e-3)"	"unprognostic (4.79e-2)"	"unprognostic (1.25e-1)"	"prognostic favorable (2.92e-9)"	"unprognostic (2.90e-1)"	"unprognostic (2.21e-1)"	"unprognostic (2.63e-3)"	"unprognostic (9.58e-3)"	1.9	0.8	4.7	0.9	5.7	0.0	7.4	5.2	4.0	6.0	28.0	5.9	0.4	13.5	10.6	2.4	6.4	3.3	1.9	5.5	6.5	5.7	0.2	0.6	0.3	8.9	8.8	7.4	0.9	9.4	2.3	0.3	5.5	5.1	1.8	0.3	6.0	8.5	0.6	2.0	1.0	12.0	6.2	2.5	1.2	9.7	4.8	0.3	0.5	2.6	0.5	2.8	3.3	6.5	4.0	0.8	25.0	67.9	0.1	0.6	4.0	0.4	0.2	0.3	0.8	0.5	1.9	0.0	0.2	1.4	5.3	0.2	4.8	1.0	0.8	0.0	1.3	0.0	0.0	0.2	0.1	0.0	0.1	1.0	2.6	0.0	0.5	16.6	1.1	0.6	0.0	0.1	1.4	0.5	0.0	0.1	39.2	2.2	1.9	0.0	9.1	0.0	5.2	1.0	0.6	102.0	1.0	1.5	2.9	8.1	0.9	0.0	0.7	1.3	1.6	1.2	4.2	0.0	0.0	0.1	0.7	0.0	1.7	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	4.7	5.7	5.2	4.0	5.5	6.5	8.9	8.8	5.5	6.2	4.8	6.5	1.4	0.0	2.3	11.4	0.0	0.9	2.0	3.1	0.0	0.1	1.5	14.0	1.6	1.5	2.4	0.0	0.0	0.3	0.1	0.1	0.0	3.1	17.9	0.5	5.5	4.0	0.0	0.0	0.6	0.2	0.1	10.1	0.0	1.0	0.0	2.0	1.1	0.1	0.1	0.0	0.9	0.3	2.0	0.0	1.2	23.7	11.5	0.6	0.0	15.0	0.0	0.6	0.0	7.5	2.1	0.7	0.7	25.9	0.0	2.9	0.0	5.0	1.8	0.0	0.0	4.8	1.3	10.6	7.5	1.1	0.9	0.1	0.3	6.5	0.3	0.7
IRAG1	"IRAG, JAW1L, MRVI1"	ENSG00000072952	"Inositol 1,4,5-triphosphate receptor associated 1"	Q9Y6F6	11	10573091-10693988	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in some"	9	"Cardiomyocytes: 7.4;Hofbauer cells: 11.1;Smooth muscle cells: 28.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in some"	4	"neutrophil: 24.0"	"Lineage enriched"	"Detected in many"	4	"granulocytes: 24.0"	"Cell line enhanced"	"Detected in some"		"ASC diff: 20.8;BJ: 15.3;BJ hTERT+: 17.6;fHDF/TERT166: 6.9;REH: 6.8"	"Region enriched"	"Detected in many"	5	"thalamus: 7.6"	"Low region specificity"	"Detected in all"			HPA008704	Uncertain		Approved	"Nuclear bodies,Cytosol"		NA	NA		220000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 43: Cardiomyocytes - Nuclear processes"	Cytosol	"Nuclear bodies"	"HPA008704: AB_1079413"	"unprognostic (2.18e-1)"	"unprognostic (3.40e-2)"	"unprognostic (2.86e-3)"	"prognostic favorable (5.78e-4)"	"unprognostic (5.30e-1)"	"unprognostic (3.37e-3)"	"unprognostic (1.04e-2)"	"unprognostic (1.87e-1)"	"unprognostic (5.63e-3)"	"unprognostic (1.04e-2)"	"unprognostic (1.48e-1)"	"unprognostic (6.98e-2)"	"prognostic unfavorable (9.70e-4)"	"unprognostic (3.72e-2)"	"unprognostic (3.28e-2)"	"unprognostic (1.97e-1)"	"unprognostic (9.97e-3)"	29.7	8.0	64.6	18.2	85.8	1.5	16.1	50.4	53.4	55.4	17.7	67.6	8.5	60.8	16.1	37.5	45.6	33.2	10.1	54.5	54.3	9.3	2.1	13.3	3.7	65.8	71.4	20.2	2.9	2.7	3.8	11.8	54.4	37.9	17.3	1.7	4.1	39.5	6.7	9.3	22.0	69.1	55.2	7.1	33.7	8.2	89.8	2.3	10.2	8.1	1.8	43.8	21.9	48.8	0.1	0.0	4.2	0.0	20.8	4.1	0.2	15.3	17.6	0.0	0.0	0.4	1.7	0.0	0.1	6.9	0.2	0.1	0.0	0.2	0.1	0.1	0.1	0.7	0.0	0.1	0.2	0.0	0.2	4.8	0.4	0.0	0.1	0.0	1.2	0.0	0.6	0.1	0.3	0.0	0.1	0.3	0.5	0.0	0.1	6.8	0.0	0.3	0.0	0.0	0.0	3.1	0.0	2.6	0.0	4.4	0.0	0.5	0.2	0.3	0.0	0.1	0.0	0.0	0.1	0.0	0.3	6.0	0.0	0.7	2.2	1.7	0.0	3.9	0.0	0.8	0.0	0.0	0.6	0.9	0.0	0.0	24.0	0.0	5.7	0.1	0.0	0.7	64.6	85.8	50.4	53.4	54.5	54.3	65.8	71.4	54.4	55.2	89.8	48.8	0.9	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.4	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.2	0.7	0.0	0.0	0.0	0.0	0.0	0.0	11.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	28.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0
ITGA8		ENSG00000077943	"Integrin subunit alpha 8"	P53708	10	15513954-15719922	"Disease related genes, Human disease related genes, Plasma proteins, Predicted membrane proteins"	"Cell adhesion, Differentiation, Neurogenesis"	"Developmental protein, Integrin, Receptor"	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"prostate: 37.4"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 82.8;Inhibitory neurons: 56.1;Microglial cells: 34.7;Oligodendrocyte precursor cells: 64.8;Plasma cells: 25.5;Sertoli cells: 52.6;Smooth muscle cells: 57.6"	"Cancer enhanced"	"Detected in many"		"prostate cancer: 6.3"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HEK 293: 8.4;HMC-1: 19.8;HSkMC: 8.7;U-266/84: 9.7"	"Low region specificity"	"Detected in some"			"Region enhanced"	"Detected in many"		"basal ganglia: 14.1"	HPA003432	Approved		Approved	"Plasma membrane"		NA	NA		200000		"Cluster 12: Smooth muscle tissue - Mixed function"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Plasma membrane"		"HPA003432: AB_1851825"	"unprognostic (2.15e-1)"	"unprognostic (1.22e-3)"	"unprognostic (1.05e-2)"	"unprognostic (2.03e-1)"	"unprognostic (1.25e-2)"	"unprognostic (8.44e-4)"	"unprognostic (2.23e-1)"	"unprognostic (6.13e-3)"	"unprognostic (6.82e-2)"	"unprognostic (3.80e-1)"	"unprognostic (2.54e-2)"	"unprognostic (1.27e-1)"	"unprognostic (4.10e-3)"	"unprognostic (1.39e-1)"	"unprognostic (1.71e-1)"	"unprognostic (2.26e-1)"	"unprognostic (6.03e-2)"	8.6	10.5	1.6	2.1	2.1	0.1	2.7	1.9	5.0	23.8	8.0	6.1	6.7	9.7	5.5	9.8	8.8	6.7	7.7	7.0	0.9	10.0	0.7	20.8	3.2	1.5	2.8	5.7	0.8	4.7	3.2	0.2	1.1	37.4	6.1	1.6	1.8	30.8	2.9	3.3	6.8	9.1	1.5	19.9	19.3	0.6	1.5	1.0	5.6	6.9	4.4	15.7	9.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	3.7	1.6	0.0	0.0	0.0	0.0	0.0	0.0	3.1	0.1	0.0	0.0	0.0	0.0	0.0	8.4	2.5	0.0	0.0	0.0	0.0	19.8	8.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.8	9.7	0.0	0.0	0.1	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	2.1	1.9	5.0	7.0	0.9	1.5	2.8	1.1	1.5	1.5	2.2	1.2	0.0	1.3	0.7	2.4	1.0	1.9	0.0	0.6	6.3	0.1	0.3	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	4.0	11.4	0.0	0.0	82.8	0.0	0.0	10.1	0.0	0.2	0.0	0.0	4.2	0.0	0.1	0.0	56.1	0.0	0.0	0.0	1.8	0.1	0.9	0.5	1.8	34.7	0.0	13.6	0.0	64.8	4.0	0.0	0.0	0.0	25.5	1.5	0.0	0.0	0.0	0.3	52.6	11.3	57.6	0.0	0.2	0.4	1.1	0.0	1.2	0.1	0.1	1.4
ITIH5	MGC10848	ENSG00000123243	"Inter-alpha-trypsin inhibitor heavy chain 5"		10	7559270-7666998	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"			"Tissue enhanced"	"Detected in many"		"adipose tissue: 112.7"	"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 282.7;Fibroblasts: 111.3;Microglial cells: 160.2;Smooth muscle cells: 110.1;Syncytiotrophoblasts: 221.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	6	"WM-115: 102.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA038305	Approved		Approved	"Golgi apparatus,Vesicles"	"Secreted to blood"	NA	NA				"Cluster 82: Adipose tissue - ECM organization"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 50: Fibroblasts - ECM organization"	"Golgi apparatus"	Vesicles	"HPA038305: AB_10670662"	"unprognostic (1.28e-1)"	"unprognostic (1.98e-1)"	"unprognostic (3.11e-3)"	"unprognostic (6.80e-2)"	"unprognostic (1.80e-1)"	"unprognostic (5.84e-3)"	"unprognostic (1.63e-1)"	"unprognostic (2.55e-2)"	"unprognostic (1.53e-1)"	"unprognostic (2.90e-1)"	"unprognostic (5.80e-3)"	"unprognostic (6.11e-2)"	"unprognostic (1.36e-1)"	"unprognostic (6.79e-3)"	"unprognostic (2.00e-2)"	"unprognostic (4.50e-2)"	"unprognostic (3.48e-2)"	112.7	3.7	17.9	19.4	18.6	0.2	53.3	19.7	23.2	17.4	28.6	62.7	13.9	24.3	6.3	21.4	10.5	27.7	16.8	14.7	18.0	16.4	1.6	22.4	12.5	18.9	18.1	21.2	15.0	6.3	5.4	86.9	19.7	24.0	16.8	3.5	9.5	46.6	17.8	12.0	21.6	28.8	15.7	3.4	24.0	6.2	22.5	3.8	24.5	22.5	13.4	51.4	15.3	15.2	0.0	0.0	0.0	0.1	0.0	0.0	7.0	18.0	0.0	0.0	0.0	0.0	0.1	0.0	3.8	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	5.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	1.7	0.0	0.0	0.0	12.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.5	14.8	0.0	0.0	0.0	0.0	1.6	0.1	0.0	0.2	0.1	0.0	0.0	0.0	102.8	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	17.9	18.6	19.7	23.2	14.7	18.0	18.9	18.1	19.7	15.7	22.5	15.2	74.9	3.2	2.7	1.3	0.2	11.3	3.0	0.1	6.8	2.7	1.6	17.3	8.7	8.6	3.7	0.0	2.1	282.7	0.8	0.1	0.0	25.7	2.0	18.7	1.5	58.8	0.0	0.0	0.5	0.4	70.2	111.3	0.0	34.1	2.5	0.5	1.8	0.1	20.7	0.0	0.7	0.0	8.2	1.2	19.6	2.2	5.3	3.6	14.2	160.2	1.1	21.9	0.0	1.5	1.0	0.3	0.0	15.4	0.9	1.8	0.2	2.1	0.7	3.2	78.9	32.3	110.1	1.7	7.7	0.7	8.8	221.9	3.0	0.3	0.0	1.6
ITPR1	"ACV, Insp3r1, IP3R1, PPP1R94, SCA15, SCA16, SCA29"	ENSG00000150995	"Inositol 1,4,5-trisphosphate receptor type 1"	Q14643	3	4493345-4847840	"Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Apoptosis, Calcium transport, Ion transport, Transport"	"Calcium channel, Ion channel, Ligand-gated ion channel, Receptor"	"Disease variant, Mental retardation, Neurodegeneration, Spinocerebellar ataxia"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 290.2;Inhibitory neurons: 183.1;Microglial cells: 84.3"	"Low cancer specificity"	"Detected in all"			"Region enhanced"	"Detected in many"		"cerebellum: 49.9"	"Immune cell enhanced"	"Detected in many"		"naive B-cell: 13.4"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 76.4;HEL: 41.1;HeLa: 74.9;HMC-1: 40.0;U-87 MG: 56.7"	"Region enhanced"	"Detected in all"		"cerebellum: 697.2"	"Region enhanced"	"Detected in all"		"cerebellum: 208.8"	"HPA014765, HPA016487"	Approved		Approved	Vesicles		NA	NA			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Vesicles		"HPA014765: AB_1851843, HPA016487: AB_1851842"	"unprognostic (1.92e-1)"	"unprognostic (5.04e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.75e-1)"	"unprognostic (2.16e-2)"	"unprognostic (3.61e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.12e-1)"	"unprognostic (1.12e-1)"	"unprognostic (3.17e-2)"	"unprognostic (1.92e-2)"	"unprognostic (2.08e-1)"	"unprognostic (2.77e-2)"	"unprognostic (1.15e-1)"	"unprognostic (1.09e-1)"	"prognostic unfavorable (3.43e-4)"	"unprognostic (2.40e-1)"	10.6	12.0	1.8	11.8	12.0	7.2	17.3	49.9	20.1	11.5	15.6	19.5	4.5	36.5	10.0	10.6	27.1	14.1	10.1	5.9	0.0	13.9	3.9	13.7	11.2	0.0	0.5	25.3	6.7	45.3	16.0	8.0	0.0	21.7	6.3	3.9	16.1	27.9	3.0	5.0	11.5	24.5	0.0	9.2	11.1	4.5	0.0	10.3	31.7	5.3	10.5	27.9	11.8	6.1	0.4	4.1	1.0	3.0	27.7	1.9	11.8	0.9	0.5	1.3	0.8	1.3	1.2	14.5	0.6	1.9	6.5	0.1	2.2	2.6	2.1	76.4	3.2	41.1	74.9	3.5	27.4	17.7	40.0	9.2	4.0	5.8	1.1	7.6	7.2	8.4	7.9	13.9	3.7	1.8	7.2	3.0	2.1	0.5	9.7	4.2	1.0	1.1	1.7	5.5	0.7	19.5	5.4	4.3	4.3	0.9	2.6	20.6	13.5	1.8	4.3	3.7	2.3	17.7	12.0	9.6	56.7	17.0	2.7	5.8	2.0	1.5	2.3	0.9	1.7	6.7	1.6	1.6	2.2	13.4	2.7	1.6	1.8	1.8	0.9	4.7	1.4	1.1	1.8	12.0	49.9	20.1	5.9	0.0	0.0	0.5	0.0	0.0	0.0	6.1	30.1	0.0	31.4	24.8	49.7	3.8	6.1	6.3	11.4	4.0	40.0	29.7	8.0	2.8	11.2	9.2	0.0	0.5	17.8	0.3	3.9	2.4	5.4	9.1	11.9	31.2	3.5	8.4	290.2	5.1	0.5	21.5	20.4	12.7	26.5	22.6	36.0	2.0	4.7	1.7	183.1	1.3	2.0	12.9	17.4	7.9	30.1	23.9	7.2	84.3	14.2	4.3	6.2	25.1	12.7	1.5	1.2	52.6	8.8	5.4	0.3	3.9	13.1	1.5	39.5	8.8	28.2	1.5	2.9	4.9	3.1	1.0	25.7	22.0	0.8	3.3
KCTD10	"BTBD28, MSTP028"	ENSG00000110906	"Potassium channel tetramerization domain containing 10"	Q9H3F6	12	109448655-109477359	"Predicted intracellular proteins"	"Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"NK-cells: 81.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA014273	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 40: NK-cells - Unknown function"	"Cluster 12: Smooth muscle tissue - Mixed function"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 63: NK-cells & T-cells - Immune response"	Nucleoplasm	Cytosol	"HPA014273: AB_1852159"	"unprognostic (7.21e-3)"	"unprognostic (3.04e-1)"	"unprognostic (2.45e-1)"	"unprognostic (1.34e-1)"	"unprognostic (1.93e-3)"	"unprognostic (2.31e-1)"	"prognostic unfavorable (5.32e-4)"	"unprognostic (1.84e-2)"	"unprognostic (1.85e-1)"	"unprognostic (7.01e-2)"	"unprognostic (9.33e-2)"	"unprognostic (3.45e-1)"	"unprognostic (7.72e-2)"	"unprognostic (5.76e-2)"	"unprognostic (3.26e-1)"	"unprognostic (3.05e-1)"	"unprognostic (1.70e-3)"	40.3	23.4	20.5	26.2	19.7	15.4	32.9	17.2	20.3	34.2	32.1	42.5	14.7	43.8	14.0	36.6	27.4	33.0	24.1	19.7	31.0	23.0	11.4	31.9	21.9	21.1	23.1	18.1	12.4	22.2	17.0	25.4	26.6	29.2	33.2	14.3	20.7	44.3	11.5	30.3	22.3	57.0	19.2	23.2	25.8	16.3	30.1	14.9	47.1	11.7	22.8	39.0	29.4	18.9	28.4	27.9	84.6	27.5	67.8	91.2	18.5	59.0	80.2	38.8	38.2	28.1	23.1	27.5	34.0	136.4	19.2	22.0	30.7	51.6	35.9	26.0	22.0	32.3	19.2	19.3	44.5	24.9	26.7	92.2	30.7	50.0	29.3	54.7	89.5	26.4	21.5	11.5	68.0	15.1	29.8	32.9	48.1	12.7	36.0	29.2	37.7	22.6	38.5	48.9	29.5	44.3	35.6	38.8	41.8	47.5	45.2	18.8	70.0	42.3	15.5	24.0	32.8	26.0	52.8	37.1	48.8	20.2	60.5	10.9	9.5	6.4	13.5	14.4	10.1	6.6	8.0	10.0	11.9	6.2	8.8	11.1	6.5	25.1	17.2	9.0	10.0	14.9	20.5	19.7	17.2	20.3	19.7	31.0	21.1	23.1	26.6	19.2	30.1	18.9	21.1	16.0	29.9	6.2	9.0	14.7	20.1	17.4	11.4	5.4	12.1	13.5	11.5	10.0	13.7	5.5	16.7	9.1	19.4	31.5	5.9	15.3	12.2	9.9	17.8	26.8	11.5	6.5	9.8	13.1	12.8	15.5	10.7	12.8	14.0	11.3	24.7	5.3	11.5	8.4	8.1	13.4	10.2	13.6	13.3	11.3	11.5	14.6	16.0	8.4	15.7	2.8	81.4	8.0	9.4	25.9	11.8	18.8	7.5	12.2	6.4	10.5	12.2	4.4	26.3	13.4	32.6	13.5	6.3	10.2	16.6	13.5	10.6	10.4	15.0	18.1
KLHL42	"Ctb9, KIAA1340, KLHDC5"	ENSG00000087448	"Kelch like family member 42"	Q9P2K6	12	27780048-27803040	"Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis, Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Peritubular cells: 172.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA020979	Uncertain					NA	NA			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 12: Smooth muscle tissue - Mixed function"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 47: Cytotrophoblasts - Unknown function"			"HPA020979: AB_1852559"	"unprognostic (4.68e-2)"	"unprognostic (1.00e-1)"	"unprognostic (3.30e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.34e-1)"	"unprognostic (5.46e-2)"	"unprognostic (7.38e-3)"	"unprognostic (8.82e-2)"	"unprognostic (1.50e-2)"	"unprognostic (4.92e-2)"	"unprognostic (4.89e-3)"	"unprognostic (1.12e-1)"	"prognostic unfavorable (2.98e-4)"	"unprognostic (2.22e-1)"	"unprognostic (1.36e-1)"	"unprognostic (1.54e-2)"	"unprognostic (2.16e-1)"	8.7	7.3	10.8	11.6	12.1	4.6	9.4	8.3	12.7	11.5	1.6	23.0	8.5	19.0	9.6	13.2	13.4	11.7	6.6	13.2	12.3	7.5	6.4	9.2	9.4	9.2	8.9	8.2	21.3	12.3	9.8	14.1	9.3	14.8	12.1	13.9	6.1	18.8	2.6	9.6	10.0	23.1	9.6	8.7	12.2	10.3	11.3	6.6	10.2	2.6	8.1	21.7	9.7	16.1	11.8	14.9	24.2	22.2	25.9	15.9	23.9	22.5	17.0	16.4	17.6	10.5	16.0	14.6	9.5	14.9	12.6	23.8	11.9	15.6	16.4	19.5	14.5	19.4	29.3	6.9	12.0	17.1	15.2	15.7	12.9	14.3	20.4	21.1	18.7	12.0	6.3	8.0	13.3	10.6	11.9	17.1	34.6	7.6	20.6	13.0	22.1	2.8	9.8	19.2	8.4	24.3	16.6	13.2	17.9	33.8	20.0	15.6	30.2	22.8	13.7	27.7	25.1	9.9	5.5	25.5	14.6	11.2	16.2	0.0	0.5	0.2	1.0	0.4	1.0	0.1	1.1	0.7	0.3	0.5	0.8	1.1	0.0	0.8	0.7	0.7	1.8	0.3	10.8	12.1	8.3	12.7	13.2	12.3	9.2	8.9	9.3	9.6	11.3	16.1	16.2	19.2	16.8	33.0	9.3	23.1	12.3	14.9	29.0	49.8	17.0	25.1	9.1	10.0	12.6	7.3	22.9	69.5	13.9	14.6	3.9	8.9	1.7	9.3	28.8	18.8	27.7	16.8	61.5	20.2	19.8	26.2	15.3	23.9	11.4	25.5	19.2	24.7	13.2	35.3	78.9	12.8	12.2	8.8	11.7	6.0	35.1	8.6	28.4	17.8	16.7	73.9	32.0	63.8	95.5	11.2	7.2	172.3	7.6	14.0	8.0	8.8	7.6	25.2	65.7	33.8	34.6	5.0	12.3	13.1	20.5	20.5	14.7	27.9	11.0	7.4
KLHL5		ENSG00000109790	"Kelch like family member 5"	Q96PQ7	4	39045039-39126857	"Plasma proteins, Predicted intracellular proteins"		Actin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Inhibitory neurons: 186.3;Microglial cells: 190.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"BJ hTERT+: 323.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA013958	Approved					NA	NA			"Cluster 6: Non-specific - Transcription"	"Cluster 15: Liver - Metabolism"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"			"HPA013958: AB_1852590"	"unprognostic (6.02e-2)"	"unprognostic (3.94e-1)"	"unprognostic (3.92e-1)"	"unprognostic (7.54e-3)"	"unprognostic (5.35e-2)"	"unprognostic (3.43e-1)"	"unprognostic (2.48e-2)"	"unprognostic (3.98e-2)"	"unprognostic (2.70e-1)"	"unprognostic (1.10e-1)"	"unprognostic (6.04e-2)"	"unprognostic (2.87e-2)"	"unprognostic (1.42e-2)"	"unprognostic (1.05e-2)"	"unprognostic (2.28e-1)"	"unprognostic (1.36e-1)"	"unprognostic (3.24e-3)"	41.4	22.4	53.9	32.3	53.8	9.0	18.7	44.8	56.5	17.0	29.4	44.4	12.7	19.1	13.5	32.0	9.4	23.1	14.4	49.8	50.0	25.0	42.3	20.2	33.7	53.5	50.2	18.4	11.3	12.9	7.5	28.0	53.0	35.9	16.1	11.8	10.2	66.0	10.7	6.1	13.2	46.1	56.7	21.0	13.1	11.0	55.2	14.6	21.5	18.9	38.9	34.8	9.5	52.6	56.7	78.2	40.9	30.2	22.9	58.5	59.1	44.2	323.1	36.6	35.4	64.6	40.4	86.4	52.4	45.5	192.7	3.3	50.7	112.3	46.6	8.8	10.1	36.8	71.4	46.5	195.6	10.9	11.9	74.5	61.9	55.5	137.7	134.1	73.7	13.8	28.2	17.0	87.1	23.8	11.5	19.6	12.6	14.3	75.5	20.9	53.7	2.1	31.3	23.0	2.8	29.7	25.0	8.0	21.8	49.0	19.3	22.9	94.2	96.8	65.4	25.5	53.8	19.3	18.7	79.0	78.6	28.3	22.9	5.4	2.2	0.4	0.7	3.2	1.1	5.1	1.4	0.8	2.5	3.7	1.1	0.5	2.3	1.0	1.4	0.9	0.2	0.8	53.9	53.8	44.8	56.5	49.8	50.0	53.5	50.2	53.0	56.7	55.2	52.6	74.9	16.0	1.1	45.7	38.0	3.7	9.4	22.9	7.4	18.8	16.5	11.2	4.5	17.2	33.7	11.0	4.2	1.0	6.3	0.3	17.6	39.3	2.8	4.0	11.1	43.6	1.2	10.9	46.1	21.0	57.9	12.6	3.1	5.3	2.5	9.5	22.9	35.6	13.3	70.7	186.3	0.4	12.2	25.4	25.8	6.6	8.1	28.6	17.8	190.2	27.5	12.1	7.2	69.9	79.0	24.3	0.1	13.9	43.0	31.5	2.0	21.8	32.7	3.4	0.0	14.2	17.3	9.8	5.6	3.3	3.4	5.7	10.7	32.4	0.7	14.1
KPNA3	"hSRP1, IPOA4, SRP1gamma, SRP4"	ENSG00000102753	"Karyopherin subunit alpha 3"	O00505	13	49699320-49792682	"Predicted intracellular proteins, Transporters"	"Host-virus interaction, Protein transport, Transport, Viral penetration into host nucleus, Virus entry into host cell"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 145.4;tongue: 94.2"	"Cell type enhanced"	"Detected in all"		"Early spermatids: 316.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA046852, HPA077643"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 29: Early spermatids - Spermatogenesis"	"Nucleoplasm, Cytosol"		"HPA046852: AB_2679840, HPA077643: "	"unprognostic (4.20e-2)"	"prognostic unfavorable (2.80e-4)"	"unprognostic (3.69e-2)"	"unprognostic (1.23e-1)"	"prognostic favorable (2.03e-4)"	"unprognostic (6.27e-3)"	"unprognostic (6.79e-2)"	"unprognostic (9.40e-3)"	"unprognostic (1.56e-2)"	"unprognostic (4.57e-3)"	"unprognostic (3.93e-3)"	"unprognostic (4.66e-2)"	"prognostic unfavorable (3.81e-4)"	"unprognostic (9.78e-2)"	"unprognostic (7.83e-2)"	"unprognostic (5.68e-3)"	"unprognostic (4.60e-3)"	20.8	10.6	13.6	16.9	15.3	29.7	11.7	14.3	19.6	13.7	9.3	17.0	12.3	13.8	11.3	25.4	12.4	14.6	31.9	16.0	15.0	13.8	23.4	17.2	18.4	14.4	13.5	8.3	10.4	12.6	7.1	14.9	14.3	15.8	16.6	33.4	10.4	19.1	145.4	16.2	12.2	25.6	16.1	13.6	13.4	28.5	15.9	19.9	19.2	94.2	20.2	20.1	11.0	17.8	41.3	28.3	53.0	44.6	53.2	58.1	26.6	73.3	60.8	63.5	46.0	86.2	37.6	89.2	14.4	86.6	42.7	47.1	64.1	59.5	105.2	53.8	44.7	65.3	25.4	101.1	51.8	98.7	40.6	42.9	42.3	53.3	69.8	41.7	79.7	36.9	36.7	23.4	88.8	19.1	53.2	53.7	61.4	57.8	19.7	68.6	52.1	27.3	39.1	33.8	22.2	34.8	27.1	33.3	29.5	43.8	19.8	39.3	73.0	46.7	37.5	43.0	49.8	18.8	27.9	76.7	28.4	44.9	47.2	10.3	3.8	3.6	6.7	4.5	9.3	4.9	6.7	6.6	4.2	2.8	6.4	5.9	2.2	6.7	6.0	2.3	8.5	3.4	13.6	15.3	14.3	19.6	16.0	15.0	14.4	13.5	14.3	16.1	15.9	17.8	44.3	67.3	33.8	64.9	35.2	43.1	30.5	21.4	43.9	29.9	23.4	15.0	76.5	21.5	25.7	12.9	33.3	15.5	31.8	26.0	17.6	49.0	316.7	57.4	35.7	44.2	30.5	39.1	90.6	53.7	17.7	30.0	27.0	40.7	33.0	25.4	30.4	36.2	33.1	52.2	83.9	18.4	20.3	37.3	38.7	168.8	22.1	41.9	19.6	55.3	47.1	49.0	35.0	73.4	85.6	51.7	15.0	50.0	36.9	41.7	14.3	28.1	45.8	65.7	26.3	29.1	32.1	66.1	31.8	52.9	49.9	10.5	38.6	61.9	24.9	33.1
LARGE1	"KIAA0609, LARGE"	ENSG00000133424	"LARGE xylosyl- and glucuronyltransferase 1"	O95461	22	33162226-33922841	"Disease related genes, Human disease related genes, Predicted intracellular proteins"		"Glycosyltransferase, Multifunctional enzyme, Transferase"	"Congenital muscular dystrophy, Disease variant, Dystroglycanopathy, Lissencephaly"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"Adipocytes: 8.5;Alveolar cells type 2: 8.2;Ductal cells: 7.1;Endometrial stromal cells: 10.5;Exocrine glandular cells: 7.9;Glandular and luminal cells: 8.6;Hofbauer cells: 6.0;Pancreatic endocrine cells: 6.3"	"Low cancer specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"amygdala: 18.3;basal ganglia: 23.4;cerebral cortex: 33.2;hippocampal formation: 45.4;white matter: 16.4"	"Immune cell enhanced"	"Detected in single"		"naive B-cell: 1.2"	"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 7: Non-specific - Mitochondria"				"unprognostic (1.16e-1)"	"unprognostic (7.77e-3)"	"unprognostic (3.79e-1)"	"unprognostic (1.74e-3)"	"unprognostic (1.63e-1)"	"unprognostic (1.48e-2)"	"unprognostic (4.90e-2)"	"unprognostic (1.39e-2)"	"unprognostic (5.21e-3)"	"unprognostic (6.00e-2)"	"unprognostic (2.12e-2)"	"unprognostic (1.35e-2)"	"unprognostic (7.12e-3)"	"unprognostic (1.19e-1)"	"unprognostic (3.68e-2)"	"unprognostic (2.93e-1)"	"unprognostic (3.96e-3)"	11.9	10.1	18.3	5.9	23.4	0.4	9.1	3.4	33.2	15.3	19.7	27.8	9.2	22.4	8.1	6.7	13.5	9.0	58.4	45.4	2.2	8.4	8.1	6.5	5.1	1.0	2.9	20.8	8.3	6.0	7.4	4.1	4.7	15.2	8.7	13.2	5.9	24.8	49.5	8.5	11.4	15.7	0.0	5.8	16.7	7.6	6.3	2.0	5.3	27.5	5.0	21.6	11.5	16.4	4.1	12.3	19.5	8.4	3.2	0.6	7.4	14.1	7.1	2.7	0.0	2.6	0.4	19.5	2.4	14.0	4.6	1.6	11.6	0.0	0.1	0.3	9.8	0.0	0.0	13.1	4.1	0.1	2.0	1.8	0.9	0.2	0.0	0.0	0.1	0.2	0.2	2.7	3.2	16.5	0.1	9.5	7.7	16.3	0.4	10.6	20.2	3.5	2.5	18.1	7.0	2.4	8.4	11.4	13.6	13.7	16.4	0.6	0.1	8.8	13.8	5.2	3.7	21.3	23.4	0.4	16.4	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.3	0.5	0.0	0.0	0.0	1.2	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	18.3	23.4	3.4	33.2	45.4	2.2	1.0	2.9	4.7	0.0	6.3	16.4	8.5	0.0	8.2	0.0	4.9	0.0	0.0	0.0	0.0	0.0	4.2	4.2	0.0	0.0	2.5	1.8	0.0	0.3	0.9	0.0	0.0	7.1	0.0	5.7	10.5	1.9	0.0	0.0	0.0	7.9	0.7	2.9	0.0	8.6	1.3	3.9	0.0	0.0	6.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.3	0.0	0.0	0.4	0.0	0.0	2.0	1.5	0.0	0.0	0.0	4.0	0.0	0.0	0.0	0.0	0.3	0.8	1.2	0.0	0.0
LBR	"DHCR14B, TDRD18"	ENSG00000143815	"Lamin B receptor"	Q14739	1	225401502-225428925	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Cholesterol biosynthesis, Cholesterol metabolism, Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis, Steroid metabolism, Sterol biosynthesis, Sterol metabolism"	"DNA-binding, Oxidoreductase, Receptor"	"Disease variant, Dwarfism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Erythroid cells: 248.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA062236	Enhanced		Supported	"Nuclear membrane"		NA	Yes			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 6: Erythroid cells - Oxygen transport"	"Nuclear membrane"		"HPA062236: AB_2684721"	"unprognostic (2.57e-1)"	"unprognostic (1.57e-1)"	"unprognostic (2.14e-3)"	"unprognostic (1.32e-2)"	"unprognostic (7.96e-2)"	"unprognostic (1.98e-1)"	"prognostic unfavorable (7.30e-4)"	"unprognostic (3.60e-2)"	"unprognostic (1.11e-2)"	"unprognostic (3.43e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.99e-1)"	"unprognostic (6.42e-2)"	"unprognostic (2.08e-1)"	"unprognostic (5.45e-1)"	"unprognostic (8.32e-2)"	"unprognostic (2.78e-1)"	28.6	9.1	8.8	53.2	9.7	95.7	17.1	9.3	11.9	27.3	9.2	61.4	40.7	47.0	44.4	29.7	31.8	21.7	10.0	8.5	10.1	19.4	47.3	19.2	81.6	12.0	9.8	19.4	16.9	5.6	6.5	27.6	11.2	23.8	46.2	5.3	11.1	36.7	9.8	13.8	39.9	41.4	10.2	41.5	28.2	20.5	9.5	105.5	11.8	12.8	70.7	32.3	23.0	13.1	122.2	42.0	154.9	69.3	64.8	39.7	77.3	31.2	39.2	65.0	69.0	87.2	207.2	248.4	66.6	32.8	38.6	88.8	114.2	32.9	98.5	142.2	107.1	61.4	40.4	81.5	39.9	274.7	105.5	34.3	21.3	58.9	52.0	33.1	82.9	117.4	189.6	164.6	44.4	16.3	254.9	156.6	140.6	121.8	14.2	164.9	141.4	234.0	75.6	52.7	40.6	53.4	52.7	39.6	26.6	68.2	53.3	181.0	50.5	17.6	91.7	49.3	115.9	56.6	83.0	274.5	24.3	120.5	61.2	83.6	44.3	67.3	43.6	31.6	50.9	39.0	43.5	48.8	38.4	39.5	42.4	52.9	211.4	41.3	25.2	21.5	61.9	69.8	8.8	9.7	9.3	11.9	8.5	10.1	12.0	9.8	11.2	10.2	9.5	13.1	98.1	28.9	36.4	13.4	86.4	27.0	33.4	17.3	21.6	4.5	11.9	11.0	8.5	48.6	34.4	31.3	6.2	40.5	98.3	33.4	5.9	23.6	1.2	31.5	31.0	53.1	27.0	248.9	10.5	19.8	23.9	29.0	29.0	53.9	10.1	24.0	48.5	73.6	44.4	11.8	14.3	43.0	12.2	88.5	18.1	3.4	33.8	71.7	26.6	19.7	56.0	11.6	82.4	37.2	34.1	20.6	24.6	32.4	74.0	32.9	19.3	26.0	26.0	10.4	39.5	13.9	46.6	21.0	26.7	68.4	35.5	11.1	81.3	13.2	73.8	36.7
LTBP1		ENSG00000049323	"Latent transforming growth factor beta binding protein 1"	Q14766	2	32946953-33399509	"Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"		"Growth factor binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"cervix: 161.4"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 108.4;Fibroblasts: 116.1;Leydig cells: 90.4;Peritubular cells: 161.0;Skeletal myocytes: 85.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	4	"basophil: 3.1"	"Lineage enriched"	"Detected in single"	14	"granulocytes: 3.1"	"Cell line enhanced"	"Detected in many"		"ASC TERT1: 569.4;HSkMC: 185.3;HUVEC TERT2: 194.5;U-2197: 181.1;U-87 MG: 255.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			CAB025428	Approved				"Secreted to extracellular matrix"	NA	NA		96000000	"Cluster 10: Basophils - Unknown function"	"Cluster 46: Fibroblasts - ECM organization"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 33: Fibroblasts - ECM organization"			"CAB025428: "	"unprognostic (1.02e-2)"	"unprognostic (1.12e-1)"	"unprognostic (5.29e-2)"	"unprognostic (6.23e-2)"	"unprognostic (3.11e-3)"	"unprognostic (1.83e-1)"	"unprognostic (1.06e-3)"	"unprognostic (5.67e-2)"	"unprognostic (7.48e-2)"	"unprognostic (1.14e-1)"	"unprognostic (9.96e-3)"	"unprognostic (1.05e-1)"	"prognostic unfavorable (7.79e-6)"	"unprognostic (4.61e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.91e-1)"	"prognostic unfavorable (1.62e-4)"	22.9	13.1	7.8	22.1	9.4	11.5	14.5	7.1	7.5	161.4	10.5	27.2	10.2	58.9	37.8	21.2	37.0	73.0	89.0	8.8	9.1	38.6	18.6	27.5	6.9	12.1	10.6	30.2	7.9	2.4	9.0	73.2	9.2	46.9	16.5	0.7	14.6	73.6	15.7	10.8	15.0	96.7	9.1	8.3	32.8	17.9	8.8	8.2	6.5	28.4	18.7	53.9	28.3	13.4	0.3	12.5	31.3	0.3	26.1	569.4	13.5	46.5	95.7	6.4	9.3	25.3	4.6	41.3	1.0	6.0	8.8	2.4	0.7	1.5	22.0	0.6	15.3	135.6	15.0	4.1	118.6	0.5	15.7	185.3	4.4	141.2	6.9	61.8	194.5	6.3	8.7	0.3	51.1	19.9	5.5	0.2	22.4	1.0	39.2	4.7	65.8	0.6	0.4	22.4	6.3	3.4	9.5	72.1	0.8	49.1	27.9	0.4	126.4	6.4	26.2	181.1	37.6	74.8	80.0	58.8	255.9	5.2	10.8	3.1	0.1	0.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.2	0.0	5.3	7.8	9.4	7.1	7.5	8.8	9.1	12.1	10.6	9.2	9.1	8.8	13.4	33.6	0.0	0.6	108.4	0.4	13.5	5.6	13.0	10.2	0.0	6.9	6.6	80.9	4.3	3.6	1.8	0.0	45.2	0.3	12.9	0.0	9.6	6.3	7.3	18.3	28.1	1.2	30.3	30.4	6.5	23.4	116.1	10.2	10.5	0.0	11.8	20.3	11.0	7.6	0.0	54.3	2.8	2.0	0.3	18.1	7.1	90.4	12.0	19.6	39.4	0.4	0.2	0.0	70.4	52.4	19.1	3.3	161.0	1.3	19.1	0.7	0.3	6.3	0.3	59.2	85.8	67.9	0.7	11.9	6.9	9.8	43.5	2.0	2.6	4.1	33.4
MACF1	"ABP620, ACF7, FLJ45612, FLJ46776, KIAA0465, KIAA1251, MACF"	ENSG00000127603	"Microtubule actin crosslinking factor 1"	Q9UPN3	1	39081316-39487177	"Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Wnt signaling pathway"	Actin-binding	"Disease variant, Lissencephaly"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 1079.0;Cone photoreceptor cells: 779.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA013713, HPA068064, HPA068103"	Approved		Supported	"Plasma membrane,Cell Junctions,Actin filaments"		NA	NA		25000	"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 9: Photoreceptor cells - Phototransduction"	"Plasma membrane, Cell Junctions, Actin filaments"		"HPA013713: AB_10600821, HPA068064: AB_2685946, HPA068103: AB_2685953"	"unprognostic (2.71e-1)"	"unprognostic (3.14e-2)"	"unprognostic (5.18e-2)"	"unprognostic (1.02e-2)"	"unprognostic (9.00e-2)"	"unprognostic (6.19e-3)"	"unprognostic (1.32e-1)"	"unprognostic (7.40e-3)"	"unprognostic (5.45e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.34e-1)"	"unprognostic (3.98e-1)"	"prognostic favorable (2.77e-5)"	"unprognostic (1.07e-1)"	"unprognostic (1.81e-1)"	"unprognostic (8.57e-2)"	"unprognostic (4.22e-2)"	69.1	62.5	172.0	27.7	197.5	36.2	54.6	174.6	181.6	65.9	119.1	148.6	18.6	130.3	48.7	46.4	92.0	46.4	127.0	159.7	166.1	85.7	63.8	183.6	35.9	190.2	179.0	92.6	51.2	96.9	69.3	34.6	182.9	68.2	25.1	121.2	57.7	41.6	73.0	121.0	62.6	54.2	155.6	84.9	71.3	50.2	193.2	39.3	73.3	55.2	22.8	80.3	62.7	185.3	48.1	54.9	66.7	29.3	53.8	47.3	29.8	62.2	79.4	38.0	33.7	34.3	56.5	24.4	64.6	84.0	62.1	30.6	12.5	45.7	51.2	43.5	33.1	34.0	43.4	56.5	66.0	30.8	15.9	37.0	46.5	105.1	54.3	83.5	104.7	52.0	63.2	25.7	137.0	16.0	23.3	52.7	95.8	20.0	31.7	38.5	89.6	4.5	206.0	50.8	38.2	38.6	24.9	17.2	62.5	76.3	7.5	37.9	115.1	61.6	48.5	28.8	101.9	19.4	19.7	28.8	101.0	32.6	55.2	7.5	1.3	3.8	12.2	2.7	5.9	2.2	5.8	7.8	1.8	3.8	4.7	6.1	1.3	6.5	2.9	2.5	3.0	2.0	172.0	197.5	174.6	181.6	159.7	166.1	190.2	179.0	182.9	155.6	193.2	185.3	135.3	150.6	128.2	1079.0	68.7	154.4	74.9	43.0	60.3	387.7	52.5	50.9	246.1	61.5	70.7	80.9	779.8	52.6	120.5	35.4	0.0	113.3	9.6	140.6	124.4	164.3	36.1	57.6	320.6	114.6	62.1	108.2	65.2	180.1	77.7	194.3	132.1	47.9	52.1	117.8	367.5	27.2	22.4	59.7	46.3	11.8	43.8	74.8	71.2	342.9	59.0	107.8	158.6	494.6	410.7	193.5	17.7	112.5	81.0	89.7	22.5	20.6	71.3	398.5	105.2	95.5	136.7	62.6	33.7	43.5	191.5	69.9	131.2	76.5	19.7	78.8
MAP1A	MAP1L	ENSG00000166963	"Microtubule associated protein 1A"	P78559	15	43510958-43531620	"FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"			"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	14	"brain: 325.5"	"Cell type enhanced"	"Detected in many"		"dendritic cells: 90.9;Horizontal cells: 299.5;Peritubular cells: 76.3"	"Cancer enhanced"	"Detected in many"		"glioma: 18.1"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	61	"plasmacytoid DC: 10.5"	"Lineage enriched"	"Detected in single"	61	"dendritic cells: 10.5"	"Cell line enhanced"	"Detected in many"		"ASC diff: 60.7;BJ hTERT+: 61.8;fHDF/TERT166: 94.0;hTEC/SVTERT24-B: 58.1;U-87 MG: 121.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039063, HPA039064, HPA066488"	Enhanced		Approved	Cytosol		No	No		55000	"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 65: Brain - Ion transport"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 62: Horizontal cells - Visual perception"	Cytosol		"HPA039063: AB_2676327, HPA039064: AB_10673302, HPA066488: AB_2685676"	"unprognostic (1.60e-1)"	"unprognostic (1.31e-1)"	"unprognostic (3.29e-2)"	"unprognostic (1.86e-3)"	"unprognostic (4.45e-2)"	"unprognostic (3.58e-2)"	"unprognostic (5.66e-2)"	"unprognostic (1.12e-1)"	"unprognostic (2.65e-2)"	"unprognostic (1.13e-3)"	"unprognostic (8.36e-3)"	"unprognostic (3.45e-3)"	"prognostic unfavorable (6.59e-5)"	"unprognostic (5.83e-2)"	"unprognostic (2.53e-1)"	"prognostic unfavorable (1.09e-5)"	"prognostic unfavorable (1.66e-5)"	7.2	6.0	65.3	3.8	78.6	0.9	4.4	39.5	325.5	8.0	0.0	16.5	1.2	8.2	2.4	3.0	7.2	4.2	15.5	92.8	37.5	1.2	0.2	2.2	1.0	201.4	41.4	5.0	1.0	2.0	11.7	2.7	186.0	4.8	3.5	21.7	2.5	7.5	4.5	3.2	4.0	13.1	22.5	0.9	4.3	3.8	85.8	24.0	4.1	5.1	0.9	11.9	4.5	156.7	0.3	2.5	11.1	6.4	60.7	41.5	0.1	36.3	61.8	10.5	10.1	4.4	0.1	0.2	15.3	94.0	3.3	0.5	15.0	0.1	6.1	5.5	1.4	14.2	3.5	0.3	5.8	0.4	5.8	31.3	0.1	58.1	0.3	15.8	8.0	41.3	24.0	0.3	42.8	0.5	26.6	0.8	8.1	0.0	1.0	7.2	32.1	0.1	0.2	0.1	34.8	10.6	1.2	0.1	0.3	14.6	2.3	0.6	1.5	33.7	11.3	11.3	0.5	0.0	1.6	5.0	121.4	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.5	0.1	0.1	65.3	78.6	39.5	325.5	92.8	37.5	201.4	41.4	186.0	22.5	85.8	156.7	6.7	3.2	1.1	11.8	2.2	5.5	1.4	1.4	2.8	43.4	1.7	3.6	55.1	0.0	7.9	3.7	25.0	0.3	90.9	1.0	0.0	0.4	13.1	33.2	19.5	5.7	11.4	3.0	34.4	0.0	0.6	46.9	2.6	1.0	7.0	16.7	4.2	0.0	2.4	299.5	45.1	1.7	10.2	0.3	7.4	5.6	51.0	9.4	8.8	12.2	0.7	16.7	0.0	9.5	51.4	0.7	0.0	76.3	1.1	0.5	0.0	0.5	63.6	27.2	32.9	45.7	48.2	10.6	25.6	1.1	4.1	1.1	5.6	3.1	1.4	0.5
MAP1B	"MAP5, PPP1R102"	ENSG00000131711	"Microtubule associated protein 1B"	P46821	5	72107234-72209565	"Plasma proteins, Predicted intracellular proteins"			"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	10	"brain: 431.3;retina: 154.9"	"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 717.2;Excitatory neurons: 571.8;Horizontal cells: 647.8;Rod photoreceptor cells: 562.1;Sertoli cells: 769.2;Smooth muscle cells: 461.2"	"Cancer enriched"	"Detected in all"	5	"glioma: 48.1"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"TIME: 301.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009792, HPA022275"	Enhanced	Supported	Enhanced	Cytosol		NA	NA		180000		"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 48: Smooth muscle cells - ECM organization"	Cytosol		"CAB009792: AB_2137420, HPA022275: AB_1853944"	"unprognostic (9.96e-2)"	"unprognostic (3.97e-2)"	"unprognostic (1.57e-2)"	"unprognostic (3.70e-1)"	"unprognostic (4.67e-3)"	"unprognostic (2.98e-2)"	"unprognostic (1.74e-1)"	"unprognostic (1.73e-1)"	"unprognostic (1.42e-1)"	"unprognostic (7.00e-2)"	"unprognostic (4.78e-3)"	"unprognostic (1.32e-1)"	"unprognostic (1.52e-2)"	"unprognostic (1.13e-2)"	"unprognostic (1.90e-1)"	"unprognostic (1.75e-2)"	"prognostic unfavorable (8.22e-5)"	30.2	19.4	135.6	10.9	127.6	0.1	17.8	181.9	299.9	14.9	0.0	16.9	2.1	16.6	9.5	13.0	11.5	11.0	25.8	138.9	310.5	4.0	2.2	7.1	2.2	392.1	297.1	7.0	3.6	2.5	16.4	10.0	431.3	20.1	5.3	154.9	7.7	25.4	6.0	13.3	7.1	26.4	222.4	1.3	15.3	12.0	332.9	1.5	8.3	9.6	1.3	26.7	11.4	272.0	1.4	62.8	133.5	48.7	80.9	140.1	0.2	32.6	22.7	29.0	34.5	0.5	1.7	0.1	71.8	108.2	87.9	0.6	73.2	2.8	43.3	0.2	12.3	6.7	22.3	18.3	43.6	0.0	5.1	142.1	9.3	116.7	42.8	25.9	91.6	0.2	10.6	0.3	49.5	0.6	0.1	0.0	36.5	0.0	21.3	0.4	16.4	0.1	2.5	0.1	89.9	63.0	28.9	0.3	14.9	109.7	0.2	6.1	301.6	90.7	44.6	69.4	140.3	8.0	0.4	0.2	98.5	0.1	72.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	135.6	127.6	181.9	299.9	138.9	310.5	392.1	297.1	431.3	222.4	332.9	272.0	45.6	0.0	2.0	85.5	1.5	31.6	71.3	2.3	5.2	240.3	14.3	34.3	366.0	2.8	11.5	9.2	717.2	1.6	0.6	0.0	0.0	12.9	13.2	75.4	116.8	97.8	77.6	0.0	571.8	3.4	1.4	220.6	6.6	27.7	1.3	25.3	42.1	0.8	6.4	647.8	350.7	0.7	18.3	1.3	28.4	23.4	309.7	10.1	80.0	91.8	0.0	406.1	0.0	131.2	269.3	7.1	0.0	384.8	0.5	22.1	0.1	0.9	48.6	562.1	769.2	85.4	461.2	8.9	8.0	1.9	50.6	4.0	4.2	269.9	0.2	20.0
MAP3K20	"MLK7, MLTK, MLTKalpha, MLTKbeta, MRK, ZAK"	ENSG00000091436	"Mitogen-activated protein kinase kinase kinase 20"	Q9NYL2	2	173075435-173268015	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Cell cycle"	"Kinase, Serine/threonine-protein kinase, Transferase"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 261.9;tongue: 279.7"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 57.5;Alveolar cells type 2: 57.7;Cytotrophoblasts: 52.6;Endometrial stromal cells: 96.7;Granulosa cells: 100.7;Smooth muscle cells: 83.2;Theca cells: 70.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"myeloid DC: 15.5"	"Group enriched"	"Detected in many"	5	"dendritic cells: 15.5;monocytes: 9.4"	"Cell line enhanced"	"Detected in many"		"U-138 MG: 176.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA017205	Approved		Supported	Cytosol		NA	Yes			"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 7: Non-specific - Mitochondria"	Cytosol		"HPA017205: AB_1858933"	"unprognostic (2.90e-2)"	"unprognostic (9.99e-3)"	"unprognostic (4.63e-3)"	"unprognostic (1.98e-1)"	"unprognostic (7.63e-2)"	"unprognostic (5.02e-2)"	"unprognostic (2.34e-2)"	"unprognostic (3.89e-3)"	"unprognostic (2.83e-2)"	"unprognostic (9.27e-2)"	"unprognostic (4.54e-2)"	"unprognostic (1.74e-1)"	"prognostic unfavorable (3.41e-6)"	"unprognostic (2.34e-1)"	"unprognostic (1.86e-1)"	"unprognostic (2.23e-1)"	"unprognostic (1.19e-2)"	71.0	11.4	9.5	20.5	9.7	4.7	21.4	10.3	8.5	44.9	15.7	65.8	13.0	76.4	18.6	50.0	48.0	31.4	195.7	9.3	12.1	7.5	25.2	22.5	9.8	13.8	14.7	69.5	11.7	49.3	3.8	27.6	11.2	44.0	20.9	2.5	12.4	57.1	261.9	14.1	19.2	75.0	11.1	12.5	31.5	10.6	12.5	11.5	16.4	279.7	10.2	56.1	21.2	9.4	34.6	28.6	22.0	29.1	62.7	92.5	13.8	121.9	94.7	55.9	59.6	19.5	22.2	26.5	31.2	122.5	48.8	22.9	33.1	64.6	124.2	52.0	22.0	43.3	30.5	4.1	24.8	39.3	43.8	74.7	27.2	105.2	164.2	46.3	37.5	28.5	19.8	4.9	36.8	14.8	24.8	19.0	12.2	28.9	16.0	36.2	45.0	0.1	13.6	19.6	12.9	12.4	47.0	11.3	19.7	35.6	12.9	20.9	37.9	176.3	71.4	53.1	27.9	0.1	0.1	5.5	126.2	10.6	18.9	0.2	9.4	0.0	1.0	8.3	1.0	1.6	0.8	1.7	15.5	2.5	0.0	0.8	2.6	0.5	8.2	0.3	0.8	3.4	9.5	9.7	10.3	8.5	9.3	12.1	13.8	14.7	11.2	11.1	12.5	9.4	57.5	38.5	57.7	0.0	2.8	0.0	0.0	0.0	0.0	0.0	20.0	44.4	0.0	0.0	7.4	11.0	0.0	52.6	2.3	0.0	1.9	43.9	0.0	36.7	96.7	14.1	0.0	0.0	0.0	27.6	21.9	36.5	0.0	35.6	5.1	100.7	0.0	0.0	19.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.2	0.0	0.0	15.5	0.0	0.0	0.0	0.0	38.6	0.0	0.0	1.4	0.0	0.0	1.9	13.1	0.0	0.0	0.0	83.2	0.0	0.0	0.0	0.0	21.6	3.6	70.5	0.0	0.0
MASP1	"CRARF, MASP, PRSS5"	ENSG00000127241	"Mannan binding lectin serine peptidase 1"	P48740	3	187217282-187291980	"Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins"	"Complement activation lectin pathway, Immunity, Innate immunity"	"Hydrolase, Protease, Serine protease"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"cervix: 120.0;heart muscle: 116.1;liver: 183.4"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 28.1;Cardiomyocytes: 38.1;Cholangiocytes: 20.0;Endometrial stromal cells: 30.6;Fibroblasts: 16.4;Hepatic stellate cells: 23.2;Hepatocytes: 65.8"	"Group enriched"	"Detected in some"	9	"glioma: 6.8;liver cancer: 7.7;prostate cancer: 3.0;renal cancer: 3.9"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	8	"BJ: 133.3;BJ hTERT+: 498.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001617, HPA009641"	Supported		Enhanced	Nucleoplasm,Cytosol	"Secreted to blood"	No	NA	8670000000	1900000000		"Cluster 85: Liver - Metabolism"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"	"Nucleoplasm, Cytosol"		"HPA001617: AB_1079314, HPA009641: AB_1079313"	"unprognostic (1.67e-1)"	"unprognostic (1.02e-2)"	"unprognostic (1.99e-1)"	"unprognostic (5.20e-2)"	"unprognostic (1.02e-2)"	"unprognostic (1.25e-6)"	"prognostic favorable (2.20e-4)"	"unprognostic (9.92e-2)"	"unprognostic (3.22e-1)"	"unprognostic (2.29e-1)"	"unprognostic (4.18e-1)"	"unprognostic (1.29e-1)"	"unprognostic (2.82e-3)"	"unprognostic (3.56e-3)"	"unprognostic (1.97e-1)"	"unprognostic (7.85e-2)"	"unprognostic (4.29e-1)"	6.3	3.6	9.4	1.3	9.4	0.0	2.8	12.9	7.0	120.0	4.9	57.5	1.9	88.4	3.3	11.1	17.7	5.1	116.1	10.4	27.0	4.8	183.4	6.0	1.0	19.2	16.5	2.7	0.2	0.3	1.0	9.0	15.3	46.0	5.6	0.0	2.3	52.2	37.5	6.3	7.5	44.4	22.2	0.8	1.6	0.5	14.6	0.2	3.2	18.9	4.3	9.9	61.5	32.0	0.0	0.0	0.3	0.4	15.7	17.3	0.1	133.3	498.3	1.8	0.9	0.0	0.0	0.1	0.0	40.8	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.4	2.6	0.0	0.0	2.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.6	0.0	0.2	0.0	0.1	0.2	0.0	0.0	5.4	0.0	0.0	0.0	0.0	4.9	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.6	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.4	9.4	12.9	7.0	10.4	27.0	19.2	16.5	15.3	22.2	14.6	32.0	1.1	0.0	1.8	28.1	0.2	2.9	0.1	0.2	0.0	0.0	0.0	0.0	38.1	20.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.5	0.9	0.7	30.6	2.0	0.0	0.0	0.2	0.0	0.3	16.4	0.0	0.7	0.0	0.2	23.2	65.8	0.4	0.0	0.9	0.0	0.0	1.9	3.7	7.5	2.5	0.3	1.8	1.0	0.0	0.0	0.0	10.1	0.2	0.0	0.0	0.7	0.1	0.1	0.0	2.4	0.0	0.0	0.0	5.4	4.5	0.0	0.0	0.2	1.7	0.1	0.5	5.1	0.0	0.1
ME1		ENSG00000065833	"Malic enzyme 1"	P48163	6	83210402-83431051	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 71.8;Excitatory neurons: 117.1;Inhibitory neurons: 70.6;Kupffer cells: 74.4;Muller glia cells: 100.6;Oligodendrocyte precursor cells: 123.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in some"	7	"MAIT T-cell: 16.0"	"Lineage enriched"	"Detected in many"	10	"T-cells: 16.0"	"Cell line enhanced"	"Detected in many"		"CACO-2: 139.4;OE19: 158.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA006493	Enhanced		Uncertain	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA		3600000	"Cluster 16: MAIT-cells - Unknown function"	"Cluster 54: Non-specific - Microtubule organization"	"Cluster 21: OE19 - Mitochondria"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Nucleoplasm, Plasma membrane"	Cytosol	"HPA006493: AB_1078272"	"unprognostic (7.21e-2)"	"unprognostic (3.99e-2)"	"unprognostic (2.24e-1)"	"unprognostic (3.12e-3)"	"prognostic unfavorable (7.73e-4)"	"unprognostic (7.98e-3)"	"prognostic unfavorable (4.57e-5)"	"unprognostic (3.24e-1)"	"unprognostic (4.44e-3)"	"unprognostic (1.41e-3)"	"unprognostic (7.10e-3)"	"unprognostic (2.43e-1)"	"prognostic unfavorable (1.81e-7)"	"unprognostic (4.07e-2)"	"unprognostic (2.49e-1)"	"unprognostic (1.85e-2)"	"unprognostic (4.51e-2)"	41.4	44.4	13.4	5.2	15.4	0.4	29.9	14.5	18.1	8.0	8.5	7.7	21.7	4.2	6.5	28.6	4.2	15.5	18.6	13.1	17.4	3.6	9.8	8.8	4.2	15.0	19.1	10.8	3.4	19.9	12.5	2.9	18.3	8.4	11.0	30.0	10.3	17.2	34.7	14.4	10.4	7.8	13.4	7.3	23.8	16.1	16.8	5.6	6.7	30.5	4.5	15.3	12.0	13.5	29.0	59.1	1.4	0.0	48.0	44.4	0.1	18.4	47.0	19.2	37.1	139.4	24.9	0.0	46.8	43.4	38.2	29.8	43.4	16.4	20.9	0.0	24.4	0.0	33.8	0.0	61.4	14.3	50.3	49.0	32.3	38.7	26.3	32.1	30.4	0.0	20.4	0.1	26.4	32.7	0.0	16.2	0.0	158.3	23.0	0.0	48.5	27.9	56.8	13.7	5.8	14.9	31.2	45.7	1.0	25.0	0.0	34.5	32.4	11.9	14.1	3.9	0.1	10.9	13.3	0.1	0.0	0.0	35.9	0.0	1.6	0.0	0.8	0.3	16.0	0.0	0.2	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.5	13.4	15.4	14.5	18.1	13.1	17.4	15.0	19.1	18.3	13.4	16.8	13.5	0.9	19.2	12.1	71.8	0.6	1.9	5.1	12.5	6.8	17.1	2.5	0.9	41.0	7.2	12.7	5.5	2.1	0.6	0.5	12.7	1.9	12.3	5.5	0.7	6.8	2.3	0.0	0.0	117.1	9.5	0.9	8.5	62.7	0.2	0.0	11.2	4.2	12.1	7.1	13.5	70.6	4.1	8.2	74.4	25.6	6.5	25.7	16.7	0.0	23.4	5.5	100.6	0.0	123.6	38.6	15.0	4.5	37.2	0.5	5.2	15.2	3.1	7.2	7.5	0.0	4.5	8.3	7.5	2.3	22.3	3.4	0.8	1.8	33.6	8.9	3.3
MGLL	"HU-K5, MAGL, MGL"	ENSG00000074416	"Monoglyceride lipase"	Q99685	3	127689062-128052190	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid degradation, Lipid metabolism"	"Hydrolase, Serine esterase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 565.4;Distal enterocytes: 398.7;Pancreatic endocrine cells: 535.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"intermediate monocyte: 84.7;plasmacytoid DC: 89.8"	"Group enriched"	"Detected in all"	14	"dendritic cells: 89.8;granulocytes: 36.0;monocytes: 84.7"	"Cell line enhanced"	"Detected in many"		"BJ: 209.1;BJ hTERT+: 238.6;LHCN-M2: 191.3;RPTEC TERT1: 170.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA011348, HPA011993, HPA011994"	Enhanced		Enhanced	Nucleoplasm		NA	NA		100000	"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Nucleoplasm		"HPA011348: AB_2668490, HPA011993: AB_1853914, HPA011994: AB_1853916"	"unprognostic (1.84e-2)"	"unprognostic (1.80e-2)"	"unprognostic (2.14e-1)"	"unprognostic (8.19e-2)"	"unprognostic (1.15e-2)"	"unprognostic (1.69e-1)"	"unprognostic (5.83e-2)"	"unprognostic (3.61e-2)"	"unprognostic (1.45e-1)"	"unprognostic (8.83e-2)"	"prognostic unfavorable (6.41e-4)"	"unprognostic (7.63e-3)"	"unprognostic (1.44e-1)"	"unprognostic (1.68e-1)"	"unprognostic (1.90e-2)"	"unprognostic (2.51e-1)"	"unprognostic (2.11e-3)"	174.8	16.1	100.8	22.9	91.0	18.9	92.0	87.2	123.4	26.8	48.0	81.9	36.9	17.7	9.9	139.9	34.3	44.8	101.9	96.9	75.9	71.0	106.9	72.0	13.5	72.5	86.6	6.1	7.8	3.6	12.5	41.6	70.9	25.8	60.4	6.2	102.1	27.5	66.0	38.1	50.3	27.8	63.0	44.9	38.2	6.2	107.2	10.0	18.9	64.9	21.3	42.5	39.4	88.6	52.4	46.2	0.1	0.5	76.8	90.0	6.2	209.1	238.6	45.3	72.2	1.2	21.0	14.0	56.9	71.3	13.7	2.1	0.4	27.9	25.2	23.5	0.9	1.6	31.4	0.4	27.7	0.3	1.7	34.2	16.1	85.0	92.4	25.6	97.5	1.0	0.3	3.0	191.3	5.6	0.5	0.9	0.5	33.6	71.5	0.2	24.6	109.4	170.4	5.9	26.5	2.1	36.3	70.4	12.6	2.0	3.5	2.1	125.9	49.5	14.8	121.0	29.1	0.5	0.4	43.4	102.4	3.4	156.6	20.6	8.3	36.0	0.5	84.7	2.8	4.9	0.5	1.1	9.2	0.5	0.2	0.2	1.5	2.0	57.2	89.8	0.0	17.1	100.8	91.0	87.2	123.4	96.9	75.9	72.5	86.6	70.9	63.0	107.2	88.6	565.4	195.5	108.6	83.2	8.5	22.8	11.9	14.1	5.7	22.8	25.2	19.9	53.7	118.7	32.2	42.3	0.0	84.6	16.1	398.7	168.3	99.4	4.1	100.0	36.4	207.7	88.6	30.7	39.0	160.7	154.6	71.5	47.9	132.1	8.8	0.1	17.2	148.7	123.9	0.0	48.9	239.1	63.1	32.8	86.3	5.8	32.6	77.8	21.4	52.5	235.2	54.5	2.1	43.2	5.8	535.2	201.0	69.6	36.2	18.5	134.2	102.0	48.0	7.8	85.5	22.3	141.4	0.7	1.7	64.7	22.3	72.7	9.3	1.1	74.0	6.0
MICALL1	"KIAA1668, MICAL-L1, MIRAB13"	ENSG00000100139	"MICAL like 1"	Q8N3F8	22	37905657-37942822	"Plasma proteins, Predicted intracellular proteins"	"Endocytosis, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Syncytiotrophoblasts: 39.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in all"		"hTCEpi: 101.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043480, HPA051956"	Approved		Supported	"Cell Junctions,Centriolar satellite,Cytosol"		NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling"	"Cell Junctions, Centriolar satellite, Cytosol"		"HPA043480: AB_10793950, HPA051956: AB_2681671"	"unprognostic (2.13e-1)"	"unprognostic (1.13e-1)"	"unprognostic (4.94e-2)"	"unprognostic (4.90e-1)"	"unprognostic (1.57e-1)"	"unprognostic (2.37e-1)"	"prognostic unfavorable (3.08e-6)"	"unprognostic (3.46e-2)"	"unprognostic (1.04e-1)"	"unprognostic (7.68e-2)"	"unprognostic (2.42e-3)"	"unprognostic (1.57e-2)"	"unprognostic (6.96e-3)"	"unprognostic (6.61e-2)"	"unprognostic (8.53e-2)"	"unprognostic (1.30e-1)"	"unprognostic (3.92e-2)"	9.6	5.8	8.2	9.3	14.8	6.2	10.2	15.7	10.3	18.4	8.0	38.6	6.4	28.4	3.1	46.6	13.6	6.4	10.7	8.7	9.8	8.7	7.0	11.7	5.9	19.7	16.8	4.8	18.5	10.6	4.4	17.3	17.4	17.0	4.6	0.8	17.8	24.0	10.8	36.6	12.5	19.7	14.1	7.2	44.0	10.8	15.3	5.4	10.0	5.2	7.1	25.4	26.0	22.2	25.4	13.7	13.0	15.4	10.4	11.9	59.9	32.3	17.5	34.8	25.3	17.3	13.1	10.8	10.5	22.2	22.7	65.0	9.1	69.9	17.2	21.2	31.3	5.7	11.6	16.7	24.0	11.6	11.8	11.3	101.2	42.5	70.1	10.4	22.1	4.9	8.9	8.1	22.7	10.6	2.9	6.7	5.0	12.9	12.1	16.6	27.4	6.1	8.1	53.0	9.6	8.5	19.3	19.7	20.2	15.4	10.8	10.9	34.3	61.1	47.3	37.8	27.5	9.4	3.7	7.2	55.2	5.8	29.0	0.1	0.2	0.1	0.4	0.2	0.3	0.3	0.3	0.5	0.3	0.5	0.3	0.2	0.5	0.5	0.1	0.6	0.1	0.4	8.2	14.8	15.7	10.3	8.7	9.8	19.7	16.8	17.4	14.1	15.3	22.2	10.9	0.0	7.8	1.3	4.8	7.5	10.1	12.8	23.9	0.7	7.3	7.9	11.9	7.2	9.5	5.5	0.0	31.0	7.8	7.7	1.9	10.5	18.1	11.3	5.4	12.2	3.5	1.3	0.7	10.2	26.3	4.3	27.5	6.8	1.3	5.8	6.4	5.9	8.7	5.0	4.4	3.9	6.1	4.4	3.4	28.8	1.8	4.3	1.8	1.0	7.2	0.7	7.2	2.5	17.8	15.4	2.2	4.1	6.4	13.6	4.4	2.7	6.0	0.7	0.0	3.5	9.4	5.5	2.2	27.2	9.1	39.4	5.2	1.5	3.7	15.2
MPDZ	MUPP1	ENSG00000107186	"Multiple PDZ domain crumbs cell polarity complex component"	O75970	9	13105706-13279692	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 85.7"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 121.5;Excitatory neurons: 213.6;Inhibitory neurons: 271.3;Oligodendrocyte precursor cells: 158.8;Oligodendrocytes: 279.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AF22: 58.1;HUVEC TERT2: 53.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB013512, HPA020255, HPA026686"	Enhanced					NA	NA				"Cluster 15: Liver - Metabolism"	"Cluster 12: NES - Nervous system development"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"			"CAB013512: AB_2533517, HPA020255: AB_1854073, HPA026686: AB_1854074"	"unprognostic (1.55e-1)"	"unprognostic (4.21e-3)"	"unprognostic (4.09e-3)"	"unprognostic (1.68e-1)"	"unprognostic (4.28e-2)"	"unprognostic (1.03e-1)"	"prognostic favorable (8.68e-4)"	"unprognostic (4.74e-2)"	"unprognostic (7.52e-2)"	"unprognostic (2.50e-1)"	"prognostic favorable (7.40e-4)"	"unprognostic (1.54e-1)"	"unprognostic (2.59e-3)"	"unprognostic (1.32e-3)"	"unprognostic (2.50e-1)"	"unprognostic (1.58e-1)"	"unprognostic (9.74e-2)"	22.7	9.9	18.0	5.3	23.2	0.2	13.2	20.3	20.6	14.3	21.7	16.1	2.8	17.8	15.3	7.6	17.5	11.7	29.8	18.0	20.4	18.8	85.7	11.1	3.9	19.8	22.4	25.6	4.6	11.3	10.7	24.7	20.3	19.2	5.3	33.0	6.3	23.2	19.9	3.8	6.4	18.6	21.4	11.1	7.6	11.5	17.7	4.3	11.7	31.3	1.8	12.6	9.9	35.3	16.1	21.2	58.1	26.0	39.2	35.4	11.8	15.9	16.4	13.8	13.1	0.0	0.0	0.0	4.5	39.6	14.2	0.3	17.3	8.8	22.3	0.0	10.2	10.5	21.9	3.9	20.8	0.1	5.4	26.5	3.6	9.7	6.6	35.3	53.5	0.0	0.3	0.1	12.5	4.2	0.0	0.2	24.9	0.0	9.0	0.0	14.2	0.0	13.7	8.5	7.2	26.9	12.6	2.8	15.5	39.7	8.1	0.1	42.8	14.1	2.7	4.7	12.4	0.0	0.0	0.0	6.8	0.0	3.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	18.0	23.2	20.3	20.6	18.0	20.4	19.8	22.4	20.3	21.4	17.7	35.3	70.9	32.1	7.9	121.5	0.2	5.1	10.1	4.8	3.4	30.9	8.6	15.6	109.7	1.5	14.7	7.3	39.6	16.1	0.4	0.1	1.9	4.2	4.2	27.0	12.4	44.6	1.8	2.1	213.6	2.0	22.9	27.4	1.5	6.3	1.3	39.5	42.5	74.4	5.8	26.9	271.3	0.2	6.1	0.6	6.8	3.7	24.2	0.9	17.8	60.9	0.6	40.2	0.0	158.8	279.6	1.8	0.0	33.8	0.1	12.9	0.0	16.4	36.6	25.4	39.5	35.1	40.8	6.7	13.9	0.1	4.0	10.8	0.8	7.6	0.0	4.7
MSRB1	"SelR, SelX, SepR, SEPX1"	ENSG00000198736	"Methionine sulfoxide reductase B1"	Q9NZV6	16	1938229-1943293	"Enzymes, Predicted intracellular proteins"	"Immunity, Innate immunity"	Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 234.2"	"Cell type enhanced"	"Detected in many"		"Hepatocytes: 275.6;monocytes: 178.7;Proximal tubular cells: 496.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	5	"eosinophil: 1414.9;neutrophil: 3051.8"	"Lineage enriched"	"Detected in all"	7	"granulocytes: 3051.8"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB008650, HPA043463, HPA069557"	Enhanced		Enhanced	Nucleoplasm		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Nucleoplasm		"CAB008650: AB_1619225, HPA043463: AB_2678489, HPA069557: AB_2686153"	"unprognostic (3.93e-2)"	"unprognostic (3.68e-1)"	"unprognostic (1.32e-1)"	"unprognostic (9.61e-2)"	"unprognostic (1.76e-2)"	"unprognostic (1.15e-1)"	"unprognostic (2.19e-1)"	"unprognostic (1.49e-1)"	"unprognostic (2.88e-2)"	"unprognostic (4.90e-2)"	"unprognostic (5.29e-2)"	"unprognostic (3.60e-1)"	"unprognostic (4.27e-2)"	"unprognostic (8.46e-2)"	"unprognostic (4.92e-2)"	"unprognostic (7.31e-2)"	"unprognostic (4.59e-3)"	28.1	15.1	26.2	31.8	27.3	96.3	21.3	27.8	28.4	17.5	25.8	36.7	29.4	29.5	11.2	45.3	33.5	23.2	47.3	25.6	26.8	80.3	234.2	30.4	17.7	29.3	28.0	16.4	149.6	14.8	14.5	13.2	27.1	32.0	17.4	2.7	16.5	29.2	76.0	31.1	27.5	36.8	27.5	67.0	33.3	17.7	28.5	13.7	12.5	93.6	12.2	40.8	20.1	27.1	23.6	59.1	21.3	50.4	39.9	17.0	36.4	27.8	36.0	41.2	35.6	96.2	25.5	22.7	90.6	33.5	36.0	37.9	36.3	25.2	12.8	127.7	41.1	17.5	20.5	154.9	36.1	49.3	40.3	32.0	21.9	29.6	6.0	12.9	41.9	28.8	28.2	12.3	22.3	131.2	28.2	82.7	29.2	42.7	33.5	40.3	29.3	106.0	66.0	37.2	20.5	26.9	32.3	35.6	17.3	13.9	38.7	87.9	24.8	12.3	33.7	24.3	16.7	32.0	53.4	42.4	12.5	47.4	22.0	493.5	412.0	1414.9	31.9	194.8	32.2	28.0	26.5	26.7	171.2	28.3	20.5	22.7	3051.8	42.2	182.9	73.2	45.9	226.7	26.2	27.3	27.8	28.4	25.6	26.8	29.3	28.0	27.1	27.5	28.5	27.1	24.9	9.6	13.4	3.9	10.0	6.5	9.1	21.5	8.0	6.5	27.9	21.3	36.1	32.9	14.9	33.1	4.2	33.3	12.3	69.1	93.9	65.9	5.9	23.9	13.4	15.4	60.3	21.5	0.8	111.2	121.4	13.7	11.7	17.0	4.5	12.2	20.7	275.6	63.5	8.4	1.2	38.6	34.6	59.2	21.2	13.9	9.3	37.9	16.0	2.8	178.7	22.5	25.7	1.5	2.9	66.0	62.8	23.0	13.0	16.3	97.3	496.8	37.9	4.2	0.0	8.1	22.8	28.9	8.7	11.1	9.5	38.6	10.6	14.8	33.5	21.9
MXRA7	"FLJ46603, PS1TP1, TMAP1"	ENSG00000182534	"Matrix remodeling associated 7"	P84157	17	76672551-76711016	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Endometrial stromal cells: 203.7;Muller glia cells: 365.7;Rod photoreceptor cells: 163.8;Theca cells: 218.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"U-87 MG: 663.8"									"HPA044819, HPA075316"	Uncertain		Enhanced	"Endoplasmic reticulum"	"Secreted to blood"	NA	NA		100000	"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 44: Heart - Cardiac muscle contraction"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 5: Muller glia cells - Visual perception"	"Endoplasmic reticulum"		"HPA044819: AB_10964134, HPA075316: "	"unprognostic (1.34e-1)"	"unprognostic (2.00e-1)"	"unprognostic (1.32e-1)"	"unprognostic (2.92e-1)"	"unprognostic (1.19e-1)"	"unprognostic (3.16e-2)"	"prognostic unfavorable (4.70e-4)"	"unprognostic (3.38e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.51e-3)"	"unprognostic (2.07e-2)"	"unprognostic (8.33e-2)"	"unprognostic (5.39e-3)"	"unprognostic (4.67e-3)"	"unprognostic (6.21e-2)"	"unprognostic (4.63e-3)"	"prognostic unfavorable (1.80e-5)"	189.2	244.3	111.9	53.4	175.1	13.5	133.5	114.5	136.5	149.4	263.7	310.7	37.5	268.3	208.8	157.0	181.0	103.6	526.4	123.4	118.4	83.0	29.9	124.9	31.8	130.3	122.7	185.4	90.3	235.7	48.8	102.8	125.3	154.3	76.1	514.6	62.0	314.8	68.8	73.0	89.4	284.4	122.1	149.7	124.0	115.7	115.4	44.6	272.1	75.9	33.3	250.5	123.1	120.4	19.1	56.1	82.4	155.3	424.0	384.4	41.0	263.8	212.8	188.8	182.8	75.1	2.9	0.5	116.8	368.0	196.8	75.7	92.5	146.5	306.4	1.4	91.7	48.7	39.2	126.8	258.4	22.9	5.9	241.1	171.2	219.3	178.7	421.8	282.0	12.3	35.2	1.2	440.8	5.3	2.9	15.9	26.5	30.0	156.7	43.2	322.2	16.5	153.1	4.8	28.8	207.3	78.5	1.0	152.6	231.6	51.5	29.3	348.5	422.7	90.1	174.3	282.6	24.5	4.9	1.4	663.8	9.9	62.5	1.3	2.8	0.5	4.0	0.8	3.1	2.3	2.1	4.5	2.1	0.4	1.3	2.9	1.1	5.4	0.3	2.4	0.5	3.4	111.9	175.1	114.5	136.5	123.4	118.4	130.3	122.7	125.3	122.1	115.4	120.4	128.3	16.0	14.6	8.5	2.0	10.3	27.0	15.0	13.6	142.0	9.4	42.5	117.3	2.8	10.3	31.3	95.9	1.4	62.6	1.3	1.9	25.5	3.5	48.7	203.7	56.1	6.7	0.8	19.3	4.1	8.1	97.2	2.0	63.9	2.5	64.7	52.5	4.2	3.5	111.0	27.9	7.5	10.2	5.0	13.3	12.4	101.2	7.4	14.2	10.3	1.3	365.7	6.2	15.1	8.9	6.5	0.3	143.3	11.0	21.2	1.6	8.1	10.2	163.8	13.1	132.1	83.6	2.3	10.7	6.0	8.8	0.8	19.7	218.5	1.5	21.1
MYADM		ENSG00000179820	"Myeloid associated differentiation marker"	Q96S97	19	53864763-53876435	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"neutrophil: 207.4"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA056301			Approved	"Nuclear speckles"		NA	NA		27000	"Cluster 52: Eosinophils - Transcription"	"Cluster 12: Smooth muscle tissue - Mixed function"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 24: Non-specific - Transcription regulation"	"Nuclear speckles"		"HPA056301: "	"unprognostic (5.17e-2)"	"unprognostic (1.41e-1)"	"unprognostic (1.85e-1)"	"unprognostic (2.94e-1)"	"unprognostic (6.41e-2)"	"unprognostic (1.01e-2)"	"unprognostic (8.21e-3)"	"prognostic unfavorable (8.15e-4)"	"unprognostic (3.97e-2)"	"unprognostic (1.29e-1)"	"unprognostic (2.52e-1)"	"unprognostic (4.11e-1)"	"prognostic unfavorable (7.71e-7)"	"unprognostic (2.28e-3)"	"unprognostic (1.29e-1)"	"unprognostic (2.37e-2)"	"unprognostic (6.14e-3)"	179.4	25.7	21.5	66.5	20.2	196.3	82.4	3.1	21.6	97.4	24.6	155.6	48.9	248.6	22.2	76.8	146.5	124.6	92.3	16.7	22.2	19.8	46.4	110.7	37.2	16.9	24.7	73.4	101.1	31.1	17.9	89.6	13.7	75.0	39.9	3.6	48.8	100.9	36.7	45.2	63.8	180.9	6.4	42.5	79.5	28.4	17.3	37.1	57.8	21.1	15.2	104.6	64.8	18.8	28.8	231.6	29.2	23.3	96.2	66.0	45.3	145.9	105.9	57.0	58.7	94.4	84.1	2.6	53.7	187.4	61.6	56.4	14.6	56.7	48.5	34.9	34.2	38.0	35.8	75.6	219.2	78.4	131.3	72.3	12.7	73.4	10.5	93.4	52.0	14.9	41.5	68.7	36.4	32.0	21.4	60.9	27.9	104.3	65.3	82.1	31.0	13.3	63.8	3.0	0.4	43.8	1.2	44.6	14.1	58.4	44.4	66.8	105.5	125.8	44.5	17.0	66.2	44.7	29.9	0.6	78.4	37.1	2.1	74.3	48.1	165.5	20.9	27.1	19.6	5.4	13.4	15.2	59.5	7.1	12.5	11.0	207.4	17.8	23.5	22.3	5.4	20.0	21.5	20.2	3.1	21.6	16.7	22.2	16.9	24.7	13.7	6.4	17.3	18.8	125.9	163.5	59.1	2.9	138.9	103.0	173.3	73.1	96.8	4.1	141.0	105.8	67.1	97.2	91.5	20.2	4.2	46.2	143.3	43.8	0.0	106.6	2.7	97.0	164.1	117.2	202.4	35.7	9.1	51.8	243.9	279.7	83.1	195.5	347.6	27.0	182.8	18.5	73.5	10.1	8.3	203.9	24.4	120.4	217.2	2.2	90.1	180.3	60.5	11.2	68.0	4.0	19.6	7.1	13.9	71.4	54.7	116.6	189.9	56.6	2.7	0.5	57.0	1.4	151.2	340.1	199.0	35.9	14.5	19.7	59.8	49.5	221.5	20.5	93.8	75.0
MYOM1		ENSG00000101605	"Myomesin 1"	P52179	18	3066807-3219968	"Predicted intracellular proteins"		"Muscle protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	23	"heart muscle: 412.8;skeletal muscle: 845.6;tongue: 435.6"	"Cell type enriched"	"Detected in many"	15	"Cardiomyocytes: 1346.0"	"Cancer enhanced"	"Detected in many"		"liver cancer: 6.5"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	10	"HAP1: 13.5;HMC-1: 3.5;HSkMC: 6.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"HPA014305, HPA049193"	Enhanced					NA	NA		33000	"Cluster 29: Plasmacytoid DCs - Unknown function"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 54: Cardiomyocytes - Muscle contraction"			"HPA014305: AB_1854257, HPA049193: AB_2680670"	"unprognostic (2.51e-1)"	"unprognostic (2.08e-3)"	"unprognostic (2.19e-3)"	"unprognostic (8.01e-3)"	"unprognostic (8.94e-2)"	"unprognostic (4.31e-2)"	"unprognostic (9.10e-2)"	"unprognostic (1.59e-1)"	"unprognostic (9.27e-2)"	"unprognostic (1.87e-1)"	"unprognostic (2.38e-1)"	"unprognostic (1.63e-2)"	"unprognostic (2.01e-1)"	"unprognostic (9.15e-2)"	"unprognostic (4.90e-2)"	"unprognostic (1.73e-1)"	"unprognostic (2.62e-1)"	15.1	2.2	7.5	1.3	9.0	0.6	4.1	7.8	6.4	3.0	3.4	14.1	1.9	6.4	2.9	14.1	6.8	14.6	412.8	5.7	11.5	1.5	24.7	1.5	1.3	11.1	12.0	2.9	11.5	0.4	1.6	1.6	11.3	12.4	2.4	2.0	5.3	4.5	845.6	1.6	4.6	11.9	8.6	0.9	3.2	5.7	8.0	0.8	2.8	435.6	0.7	7.6	2.4	8.6	0.0	0.1	0.2	0.0	0.7	0.7	0.3	0.4	0.5	0.0	0.0	0.1	0.1	0.4	0.1	0.1	0.1	0.0	13.5	0.1	0.2	0.4	0.1	0.1	0.1	0.1	0.1	0.0	3.5	6.2	0.3	0.2	0.0	0.3	0.0	0.2	0.0	0.4	0.2	0.0	0.2	0.3	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.4	0.0	0.1	0.3	0.0	0.1	0.2	0.0	0.5	0.2	0.0	0.4	0.0	0.0	0.0	0.1	0.6	0.0	0.0	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.2	0.4	0.1	0.2	0.0	0.6	0.0	0.2	7.5	9.0	7.8	6.4	5.7	11.5	11.1	12.0	11.3	8.6	8.0	8.6	1.2	0.0	0.5	49.0	1.7	1.7	2.3	0.7	0.0	2.1	1.0	0.8	1346.0	27.1	1.2	0.0	2.1	0.9	2.7	7.4	0.0	0.6	11.7	1.1	0.4	12.0	0.0	0.8	3.5	6.3	0.1	27.4	6.6	1.0	0.0	3.4	2.5	19.1	0.3	1.7	7.1	0.7	4.1	1.3	2.1	14.1	2.1	1.3	0.0	7.5	1.5	0.2	2.1	24.6	13.5	1.5	88.9	4.1	0.1	0.8	0.5	0.3	2.1	1.6	6.6	24.6	40.8	4.4	5.4	0.1	1.3	2.2	1.3	1.3	0.6	0.6
NPNT	"EGFL6L, POEM"	ENSG00000168743	Nephronectin	Q6UXI9	4	105894775-106004027	"Predicted intracellular proteins, Predicted secreted proteins"	"Cell adhesion, Differentiation"	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lung: 137.0;thyroid gland: 234.5"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 185.9;Alveolar cells type 2: 103.7;Club cells: 56.4"	"Cancer enhanced"	"Detected in all"		"thyroid cancer: 104.1"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BEWO: 30.9;CAPAN-2: 19.1;HeLa: 32.3;Hep G2: 27.1;MCF7: 24.3;RPTEC TERT1: 37.7;T-47d: 51.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003711, HPA050203"	Supported		Approved	"Nucleoplasm,Cell Junctions,Cytosol"	"Secreted to extracellular matrix"	NA	NA		120000		"Cluster 7: Kidney - Transmembrane transport"	"Cluster 6: T47d - Mammary gland"	"Cluster 11: Alveolar cells - Smell perception"	"Nucleoplasm, Cell Junctions, Cytosol"		"HPA003711: AB_1854591, HPA050203: AB_2681050"	"unprognostic (1.24e-1)"	"unprognostic (7.93e-2)"	"unprognostic (1.59e-1)"	"unprognostic (2.43e-2)"	"unprognostic (3.92e-1)"	"unprognostic (2.49e-1)"	"unprognostic (1.87e-1)"	"unprognostic (7.85e-3)"	"unprognostic (4.78e-4)"	"unprognostic (1.19e-2)"	"unprognostic (1.57e-1)"	"unprognostic (1.68e-1)"	"prognostic favorable (8.28e-8)"	"unprognostic (4.81e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.77e-1)"	"unprognostic (2.31e-2)"	22.8	6.3	9.7	5.6	7.9	0.2	27.0	4.7	8.0	32.4	5.7	24.5	56.1	20.9	22.2	10.9	22.4	30.5	5.2	7.5	14.6	105.0	4.0	137.0	4.5	6.1	31.8	10.9	40.1	1.0	47.4	3.4	9.2	82.9	25.2	2.4	8.9	18.7	4.9	8.2	74.1	14.1	4.4	14.8	14.9	3.1	10.5	14.2	234.5	11.5	5.4	9.7	22.1	6.6	0.0	0.2	0.3	0.6	0.0	0.0	30.9	0.2	0.1	0.0	0.0	14.9	19.1	0.2	0.8	0.2	0.0	1.7	7.4	0.0	0.0	0.0	8.4	0.8	32.3	27.1	0.1	0.0	0.2	3.2	2.4	0.0	0.0	0.3	0.0	0.4	0.1	0.4	0.0	24.3	0.4	1.5	0.3	0.1	12.0	0.0	0.1	0.3	37.7	1.6	1.7	0.6	1.8	14.1	0.0	4.1	51.2	1.3	0.0	0.6	0.4	0.5	1.1	0.3	1.1	0.0	0.2	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.7	7.9	4.7	8.0	7.5	14.6	6.1	31.8	9.2	4.4	10.5	6.6	5.2	185.9	103.7	15.3	0.0	1.9	5.2	13.1	1.8	1.1	22.2	7.0	2.5	27.1	56.4	33.1	0.0	2.4	0.7	5.9	1.9	24.7	11.0	1.0	1.5	18.4	15.6	0.0	1.0	2.5	0.2	8.3	1.1	1.9	0.0	3.3	2.9	0.3	0.3	0.0	10.0	10.6	4.1	0.0	1.5	15.4	2.5	0.6	5.4	14.0	0.0	0.0	0.0	2.0	0.3	7.5	3.4	0.0	0.0	28.4	19.6	4.3	6.4	0.2	0.0	1.9	26.4	2.4	2.0	3.6	1.1	1.5	0.3	1.5	11.0	5.7
NPTN	"GP55, GP65, np55, np65, SDFR1, SDR1"	ENSG00000156642	Neuroplastin	Q9Y639	15	73560014-73634134	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Cell adhesion, Neurogenesis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Excitatory neurons: 216.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA051497, HPA072453"	Approved		Approved	"Plasma membrane"		NA	No		15000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 12: Smooth muscle tissue - Mixed function"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Plasma membrane"		"HPA051497: AB_2681507, HPA072453: AB_2686523"	"unprognostic (9.30e-3)"	"unprognostic (1.70e-1)"	"unprognostic (5.01e-2)"	"unprognostic (4.14e-1)"	"unprognostic (3.11e-2)"	"unprognostic (7.42e-3)"	"unprognostic (9.74e-2)"	"unprognostic (9.67e-2)"	"unprognostic (3.63e-2)"	"unprognostic (1.68e-1)"	"unprognostic (3.57e-2)"	"unprognostic (1.93e-1)"	"unprognostic (1.60e-3)"	"unprognostic (5.55e-2)"	"unprognostic (7.41e-2)"	"unprognostic (1.70e-1)"	"unprognostic (1.17e-1)"	84.6	95.7	81.4	75.9	104.4	32.7	82.6	52.1	176.7	112.4	72.4	133.0	134.9	180.7	150.9	133.9	135.0	97.2	196.4	122.6	65.6	126.5	74.0	110.5	48.7	42.9	42.2	79.1	96.6	167.2	47.1	123.1	39.8	170.8	142.0	135.5	101.0	204.4	51.2	68.1	124.9	298.4	28.5	71.8	96.4	69.2	60.4	42.6	112.4	70.1	69.4	140.6	84.9	87.9	101.9	179.1	100.9	74.5	201.6	180.7	141.1	229.1	373.5	258.3	228.4	122.4	317.7	58.7	133.0	331.2	319.2	411.1	164.4	191.3	147.6	105.6	109.3	46.7	83.3	110.2	143.1	72.6	124.9	149.1	165.2	167.4	100.7	254.8	139.5	52.0	26.7	65.2	187.2	81.2	32.4	45.3	93.5	127.3	63.3	52.1	115.8	49.9	353.7	148.3	61.6	19.2	222.4	122.4	151.3	249.6	110.9	97.7	159.0	199.7	133.8	116.0	135.8	56.5	113.8	51.4	185.8	111.0	140.0	5.9	13.5	13.8	6.4	18.5	5.2	3.8	3.6	5.9	5.3	2.9	3.6	4.2	28.0	3.9	14.8	5.5	4.3	13.6	81.4	104.4	52.1	176.7	122.6	65.6	42.9	42.2	39.8	28.5	60.4	87.9	67.1	76.9	66.0	72.1	18.3	65.0	27.0	43.3	51.2	93.0	50.5	45.7	106.9	48.6	60.6	82.8	50.1	7.0	28.8	133.8	1.9	18.1	3.7	73.4	46.7	44.6	103.0	7.4	216.6	24.0	9.2	64.5	41.3	92.1	28.4	33.9	50.0	43.1	25.0	38.7	162.7	90.9	42.7	77.4	46.6	9.9	15.2	61.8	42.7	86.2	43.4	41.2	12.3	63.8	67.4	41.4	66.7	38.4	20.2	26.9	52.3	20.7	92.1	49.7	19.7	35.5	74.0	11.7	10.8	61.9	54.6	6.8	23.9	35.3	52.6	30.7
OXCT1	"OXCT, SCOT"	ENSG00000083720	"3-oxoacid CoA-transferase 1"	P55809	5	41730065-41870425	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"		Transferase	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 245.9"	"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 243.7;Distal tubular cells: 187.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HeLa: 238.7;SiHa: 319.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA012047, HPA061425"	Enhanced		Enhanced	Mitochondria	"Intracellular and membrane"	NA	NA		440000	"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 44: Heart - Cardiac muscle contraction"	"Cluster 20: HeLa - Mitochondria"	"Cluster 39: Non-specific - Basic cellular processes"	Mitochondria		"HPA012047: AB_1854857, HPA061425: AB_2684515"	"unprognostic (4.26e-2)"	"unprognostic (2.10e-2)"	"unprognostic (2.89e-2)"	"unprognostic (1.51e-1)"	"unprognostic (5.51e-2)"	"unprognostic (1.82e-2)"	"prognostic unfavorable (1.03e-4)"	"unprognostic (7.42e-3)"	"unprognostic (1.74e-3)"	"unprognostic (1.67e-1)"	"unprognostic (2.80e-2)"	"unprognostic (3.62e-1)"	"prognostic favorable (1.86e-8)"	"unprognostic (2.66e-2)"	"unprognostic (9.99e-2)"	"unprognostic (5.86e-3)"	"unprognostic (2.28e-3)"	52.7	15.8	30.4	16.6	34.9	13.3	18.5	23.9	32.7	13.5	15.9	19.2	8.3	14.9	17.6	26.8	12.4	15.2	245.9	36.2	27.1	53.1	1.3	8.0	21.7	19.5	21.4	13.8	5.3	48.6	14.7	5.0	20.0	25.5	21.1	23.6	18.9	29.8	28.5	23.1	12.8	36.6	19.3	11.0	34.2	13.2	25.7	76.8	27.3	42.6	25.9	15.1	13.8	24.5	35.3	1.6	27.9	33.6	84.7	45.0	0.1	62.1	38.9	50.3	30.4	5.7	23.5	91.2	15.0	47.5	25.8	20.5	77.5	55.9	58.5	78.5	9.1	63.9	238.7	11.9	36.8	125.8	20.9	42.7	15.3	49.3	82.2	24.6	46.4	81.6	13.3	114.0	58.1	4.5	105.5	6.1	6.4	0.0	24.5	82.8	78.9	68.7	41.7	2.9	27.9	28.8	319.5	0.3	38.3	2.5	0.4	27.4	28.3	39.7	51.9	68.6	50.6	18.6	16.5	3.6	59.9	90.9	30.9	1.4	1.4	4.7	11.6	1.5	13.8	10.0	11.5	12.7	6.3	7.5	13.6	10.9	0.4	11.3	2.5	2.4	21.5	6.6	30.4	34.9	23.9	32.7	36.2	27.1	19.5	21.4	20.0	19.3	25.7	24.5	8.4	6.4	9.2	37.5	19.2	14.8	11.7	12.4	17.6	14.1	18.8	14.2	243.7	7.2	14.3	11.0	2.1	7.0	18.3	5.0	187.9	5.4	19.1	11.7	18.8	9.8	13.2	23.1	71.5	0.7	11.9	21.3	20.4	31.2	9.5	8.7	6.8	0.3	38.2	13.5	84.2	18.6	12.2	1.3	7.0	8.6	6.2	5.2	16.0	26.2	4.4	11.8	10.3	66.4	46.8	4.8	5.3	7.5	31.3	12.1	2.9	27.4	5.6	21.6	13.1	9.7	24.6	35.6	19.7	27.6	21.6	6.8	26.6	8.6	18.1	9.0
PCYT1B	"CCT-beta, CTB"	ENSG00000102230	"Phosphate cytidylyltransferase 1, choline, beta"	Q9Y5K3	X	24558087-24672677	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism"	"Nucleotidyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 13.2;retina: 12.1;testis: 13.4"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 23.5;Early spermatids: 29.1;Late spermatids: 90.1;Muller glia cells: 30.1;Oligodendrocyte precursor cells: 23.6;Oligodendrocytes: 41.9"	"Cancer enhanced"	"Detected in some"		"glioma: 4.4"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 10.3;CACO-2: 22.2;HEL: 25.7;Hep G2: 10.2;NTERA-2: 11.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA006367	Uncertain					NA	NA			"Cluster 17: Basophils - Unknown function"	"Cluster 77: Retina - Visual perception"	"Cluster 36: HEL - Hemostasis"	"Cluster 31: Spermatids - Spermatogenesis"			"HPA006367: AB_1079585"	"unprognostic (4.49e-1)"	"unprognostic (2.20e-1)"	"unprognostic (1.16e-1)"	"unprognostic (7.39e-2)"	"unprognostic (9.88e-2)"	"unprognostic (6.83e-2)"	"unprognostic (5.05e-2)"	"unprognostic (2.92e-1)"	"unprognostic (1.61e-2)"	"unprognostic (1.67e-1)"	"unprognostic (1.65e-2)"	"unprognostic (5.64e-2)"	"unprognostic (2.63e-6)"	"unprognostic (2.62e-4)"	"unprognostic (4.56e-2)"	"unprognostic (1.75e-2)"	"unprognostic (1.96e-4)"	0.1	0.8	12.1	0.2	12.2	0.8	0.1	10.6	12.8	0.7	7.5	1.2	0.3	1.6	0.6	0.8	2.2	0.4	2.9	13.2	9.8	0.2	0.0	0.7	0.0	9.5	10.2	1.4	1.5	0.0	1.3	1.3	9.8	0.8	0.2	12.1	0.1	2.4	0.0	0.1	0.6	2.5	8.6	0.2	0.2	13.4	11.4	0.5	0.0	0.0	0.0	0.3	0.3	12.9	0.0	0.0	10.3	0.1	0.0	0.0	0.1	0.0	0.9	0.3	0.1	22.2	0.0	0.0	5.2	0.0	0.0	1.0	4.2	0.0	0.0	0.0	0.1	25.7	0.0	10.2	0.1	0.0	0.3	0.0	0.1	0.3	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	3.9	0.5	11.4	0.0	0.0	0.0	1.4	0.0	0.0	0.0	7.2	5.8	0.0	0.0	0.5	7.1	0.1	0.0	0.0	0.0	0.3	0.0	0.5	0.2	0.0	0.0	4.4	0.7	0.3	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.1	0.1	0.0	0.2	12.1	12.2	10.6	12.8	13.2	9.8	9.5	10.2	9.8	8.6	11.4	12.9	0.0	0.0	0.0	23.5	0.0	0.0	0.2	0.1	0.0	0.4	0.0	0.5	1.6	0.0	0.7	0.0	0.0	0.1	0.0	0.0	0.0	0.8	29.1	10.7	0.2	0.1	1.8	1.3	5.6	0.0	0.0	0.4	0.0	0.2	4.5	5.8	0.0	0.0	0.0	0.0	9.1	0.0	0.0	0.0	0.0	90.1	0.3	0.9	0.0	3.7	0.3	30.1	0.0	23.6	41.9	0.2	0.0	2.6	0.1	0.1	0.0	0.5	6.4	1.6	0.0	0.0	1.0	1.8	0.5	0.0	0.0	0.0	0.0	0.8	0.0	0.1
PFN1		ENSG00000108518	"Profilin 1"	P07737	17	4945652-4949061	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"		Actin-binding	"Amyotrophic lateral sclerosis, Disease variant, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Extravillous trophoblasts: 5241.0;monocytes: 4824.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB037134, CAB037140"	Enhanced		Approved	Cytosol		NA	NA		660000000	"Cluster 31: Non-specific - Inflammatory response"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 3: Monocytes - Immune response regulation"	Cytosol		"CAB037134: AB_1079599, CAB037140: AB_1079598"	"unprognostic (1.07e-1)"	"unprognostic (3.57e-1)"	"unprognostic (1.60e-1)"	"unprognostic (5.45e-3)"	"unprognostic (1.65e-1)"	"unprognostic (7.54e-2)"	"unprognostic (4.01e-3)"	"unprognostic (7.83e-3)"	"unprognostic (3.38e-1)"	"unprognostic (1.09e-3)"	"unprognostic (2.17e-1)"	"unprognostic (3.40e-2)"	"prognostic unfavorable (1.06e-4)"	"unprognostic (3.62e-1)"	"unprognostic (8.17e-2)"	"unprognostic (1.02e-2)"	"unprognostic (1.28e-1)"	573.1	365.8	278.0	1133.4	302.0	1613.0	397.0	323.2	333.0	393.7	289.2	970.2	764.0	734.4	346.4	582.7	500.9	372.7	343.8	281.8	301.5	460.9	661.6	559.2	1357.9	347.3	325.4	247.7	246.4	311.3	198.9	581.1	348.6	419.4	808.4	71.8	346.9	601.4	337.9	449.8	772.9	1034.7	315.2	910.8	675.1	116.2	366.2	1197.6	269.2	238.7	1440.0	842.6	425.0	355.2	3019.5	4276.8	1461.5	1205.2	778.8	977.1	1972.7	2416.8	1970.4	2568.6	1923.7	1684.1	1181.1	2476.9	1892.0	2542.0	1453.6	1825.4	1383.6	3040.5	2049.6	3560.1	2355.1	2516.6	2034.3	2225.8	2144.0	1630.4	5006.0	1152.4	1331.9	1957.6	1939.8	1477.6	2361.3	1646.4	1488.6	1736.7	3150.5	1815.0	2469.9	3448.0	2095.2	1474.7	2297.3	2451.9	2035.1	1494.6	2491.7	1909.8	564.0	1586.2	1910.5	1180.9	1679.7	1226.8	1121.0	1359.7	2731.7	2136.6	1675.1	1512.3	3969.3	931.3	1070.7	1799.3	1834.4	1949.7	3316.4	8100.1	8206.3	13914.4	9850.0	10858.8	6780.3	5722.0	8185.7	9586.6	9920.0	4970.0	5238.0	7604.7	9387.0	9112.1	13547.4	7809.7	11245.6	23570.1	278.0	302.0	323.2	333.0	281.8	301.5	347.3	325.4	348.6	315.2	366.2	355.2	561.8	112.2	176.1	12.1	1070.6	1806.0	873.2	3658.3	1003.3	25.0	767.4	914.1	147.6	457.5	1020.0	741.2	0.0	1911.0	1725.6	1733.8	992.0	1866.6	19.7	313.4	546.1	806.6	603.7	713.5	7.1	1625.2	5241.0	599.9	733.4	422.7	486.5	291.2	637.5	754.3	4094.2	38.7	6.4	1399.7	1452.6	1434.3	2934.8	31.0	263.8	1854.7	873.4	21.5	4824.7	99.8	3216.3	9.0	37.2	2933.5	1585.7	375.0	927.8	1238.2	1472.2	1671.2	559.4	17.8	506.2	282.3	1838.4	97.4	355.4	1170.1	1513.5	1682.8	1804.7	410.7	1355.5	1177.9
PLAAT3	"AdPLA, H-REV107-1, HRASLS3, HREV107, HREV107-3, MGC118754., PLA2G16, PLAAT-3"	ENSG00000176485	"Phospholipase A and acyltransferase 3"	P53816	11	63573195-63616883	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins, RAS pathway related proteins"	"Host-virus interaction, Lipid degradation, Lipid metabolism"	"Hydrolase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adipose tissue: 318.7;brain: 394.8"	"Cell type enhanced"	"Detected in some"		"Adipocytes: 80.5;Cardiomyocytes: 151.9;Cytotrophoblasts: 137.4;Extravillous trophoblasts: 365.5;Hofbauer cells: 71.0;Syncytiotrophoblasts: 290.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"plasmacytoid DC: 187.8"	"Group enriched"	"Detected in all"	6	"dendritic cells: 187.8;T-cells: 55.0"	"Cell line enhanced"	"Detected in many"		"A549: 135.1;ASC diff: 148.2;CAPAN-2: 247.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA011749, HPA058997"	Approved		Supported	Mitochondria		NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 38: Extravillous trophoblasts - Unknown function"	Mitochondria		"HPA011749: , HPA058997: AB_2683874"	"unprognostic (5.18e-2)"	"unprognostic (3.67e-2)"	"unprognostic (7.92e-2)"	"unprognostic (3.89e-2)"	"unprognostic (1.94e-1)"	"unprognostic (1.78e-1)"	"unprognostic (1.13e-1)"	"unprognostic (3.06e-2)"	"unprognostic (6.97e-2)"	"unprognostic (1.14e-1)"	"prognostic unfavorable (5.58e-6)"	"unprognostic (6.38e-2)"	"unprognostic (1.93e-3)"	"unprognostic (1.62e-1)"	"unprognostic (1.75e-1)"	"prognostic favorable (2.54e-5)"	"unprognostic (2.35e-1)"	318.7	36.2	208.5	10.2	287.0	3.1	166.8	234.7	261.6	13.3	142.8	32.8	8.7	17.6	26.6	13.2	33.0	29.1	103.0	197.7	215.3	65.0	76.5	37.6	11.6	283.0	250.7	73.4	32.4	28.6	33.4	40.3	279.8	16.4	7.6	26.6	28.9	29.9	108.9	10.7	21.8	15.8	241.2	15.9	31.9	54.7	237.1	7.1	41.2	118.7	4.4	26.7	9.6	394.8	87.7	135.1	3.7	0.2	148.2	25.1	24.1	3.2	26.9	22.3	11.2	30.8	247.1	0.0	55.3	6.9	72.4	4.4	127.4	6.8	16.9	108.0	5.0	1.3	33.3	5.4	87.8	0.0	1.3	15.2	0.7	55.4	2.2	88.1	35.4	0.0	1.6	9.6	24.0	15.3	0.2	0.6	10.8	55.0	43.0	0.0	0.0	8.7	71.2	12.3	1.7	9.7	18.0	51.5	28.7	54.6	111.6	4.5	52.2	10.0	0.7	34.0	7.7	39.6	28.0	0.3	40.1	0.0	1.0	0.1	21.1	0.1	55.0	9.1	30.3	7.4	12.1	40.5	6.4	1.2	3.9	30.0	1.3	21.0	0.6	187.8	9.3	27.2	208.5	287.0	234.7	261.6	197.7	215.3	283.0	250.7	279.8	241.2	237.1	394.8	80.5	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	151.9	0.0	0.0	0.0	0.0	137.4	18.6	0.0	0.0	0.0	0.0	0.0	0.0	12.0	0.0	0.0	0.0	0.0	365.5	14.7	0.0	0.0	0.0	0.0	0.0	0.0	71.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.0	0.0	0.0	0.0	0.0	290.6	2.0	0.0	0.0	0.0
PRKAG2	"AAKG, AAKG2, CMH6, H91620p, WPWS"	ENSG00000106617	"Protein kinase AMP-activated non-catalytic subunit gamma 2"	Q9UGJ0	7	151556124-151877125	"Disease related genes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism"		"Cardiomyopathy, Disease variant, FDA approved drug targets, Glycogen storage disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 143.0"	"Cell type enhanced"	"Detected in all"		"Excitatory neurons: 208.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"GAMG: 178.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004246, CAB018641"	Uncertain		Approved	Nucleoplasm		NA	NA			"Cluster 34: Basophils - Unknown function"	"Cluster 44: Heart - Cardiac muscle contraction"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Nucleoplasm		"CAB018641: AB_2170355, HPA004246: AB_1078151"	"unprognostic (4.11e-2)"	"unprognostic (2.82e-1)"	"unprognostic (1.46e-2)"	"unprognostic (9.29e-2)"	"unprognostic (1.76e-1)"	"unprognostic (4.33e-3)"	"unprognostic (7.13e-2)"	"unprognostic (8.09e-2)"	"unprognostic (1.77e-1)"	"unprognostic (1.18e-1)"	"unprognostic (2.46e-2)"	"unprognostic (1.42e-1)"	"unprognostic (1.35e-1)"	"unprognostic (1.67e-1)"	"unprognostic (3.80e-1)"	"unprognostic (3.61e-2)"	"unprognostic (4.52e-1)"	27.1	7.7	21.7	12.8	20.3	8.1	18.4	16.7	22.8	16.2	11.1	25.8	24.4	19.8	14.3	16.2	17.9	12.8	143.0	23.7	21.1	22.5	36.1	14.2	11.6	19.3	17.4	10.9	10.9	9.2	9.5	16.1	19.7	25.3	18.9	2.9	15.0	19.5	15.0	13.5	26.2	16.5	15.8	17.6	26.7	12.8	18.5	7.9	16.6	21.7	9.8	47.9	17.5	19.6	46.6	13.6	9.1	10.6	36.4	28.6	14.4	21.5	19.5	22.7	22.3	8.6	52.5	0.0	34.0	28.9	178.2	13.9	5.7	22.4	30.0	15.8	6.2	11.5	1.8	0.9	60.8	8.5	11.4	16.5	49.7	21.8	21.0	34.1	40.2	14.9	4.1	5.6	66.2	17.2	3.5	6.7	9.7	18.8	37.5	5.6	6.9	9.7	39.2	10.9	38.5	6.7	10.7	19.9	10.0	22.9	4.0	13.6	52.8	5.0	4.3	2.8	13.1	3.5	5.1	0.0	63.5	29.8	45.9	26.2	9.3	10.9	5.3	7.0	4.1	9.6	4.9	4.8	6.5	4.0	4.8	7.3	11.1	4.4	6.4	6.0	2.9	5.3	21.7	20.3	16.7	22.8	23.7	21.1	19.3	17.4	19.7	15.8	18.5	19.6	19.2	6.4	19.8	37.5	24.8	10.6	39.9	25.0	19.9	22.3	20.6	14.5	122.3	8.6	22.9	46.0	8.4	3.9	43.8	29.5	64.6	14.1	49.3	75.1	16.9	20.4	13.1	3.8	208.5	22.7	31.2	24.9	21.9	98.1	22.2	4.6	18.9	76.8	17.7	3.3	85.2	34.5	105.8	57.2	48.2	35.8	7.5	50.9	16.0	73.1	62.9	14.7	37.0	39.2	4.4	27.5	21.9	7.9	23.4	45.7	77.7	19.7	14.2	6.1	13.1	6.9	27.3	4.0	32.3	12.8	10.9	50.6	27.3	5.0	28.0	45.2
PSMC3	"TBP-1, TBP1"	ENSG00000165916	"Proteasome 26S subunit, ATPase 3"	P17980	11	47418769-47426473	"Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA006065	Approved		Approved	"Nucleoplasm,Nuclear bodies,Cytosol"		NA	NA		290000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 10: Non-specific - Unknown function"	"Nucleoplasm, Cytosol"	"Nuclear bodies"	"HPA006065: AB_1079706"	"unprognostic (2.01e-2)"	"unprognostic (5.08e-3)"	"unprognostic (9.43e-2)"	"unprognostic (8.12e-3)"	"unprognostic (6.32e-2)"	"unprognostic (5.71e-2)"	"unprognostic (8.99e-3)"	"unprognostic (1.63e-1)"	"unprognostic (9.95e-2)"	"unprognostic (1.27e-2)"	"unprognostic (3.88e-2)"	"unprognostic (1.12e-1)"	"prognostic unfavorable (4.24e-4)"	"unprognostic (1.49e-1)"	"unprognostic (2.25e-1)"	"unprognostic (2.55e-2)"	"unprognostic (1.84e-1)"	85.3	86.1	106.8	64.7	117.3	96.1	77.9	105.3	131.0	73.7	105.8	110.2	52.2	89.9	62.5	88.7	69.0	44.0	172.1	107.8	106.3	73.8	117.7	76.2	65.3	108.6	114.7	58.2	81.4	74.1	55.4	78.8	111.0	74.2	59.1	30.9	73.0	69.8	292.0	103.4	64.0	77.5	104.6	67.8	87.7	74.7	115.2	90.6	69.4	162.9	76.5	80.8	71.7	107.0	223.7	248.2	233.5	173.3	109.6	117.3	226.5	181.5	267.4	445.7	313.8	223.3	126.8	179.5	110.1	230.1	195.7	218.3	206.7	237.7	199.0	269.4	268.1	173.1	301.1	218.5	141.4	203.7	177.0	131.4	126.1	181.6	202.5	98.4	253.8	182.7	249.2	164.7	276.0	497.0	259.5	258.4	229.5	280.7	296.1	269.3	458.8	157.3	209.5	165.2	170.0	147.1	148.7	206.9	116.2	98.2	255.7	209.8	181.3	253.7	321.1	363.8	474.7	176.5	220.0	209.2	262.4	201.7	325.1	111.5	154.3	121.8	160.8	194.6	146.7	146.8	132.9	147.8	160.6	122.4	116.5	118.6	33.9	173.3	211.6	160.0	191.0	254.7	106.8	117.3	105.3	131.0	107.8	106.3	108.6	114.7	111.0	104.6	115.2	107.0	81.5	57.7	42.0	3.9	59.5	86.3	112.8	198.5	50.7	41.2	61.4	64.1	217.6	81.5	103.7	68.0	16.7	265.9	60.0	143.9	152.6	199.2	152.5	72.0	75.7	96.0	64.5	136.6	6.4	202.6	257.9	100.4	54.0	70.1	75.3	79.2	77.1	144.2	158.2	37.0	5.3	111.5	75.3	62.4	80.0	217.6	88.6	62.5	99.6	1.9	132.0	120.2	74.2	3.0	5.2	214.2	110.8	100.1	96.3	102.8	127.7	191.3	76.9	47.4	118.3	75.1	193.3	147.0	63.6	51.3	77.3	352.9	61.8	74.1	117.6	101.6
RAB23		ENSG00000112210	"RAB23, member RAS oncogene family"	Q9ULC3	6	57186992-57222307	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Protein transport, Transport"	"Developmental protein"	"Craniosynostosis, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Fibroblasts: 22.3;Peritubular cells: 30.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in all"		"ASC TERT1: 97.2;U-2197: 177.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029135, HPA029136"	Enhanced		Enhanced	"Plasma membrane,Cytosol"		NA	NA			"Cluster 29: Plasmacytoid DCs - Unknown function"	"Cluster 12: Smooth muscle tissue - Mixed function"	"Cluster 18: U-2197 - ECM organization"	"Cluster 33: Fibroblasts - ECM organization"	"Plasma membrane, Cytosol"		"HPA029135: AB_10602070, HPA029136: AB_10601794"	"unprognostic (8.78e-2)"	"unprognostic (6.55e-2)"	"unprognostic (7.17e-2)"	"unprognostic (1.10e-1)"	"unprognostic (2.14e-2)"	"unprognostic (2.28e-2)"	"unprognostic (2.55e-2)"	"unprognostic (5.33e-3)"	"unprognostic (6.41e-2)"	"unprognostic (6.55e-2)"	"unprognostic (1.05e-1)"	"unprognostic (2.97e-2)"	"unprognostic (9.12e-3)"	"unprognostic (1.36e-2)"	"unprognostic (2.38e-1)"	"unprognostic (6.37e-2)"	"unprognostic (1.46e-3)"	9.6	6.1	8.6	13.2	9.0	0.8	7.8	10.9	9.6	45.9	6.1	59.7	7.0	52.6	14.1	19.9	14.5	26.9	12.3	8.5	15.2	7.3	4.1	10.6	4.5	8.7	8.7	10.8	2.9	5.7	3.4	27.6	9.5	38.7	15.9	3.9	3.9	55.7	6.1	4.8	10.8	75.0	9.2	2.2	11.6	5.1	9.7	3.2	32.6	10.4	4.1	46.7	14.7	11.5	15.6	6.1	21.6	15.3	32.3	97.2	19.8	44.9	77.4	38.6	39.7	13.4	7.3	3.1	13.6	72.3	19.3	5.5	22.7	16.4	45.6	11.6	10.5	11.3	9.4	10.6	19.8	5.9	1.6	36.5	18.6	48.1	44.7	18.7	20.3	6.6	17.6	9.3	43.4	13.2	5.2	6.3	8.1	10.3	8.2	5.7	31.7	4.7	26.8	10.7	11.2	7.6	22.5	10.6	11.6	26.8	9.7	6.8	27.4	59.6	18.5	177.4	26.6	8.0	9.3	7.6	33.5	12.5	30.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.1	0.0	0.1	0.1	0.2	0.0	0.0	8.6	9.0	10.9	9.6	8.5	15.2	8.7	8.7	9.5	9.2	9.7	11.5	2.9	12.8	5.0	6.8	0.7	4.1	1.6	2.0	5.7	2.5	4.0	3.0	3.4	1.5	1.6	0.0	2.1	11.5	1.7	2.4	0.0	3.4	2.4	6.5	15.5	2.6	1.2	4.8	13.0	2.9	10.7	22.3	1.1	6.2	0.0	3.7	4.6	3.4	4.2	1.7	12.3	1.4	2.0	0.8	3.1	2.5	19.9	1.4	5.4	11.2	7.7	4.4	0.0	8.0	5.3	2.6	0.1	30.5	0.5	3.5	0.6	6.1	5.3	0.9	0.0	17.2	14.5	6.6	7.8	4.1	5.1	13.7	0.8	4.0	1.6	1.8
RASL12	RIS	ENSG00000103710	"RAS like family 12"	Q9NYN1	15	65053337-65076690	"Enzymes, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"Astrocytes: 22.5;Peritubular cells: 57.9;Sertoli cells: 98.6;Smooth muscle cells: 55.7"	"Cancer enhanced"	"Detected in all"		"glioma: 21.2"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC TERT1: 5.0;CACO-2: 14.5;EFO-21: 22.7;NTERA-2: 9.9;SuSa: 17.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA				"Cluster 57: Non-specific - Angiogenesis"	"Cluster 38: EFO-21 - Unknown function"	"Cluster 48: Smooth muscle cells - ECM organization"				"unprognostic (6.13e-3)"	"unprognostic (1.06e-1)"	"unprognostic (2.47e-2)"	"unprognostic (6.95e-2)"	"unprognostic (1.39e-1)"	"unprognostic (1.21e-2)"	"unprognostic (4.10e-2)"	"unprognostic (1.40e-1)"	"unprognostic (1.29e-3)"	"unprognostic (1.60e-1)"	"unprognostic (4.45e-2)"	"unprognostic (1.51e-1)"	"prognostic unfavorable (7.20e-5)"	"unprognostic (1.76e-2)"	"unprognostic (4.72e-2)"	"unprognostic (1.21e-1)"	"prognostic unfavorable (2.17e-4)"	27.9	3.9	32.9	5.1	36.8	0.0	15.7	30.8	24.4	49.8	8.5	35.6	3.6	61.6	27.9	19.2	54.7	13.2	53.4	26.0	38.4	6.9	1.1	38.4	3.3	39.4	57.4	16.5	2.4	1.8	7.0	17.0	38.0	52.5	6.7	3.3	8.0	76.4	37.1	12.1	9.4	33.0	38.8	9.6	7.7	15.6	66.1	0.9	8.4	20.6	1.7	40.2	33.5	32.6	0.1	0.1	0.2	0.0	0.6	5.0	0.2	0.0	0.5	0.0	0.0	14.5	0.1	0.0	22.7	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	9.9	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	17.3	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	32.9	36.8	30.8	24.4	26.0	38.4	39.4	57.4	38.0	38.8	66.1	32.6	7.4	0.0	0.0	22.5	0.0	1.5	3.9	0.0	0.0	0.3	2.0	5.6	16.3	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	4.7	0.3	12.6	3.6	0.0	0.0	0.1	0.0	0.1	15.2	0.5	0.5	0.0	12.3	1.4	0.1	0.3	0.0	0.1	0.0	2.0	0.0	1.3	3.9	13.1	0.2	0.0	2.8	0.0	17.9	0.0	0.0	0.0	0.1	0.0	57.9	0.0	0.4	0.5	0.0	0.0	0.8	98.6	0.9	55.7	0.7	1.1	0.4	0.1	0.3	0.2	0.4	0.2	0.1
RBM24	"dJ259A10.1, FLJ30829, RNPC6"	ENSG00000112183	"RNA binding motif protein 24"	Q9BX46	6	17281361-17293871	"Predicted intracellular proteins"	"Differentiation, mRNA processing, mRNA splicing, Translation regulation"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"heart muscle: 142.1;skeletal muscle: 313.0;tongue: 105.7"	"Cell type enriched"	"Detected in many"	5	"Cardiomyocytes: 193.2"	"Cancer enhanced"	"Detected in many"		"testis cancer: 5.8"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"LHCN-M2: 58.7;RH-30: 59.7;T-47d: 28.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA066927, HPA067231"	Enhanced		Enhanced	Nucleoplasm,Cytosol		NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 54: Cardiomyocytes - Muscle contraction"	Nucleoplasm	Cytosol	"HPA066927: AB_2685750, HPA067231: AB_2685808"	"unprognostic (9.05e-3)"	"unprognostic (2.57e-1)"	"unprognostic (2.24e-1)"	"unprognostic (1.67e-3)"	"unprognostic (1.53e-1)"	"unprognostic (4.54e-4)"	"unprognostic (3.34e-2)"	"unprognostic (1.33e-2)"	"unprognostic (2.97e-3)"	"unprognostic (3.38e-2)"	"unprognostic (2.98e-2)"	"unprognostic (1.43e-1)"	"unprognostic (1.45e-1)"	"unprognostic (1.16e-2)"	"unprognostic (3.06e-2)"	"unprognostic (1.08e-2)"	"unprognostic (2.33e-4)"	5.4	0.5	3.7	1.7	4.1	0.1	3.7	0.1	5.7	13.9	2.5	9.7	1.6	31.2	16.8	7.4	24.0	2.6	142.1	4.5	4.9	0.9	1.1	1.3	0.5	1.6	1.9	2.1	0.2	2.1	5.5	0.6	0.7	9.9	7.4	0.4	4.1	5.8	313.0	1.4	3.6	29.3	0.6	1.2	2.1	4.2	3.0	0.8	2.1	105.7	0.3	8.8	3.6	2.2	1.5	9.3	12.0	0.0	0.0	0.0	0.0	18.7	6.8	12.4	13.0	0.0	1.1	0.0	5.7	13.4	19.5	0.0	11.5	0.4	22.3	0.0	0.4	0.0	1.0	6.4	0.5	0.0	1.1	6.4	0.0	2.4	0.5	15.8	1.6	0.0	0.0	0.0	58.7	2.8	0.0	0.2	4.1	0.0	1.4	0.1	59.7	0.0	0.0	0.0	7.8	0.9	0.2	0.0	0.2	9.3	28.2	0.4	0.0	4.2	10.0	0.0	16.2	0.0	0.0	0.1	0.3	0.0	4.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.7	4.1	0.1	5.7	4.5	4.9	1.6	1.9	0.7	0.6	3.0	2.2	1.1	0.0	0.0	0.0	0.0	1.1	0.2	1.1	0.0	2.3	3.2	0.8	193.2	0.0	1.8	0.0	0.0	0.1	0.1	4.3	0.0	0.0	0.6	33.5	13.6	1.5	4.8	0.0	11.6	0.0	13.4	6.4	0.0	9.9	1.3	0.5	0.4	0.0	0.3	1.7	6.6	4.5	0.0	0.0	0.7	1.9	0.0	0.3	1.8	1.9	0.0	0.7	0.0	0.5	0.4	0.3	2.2	0.7	0.0	0.3	0.0	0.6	21.9	0.0	6.6	23.9	19.7	0.4	7.3	0.2	1.0	0.8	0.5	0.0	3.0	0.1
ROCK2		ENSG00000134318	"Rho associated coiled-coil containing protein kinase 2"	O75116	2	11179759-11348330	"Enzymes, FDA approved drug targets, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Biological rhythms"	"Kinase, Serine/threonine-protein kinase, Transferase"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in all"		"Excitatory neurons: 280.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007459, CAB008666, HPA044109"	Approved		Supported	Cytosol		NA	NA		710000	"Cluster 15: NK-cells - Transcription"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 48: Smooth muscle cells - ECM organization"	Cytosol		"CAB008666: AB_1622617, HPA007459: AB_1079828, HPA044109: AB_2678813"	"unprognostic (4.55e-2)"	"unprognostic (1.05e-2)"	"unprognostic (4.18e-3)"	"unprognostic (4.87e-2)"	"unprognostic (1.49e-1)"	"unprognostic (2.71e-1)"	"unprognostic (1.39e-2)"	"unprognostic (2.72e-1)"	"unprognostic (3.62e-2)"	"unprognostic (6.66e-2)"	"unprognostic (3.83e-2)"	"unprognostic (1.48e-1)"	"prognostic unfavorable (1.57e-5)"	"unprognostic (1.51e-1)"	"unprognostic (1.99e-1)"	"unprognostic (2.52e-2)"	"unprognostic (3.47e-2)"	36.4	9.3	6.7	13.5	16.3	6.8	22.3	19.1	14.3	18.7	0.8	22.6	16.7	22.0	10.3	16.2	13.6	15.6	17.0	12.1	3.5	14.5	16.5	16.9	10.1	1.7	4.4	19.0	11.7	12.8	5.9	24.9	1.4	17.4	26.2	13.5	14.6	18.1	30.4	8.5	19.2	27.9	2.0	16.4	14.1	7.8	6.4	8.4	13.9	28.9	8.8	21.1	11.0	10.4	17.5	41.7	33.8	33.2	59.7	41.6	21.6	40.4	37.7	25.8	27.1	39.8	37.2	21.9	23.4	64.5	31.3	18.9	24.7	23.4	40.6	31.2	14.7	43.8	70.6	79.7	21.4	24.7	12.1	32.6	14.6	31.9	22.6	21.0	42.0	11.9	38.6	8.6	38.8	14.8	18.2	12.7	18.8	36.9	25.3	21.7	74.2	7.0	14.0	48.8	15.9	16.9	79.6	27.4	27.4	25.5	11.3	13.6	57.3	52.9	38.2	21.2	36.0	6.8	8.9	18.8	22.8	28.2	75.4	0.9	0.4	0.4	0.6	0.4	0.7	0.3	0.4	0.4	0.3	0.5	0.4	0.4	0.6	0.8	0.4	0.6	0.4	0.2	6.7	16.3	19.1	14.3	12.1	3.5	1.7	4.4	1.4	2.0	6.4	10.4	114.5	115.4	79.1	81.3	16.0	39.9	43.0	15.3	21.1	35.7	33.5	41.1	107.0	37.1	53.1	22.0	58.4	26.3	20.4	97.7	1.9	27.1	11.0	53.6	141.2	90.3	21.2	22.5	280.4	39.5	19.1	64.0	18.3	55.3	29.0	36.9	56.0	43.1	19.6	80.8	158.1	92.2	10.2	20.3	27.0	4.9	43.8	30.4	23.2	107.7	20.6	38.4	15.5	99.0	66.9	39.1	43.6	78.6	16.2	53.5	45.3	15.7	32.7	48.5	131.5	70.0	118.5	30.3	24.6	19.9	27.8	31.5	18.5	34.2	54.8	40.7
SACS	"ARSACS, DKFZp686B15167, DNAJC29, KIAA0730, PPP1R138, SPAX6"	ENSG00000151835	"Sacsin molecular chaperone"	Q9NZJ4	13	23328826-23433740	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"		Chaperone	"Cancer-related genes, Disease variant, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 70.5;Excitatory neurons: 86.3;Inhibitory neurons: 108.2;Oligodendrocyte precursor cells: 76.4;Oligodendrocytes: 111.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB017714	Uncertain					NA	NA			"Cluster 24: B-cells - Unknown function"	"Cluster 47: Non-specific - Unknown function"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"			"CAB017714: "	"unprognostic (1.22e-1)"	"unprognostic (2.18e-1)"	"unprognostic (2.02e-3)"	"prognostic unfavorable (9.04e-4)"	"unprognostic (1.26e-2)"	"unprognostic (1.66e-1)"	"unprognostic (2.05e-3)"	"unprognostic (2.59e-2)"	"unprognostic (2.49e-1)"	"unprognostic (4.14e-2)"	"unprognostic (5.05e-1)"	"unprognostic (2.04e-1)"	"prognostic unfavorable (6.21e-6)"	"unprognostic (2.84e-1)"	"unprognostic (4.06e-2)"	"unprognostic (3.67e-2)"	"unprognostic (7.65e-4)"	4.8	4.4	4.7	4.0	10.0	5.6	4.3	7.2	16.1	4.8	0.0	8.0	0.9	6.2	2.7	3.7	5.8	2.2	8.7	7.6	3.0	3.2	2.2	4.8	4.3	8.4	5.2	4.7	4.8	15.2	6.8	1.3	9.4	7.6	1.5	4.6	6.6	2.3	14.0	2.4	5.0	4.9	2.0	8.5	5.1	6.8	10.3	4.2	2.6	13.1	3.6	9.9	4.4	11.4	8.1	10.5	21.3	6.5	6.5	24.3	3.1	18.1	23.2	6.9	5.7	5.0	4.2	5.5	7.4	38.8	9.0	1.6	30.7	10.8	22.5	12.9	12.6	20.7	8.1	7.4	4.8	38.1	7.9	7.8	2.5	44.3	21.2	9.7	23.1	17.0	12.1	2.6	31.6	3.8	13.6	14.6	17.5	2.8	8.2	16.0	38.7	16.7	12.0	0.9	15.4	14.8	10.0	3.6	7.8	9.7	1.9	10.0	49.8	21.1	17.4	11.5	34.6	5.0	5.7	13.3	10.1	13.2	18.7	0.0	0.1	0.2	0.2	0.2	0.4	0.2	0.3	0.2	0.4	0.7	0.2	0.3	0.0	0.3	0.0	0.3	0.7	0.1	4.7	10.0	7.2	16.1	7.6	3.0	8.4	5.2	9.4	2.0	10.3	11.4	10.3	0.0	1.3	70.5	14.5	6.1	5.4	2.0	6.8	16.5	8.2	8.0	21.3	1.5	1.4	1.8	0.0	0.4	15.3	0.2	0.0	9.0	13.1	5.6	28.1	11.6	1.2	9.7	86.3	10.4	1.5	17.4	3.1	3.3	2.5	18.8	3.6	0.7	3.4	25.2	108.2	0.4	2.0	4.9	19.4	11.6	4.1	8.1	8.8	19.7	3.9	13.6	6.2	76.4	111.0	16.7	0.2	5.3	12.9	8.1	0.0	1.3	1.2	5.3	13.1	45.6	20.9	20.5	9.5	5.3	5.1	0.0	18.1	20.0	0.8	2.9
SAE1	"AOS1, FLJ3091, Sua1"	ENSG00000142230	"SUMO1 activating enzyme subunit 1"	Q9UBE0	19	47113274-47210636	"Metabolic proteins, Predicted intracellular proteins"	"Ubl conjugation pathway"	Ligase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Spermatocytes: 151.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041906, HPA043552"	Supported		Enhanced	Nucleoplasm,Cytosol		NA	NA		37000	"Cluster 32: T-cells - Unknown function"	"Cluster 71: Testis - DNA repair"	"Cluster 24: NB-4 - Immune response"	"Cluster 12: Non-specific - Cell cycle regulation"	"Nucleoplasm, Cytosol"		"HPA041906: AB_2677735, HPA043552: AB_2678548"	"unprognostic (9.69e-3)"	"unprognostic (1.96e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.68e-1)"	"unprognostic (1.37e-1)"	"unprognostic (2.49e-1)"	"prognostic unfavorable (5.49e-8)"	"unprognostic (9.86e-2)"	"unprognostic (1.62e-2)"	"unprognostic (1.58e-1)"	"unprognostic (1.93e-3)"	"unprognostic (1.58e-1)"	"prognostic unfavorable (8.15e-5)"	"unprognostic (1.80e-1)"	"unprognostic (1.24e-1)"	"prognostic unfavorable (2.76e-4)"	"unprognostic (1.27e-1)"	43.9	34.7	33.1	18.7	33.9	21.5	38.9	30.2	39.9	47.8	29.7	115.7	9.9	58.5	4.9	53.0	44.5	14.7	44.3	34.2	34.3	29.4	32.4	39.5	23.1	33.4	33.5	36.4	29.3	22.1	27.2	21.6	33.4	38.5	15.8	11.0	31.0	22.3	53.6	41.3	43.2	27.6	30.5	51.8	59.1	76.6	35.6	36.5	50.8	17.7	24.9	68.1	42.3	34.4	126.7	71.6	189.2	81.8	57.9	68.8	51.3	180.7	130.3	154.7	192.7	76.0	61.6	131.4	72.6	112.0	89.6	49.4	179.6	93.2	141.0	138.4	172.0	117.4	45.2	62.7	68.4	142.3	81.7	64.0	42.2	75.4	72.0	58.9	142.2	141.3	138.7	51.3	135.9	68.0	127.1	396.8	87.3	116.0	68.5	171.7	110.2	47.9	56.2	77.1	59.9	79.3	126.8	87.9	79.3	84.3	70.8	75.9	72.7	71.0	103.8	47.0	161.9	97.0	352.1	206.5	44.7	108.7	98.5	55.3	37.6	21.7	41.6	34.7	45.2	37.2	50.4	43.2	45.2	29.6	69.9	54.6	18.9	63.8	23.6	30.1	69.4	65.3	33.1	33.9	30.2	39.9	34.2	34.3	33.4	33.5	33.4	30.5	35.6	34.4	29.2	9.6	18.7	11.4	24.1	25.6	32.6	33.2	16.5	20.1	19.2	16.3	21.9	15.7	18.6	12.9	6.2	77.7	20.5	18.5	11.7	41.6	13.1	13.3	34.4	39.4	19.2	36.6	20.9	34.9	107.2	30.8	17.3	22.0	15.2	40.2	22.1	21.0	57.6	20.2	21.8	25.2	42.7	17.2	25.0	19.1	15.5	19.2	46.2	10.3	48.5	25.8	41.2	10.6	16.3	38.1	20.1	18.8	26.3	32.6	11.4	15.6	7.2	16.6	52.6	16.5	39.0	151.3	113.7	22.4	24.6	57.5	33.5	35.4	32.5	30.5
SBDS	"CGI-97, FLJ10917, SDS, SWDS"	ENSG00000126524	"SBDS ribosome maturation factor"	Q9Y3A5	7	66987680-66995587	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Ribosome biogenesis"		"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Late spermatids: 2042.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA028891	Approved		Supported	Nucleoplasm,Cytosol		NA	NA		190000	"Cluster 44: Non-specific - Transcription"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 31: Spermatids - Spermatogenesis"	"Nucleoplasm, Cytosol"		"HPA028891: AB_10601500"	"prognostic unfavorable (1.49e-4)"	"unprognostic (1.87e-2)"	"unprognostic (5.73e-2)"	"unprognostic (1.71e-3)"	"unprognostic (8.06e-3)"	"prognostic unfavorable (3.65e-4)"	"unprognostic (1.07e-1)"	"unprognostic (2.22e-2)"	"unprognostic (1.44e-1)"	"unprognostic (6.99e-2)"	"unprognostic (7.84e-3)"	"unprognostic (4.59e-1)"	"unprognostic (1.04e-2)"	"unprognostic (9.38e-3)"	"unprognostic (1.83e-1)"	"unprognostic (2.30e-1)"	"unprognostic (5.06e-3)"	139.1	107.5	136.1	57.9	152.1	157.2	113.7	151.2	168.3	97.3	115.8	143.6	127.8	117.2	83.3	128.6	99.2	84.9	238.0	133.1	148.4	117.8	126.8	113.8	43.8	156.2	142.3	90.1	89.3	145.0	87.4	106.2	155.0	107.9	111.6	90.3	80.7	122.6	374.0	92.0	114.2	128.2	152.6	57.3	104.6	60.9	143.4	38.8	107.0	263.3	52.5	113.9	90.7	169.7	168.3	68.9	59.9	54.6	212.7	157.9	67.0	281.4	225.4	206.1	157.1	143.1	83.0	62.2	209.7	253.5	136.3	80.1	101.7	164.3	219.4	59.8	136.4	31.1	125.9	86.6	188.9	78.1	40.8	144.0	215.1	157.0	269.8	105.9	129.2	39.7	227.2	65.0	324.2	100.0	41.8	112.4	67.2	227.3	165.9	31.3	132.6	129.3	218.1	73.6	91.7	63.7	142.3	235.5	194.3	131.0	176.2	64.8	176.4	276.5	96.7	142.5	205.4	40.6	51.4	141.0	95.7	125.5	157.4	75.5	33.2	61.4	64.7	37.7	81.7	62.8	82.7	75.2	33.4	59.9	104.4	85.7	13.0	51.8	35.1	45.4	80.2	62.2	136.1	152.1	151.2	168.3	133.1	148.4	156.2	142.3	155.0	152.6	143.4	169.7	169.9	304.5	128.0	10.7	101.6	464.2	466.2	213.2	145.7	73.7	118.5	154.0	286.6	108.7	160.3	92.0	12.5	130.5	98.0	270.9	262.2	177.4	583.0	93.0	131.2	153.2	101.9	51.3	12.5	165.7	232.1	197.7	96.8	128.2	150.0	29.7	138.5	102.1	107.0	58.9	15.3	221.9	142.4	47.2	238.1	2042.9	127.1	74.8	256.1	11.2	66.5	161.9	30.9	7.5	36.0	300.0	242.2	168.5	117.5	267.2	359.3	264.6	75.6	56.8	164.3	512.9	266.2	86.3	47.9	129.9	430.0	398.5	144.5	132.2	165.4	318.5
SCARA3	"APC7, CSR, CSR1, MSLR1, MSRL1"	ENSG00000168077	"Scavenger receptor class A member 3"	Q6AZY7	8	27633868-27676776	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 136.5"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 238.6;Collecting duct cells: 66.2;Cytotrophoblasts: 45.8;Muller glia cells: 52.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC TERT1: 179.9;HeLa: 203.2;HUVEC TERT2: 140.1;U-2 OS: 120.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029861, HPA047386"	Uncertain		Supported	"Endoplasmic reticulum"		NA	NA				"Cluster 57: Non-specific - Angiogenesis"	"Cluster 20: HeLa - Mitochondria"	"Cluster 64: Astrocytes - Nervous system maintenance"	"Endoplasmic reticulum"		"HPA029861: AB_2673225, HPA047386: AB_2680024"	"unprognostic (2.24e-1)"	"unprognostic (5.36e-3)"	"unprognostic (2.68e-3)"	"unprognostic (1.36e-1)"	"unprognostic (1.48e-2)"	"unprognostic (1.17e-1)"	"unprognostic (4.31e-1)"	"unprognostic (1.60e-1)"	"unprognostic (3.58e-2)"	"unprognostic (1.45e-1)"	"unprognostic (3.80e-1)"	"unprognostic (1.66e-1)"	"unprognostic (3.41e-2)"	"unprognostic (1.78e-2)"	"unprognostic (4.95e-2)"	"unprognostic (6.31e-3)"	"unprognostic (6.03e-3)"	23.8	7.2	53.4	15.7	58.6	0.0	17.6	55.6	57.8	58.7	29.9	34.5	5.0	87.9	9.5	23.7	86.8	30.5	13.9	50.3	68.1	11.3	3.9	15.2	13.4	136.5	89.5	13.8	4.1	1.5	9.6	19.5	79.2	25.6	8.5	8.8	35.7	66.5	2.6	17.5	15.4	68.1	80.3	2.8	14.7	3.2	79.2	15.9	51.3	8.0	23.0	31.1	20.7	71.4	1.8	61.0	9.4	0.2	49.9	179.9	40.0	23.8	38.2	25.8	19.1	22.7	15.8	0.0	52.7	50.3	21.1	44.5	0.1	44.9	12.7	0.2	5.1	17.8	203.2	0.8	5.3	0.0	0.1	75.6	2.9	40.2	2.3	35.0	140.1	4.6	0.0	0.2	15.0	11.8	0.2	0.1	12.3	0.0	22.3	0.1	0.0	0.3	8.2	27.4	0.2	5.9	5.7	32.0	0.1	4.8	31.1	0.5	49.9	20.7	120.1	77.2	12.8	0.1	0.1	0.2	35.7	0.0	4.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	53.4	58.6	55.6	57.8	50.3	68.1	136.5	89.5	79.2	80.3	79.2	71.4	2.3	0.0	0.5	238.6	0.0	3.6	16.2	4.8	14.8	1.0	12.6	19.8	2.2	8.6	6.0	66.2	0.0	45.8	0.6	0.1	0.0	0.4	2.9	3.8	10.1	6.4	0.0	0.0	38.4	0.8	20.4	25.1	1.5	2.0	0.0	5.3	15.4	0.4	4.7	0.0	30.4	0.1	0.0	0.3	2.1	1.3	15.8	0.5	17.8	21.5	0.6	52.4	0.0	19.1	18.1	2.2	0.1	6.4	0.0	5.4	0.0	0.0	6.5	1.5	6.6	1.8	14.7	0.2	1.5	6.2	3.8	8.2	0.3	1.9	0.3	10.3
SCRG1	SCRG-1	ENSG00000164106	"Stimulator of chondrogenesis 1"	O75711	4	173384701-173406380	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 30.7;choroid plexus: 15.2"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 46.4;Muller glia cells: 148.3;Oligodendrocyte precursor cells: 102.1"	"Cancer enriched"	"Detected in many"	6	"glioma: 35.7"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Cell line enriched"	"Detected in some"	5	"WM-115: 17.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA012882	Approved				"Secreted in brain"	NA	NA		240000	"Cluster 17: Basophils - Unknown function"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 5: Muller glia cells - Visual perception"			"HPA012882: AB_1856635"	"unprognostic (1.09e-1)"	"unprognostic (1.83e-2)"	"unprognostic (2.60e-5)"	"unprognostic (2.58e-1)"	"unprognostic (3.22e-2)"	"unprognostic (7.51e-2)"	"unprognostic (3.58e-2)"	"unprognostic (1.14e-3)"	"unprognostic (2.08e-1)"	"unprognostic (2.25e-2)"	"unprognostic (2.19e-1)"	"unprognostic (1.49e-1)"	"unprognostic (3.95e-10)"	"unprognostic (4.86e-2)"	"unprognostic (2.21e-1)"	"unprognostic (4.34e-3)"	"unprognostic (8.74e-4)"	1.3	0.8	19.0	0.6	20.5	0.7	0.5	20.6	30.7	1.6	15.2	4.4	0.5	1.8	0.9	0.4	2.5	1.5	2.9	19.4	20.3	0.2	0.1	0.4	0.2	22.8	19.9	0.8	0.3	0.0	1.0	0.2	22.5	2.3	0.5	2.3	1.1	3.2	0.5	0.5	0.9	4.7	21.6	0.5	2.8	10.8	19.4	0.0	0.3	0.0	0.1	2.0	0.8	24.7	0.1	0.0	0.6	0.2	0.2	0.0	0.2	0.1	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.2	0.4	0.2	0.5	0.2	0.1	3.5	0.0	0.0	0.1	0.1	0.0	0.1	0.1	0.5	0.0	0.2	0.1	0.3	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.1	0.2	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.2	0.1	0.2	0.2	0.1	0.0	0.1	0.1	0.1	17.1	1.8	0.5	0.3	0.2	0.4	0.1	0.2	0.1	0.2	0.2	0.3	0.2	0.3	1.2	0.5	0.5	0.3	0.1	0.1	19.0	20.5	20.6	30.7	19.4	20.3	22.8	19.9	22.5	21.6	19.4	24.7	1.3	0.0	3.0	46.4	1.0	3.6	1.1	0.0	0.0	14.5	2.4	3.9	1.3	0.0	0.7	0.0	37.5	0.2	3.3	0.3	0.0	0.3	18.3	0.7	1.7	2.1	1.2	0.0	19.0	0.0	0.4	17.3	1.1	0.4	8.9	0.9	4.2	0.3	0.6	16.8	20.9	0.5	0.0	3.3	2.6	32.3	26.1	3.8	23.2	2.8	1.9	148.3	2.1	102.1	26.4	0.2	0.1	20.7	1.0	1.9	0.4	0.3	0.8	28.3	13.1	2.4	20.3	3.1	2.4	0.1	2.6	0.7	3.1	0.5	0.3	1.0
SCRN1	KIAA0193	ENSG00000136193	"Secernin 1"	Q12765	7	29920104-29990289	"Enzymes, Predicted intracellular proteins"	Exocytosis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 159.0"	"Cell type enhanced"	"Detected in many"		"Muller glia cells: 80.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"WM-115: 326.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA024517	Enhanced		Approved	Cytosol		No	No		160000	"Cluster 51: Monocytes - Innate immune response"	"Cluster 77: Retina - Visual perception"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 5: Muller glia cells - Visual perception"	Cytosol		"HPA024517: AB_2184811"	"prognostic unfavorable (8.32e-4)"	"prognostic unfavorable (8.46e-4)"	"unprognostic (1.45e-1)"	"prognostic unfavorable (4.00e-5)"	"unprognostic (1.87e-2)"	"unprognostic (2.43e-1)"	"unprognostic (1.13e-3)"	"unprognostic (1.10e-1)"	"unprognostic (2.29e-1)"	"prognostic unfavorable (7.27e-4)"	"unprognostic (1.09e-2)"	"unprognostic (1.02e-1)"	"prognostic favorable (1.15e-5)"	"unprognostic (2.57e-2)"	"unprognostic (2.10e-1)"	"unprognostic (2.23e-1)"	"prognostic unfavorable (2.60e-4)"	13.9	27.9	112.4	13.1	118.9	8.1	14.3	128.2	117.9	22.2	52.2	27.5	6.5	27.4	16.2	19.0	26.0	16.5	19.8	112.5	129.0	23.7	2.6	16.4	14.3	112.5	159.0	32.4	36.7	54.5	34.0	15.8	115.5	27.9	10.4	102.5	18.0	37.2	2.4	11.1	15.8	34.3	116.1	10.8	19.3	23.0	122.5	28.9	13.5	11.0	21.6	22.0	17.8	127.1	106.3	75.0	119.9	48.6	83.1	126.9	0.5	97.0	128.8	102.5	110.0	87.1	81.8	13.0	83.7	124.7	227.3	46.7	137.7	41.2	148.9	0.6	29.0	43.8	49.7	56.6	105.9	0.3	0.5	106.5	58.1	93.5	49.6	139.4	95.9	28.0	0.5	33.3	146.6	59.5	15.5	0.1	109.4	0.2	79.6	0.3	127.7	1.1	71.7	51.5	43.7	103.1	99.9	64.1	112.5	149.7	86.3	6.9	106.7	132.2	113.3	1.7	123.7	10.8	177.0	1.1	62.4	0.5	326.5	3.7	3.4	10.3	0.9	14.1	10.7	14.0	0.2	1.0	10.9	7.6	0.7	1.4	0.5	7.1	25.4	10.8	0.0	3.5	112.4	118.9	128.2	117.9	112.5	129.0	112.5	159.0	115.5	116.1	122.5	127.1	5.9	28.9	14.1	42.7	15.4	3.1	12.6	14.0	14.2	66.9	7.6	5.2	15.8	20.0	22.3	33.1	45.9	0.4	16.2	1.1	15.6	24.1	61.1	7.3	11.9	10.9	12.1	2.5	52.0	25.1	1.9	17.2	5.6	6.7	8.2	22.9	1.8	0.3	5.4	69.0	51.4	0.7	14.2	8.8	13.9	68.1	13.7	11.1	7.2	16.9	11.5	80.8	12.3	31.2	35.6	21.2	17.3	21.1	12.5	17.4	0.1	2.8	29.2	41.1	6.6	9.6	11.9	3.1	11.0	5.1	1.7	1.0	2.8	8.5	1.2	22.3
SCUBE3	"CEGF3, FLJ34743"	ENSG00000146197	"Signal peptide, CUB domain and EGF like domain containing 3"	Q8IX30	6	35213956-35253079	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"thyroid gland: 28.9"	"Cell type enhanced"	"Detected in some"		"Enteroendocrine cells: 10.8;Horizontal cells: 10.1;Rod photoreceptor cells: 7.1"	"Cancer enhanced"	"Detected in many"		"thyroid cancer: 9.2"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 26.0;ASC diff: 76.7;ASC TERT1: 102.2;HSkMC: 48.1;hTEC/SVTERT24-B: 30.1;U-138 MG: 29.1;WM-115: 25.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA040606	Uncertain		Approved	"Plasma membrane"	"Secreted to blood"	NA	NA	1890000	490000		"Cluster 1: Thyroid gland - Transcription"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 62: Horizontal cells - Visual perception"	"Plasma membrane"		"HPA040606: AB_10795383"	"unprognostic (1.45e-1)"	"unprognostic (1.79e-2)"	"unprognostic (2.22e-1)"	"unprognostic (2.41e-3)"	"unprognostic (1.52e-1)"	"unprognostic (1.27e-1)"	"unprognostic (4.43e-2)"	"unprognostic (5.01e-2)"	"unprognostic (2.00e-2)"	"unprognostic (7.41e-2)"	"unprognostic (1.57e-1)"	"unprognostic (2.64e-2)"	"unprognostic (4.83e-8)"	"unprognostic (1.54e-2)"	"unprognostic (2.12e-1)"	"prognostic unfavorable (1.38e-4)"	"unprognostic (3.06e-3)"	1.7	2.4	0.7	0.9	1.1	0.1	0.4	2.0	1.0	0.5	2.9	4.2	0.1	0.6	0.9	0.7	0.8	0.5	3.4	0.5	0.6	2.9	0.1	0.7	0.1	0.8	1.0	0.5	0.1	0.1	1.7	0.7	0.3	2.2	0.9	1.4	0.2	4.5	0.3	0.8	0.7	0.9	0.1	0.2	1.4	1.1	0.7	0.1	28.9	0.0	0.2	5.1	0.9	0.8	0.0	0.1	26.0	0.2	76.7	102.2	0.3	6.7	3.3	0.1	0.1	0.5	0.1	0.0	0.9	15.5	0.0	0.0	5.3	0.0	0.4	0.0	0.1	0.0	0.7	0.1	0.1	0.0	0.0	48.1	0.0	30.1	0.0	0.5	0.0	0.0	0.1	0.2	0.2	0.3	0.0	0.0	1.2	0.0	0.4	0.1	0.0	0.0	0.1	2.9	0.5	0.0	0.1	0.7	1.9	10.2	0.7	0.1	1.5	29.1	1.3	0.0	0.2	0.1	0.0	0.0	4.6	0.0	25.2	0.3	0.1	0.2	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.1	0.1	0.4	0.1	0.1	0.2	0.1	0.0	0.7	1.1	2.0	1.0	0.5	0.6	0.8	1.0	0.3	0.1	0.7	0.8	0.2	0.0	0.6	0.7	0.5	0.0	0.2	0.4	0.0	2.6	0.3	0.0	3.5	0.0	2.0	1.8	2.1	1.2	0.5	0.0	0.0	0.0	2.1	1.2	0.4	0.6	10.8	0.0	2.2	0.0	2.1	1.3	0.0	0.4	1.3	0.5	0.0	0.1	0.3	10.1	3.2	0.1	0.0	0.6	0.4	3.3	0.9	0.2	1.8	0.0	0.1	3.0	0.0	4.0	3.5	0.1	0.0	3.8	0.4	0.1	0.0	0.1	0.9	7.1	0.0	0.6	3.2	0.5	2.1	0.0	0.0	0.7	0.2	0.1	0.0	0.2
SEC23A		ENSG00000100934	"Sec23 homolog A, COPII coat complex component"	Q15436	14	39031919-39109646	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"ER-Golgi transport, Protein transport, Transport"		"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"Hep G2: 347.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043806, HPA069974"	Uncertain		Approved	Nucleoplasm,Vesicles		NA	NA		83000	"Cluster 46: Basophils - DNA binding"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Nucleoplasm, Vesicles"		"HPA043806: , HPA069974: AB_2686223"	"unprognostic (2.40e-1)"	"prognostic unfavorable (5.75e-4)"	"prognostic favorable (3.56e-4)"	"unprognostic (3.30e-2)"	"unprognostic (1.18e-1)"	"unprognostic (6.39e-2)"	"unprognostic (1.15e-2)"	"unprognostic (5.85e-2)"	"unprognostic (1.71e-1)"	"unprognostic (2.69e-1)"	"unprognostic (1.28e-2)"	"unprognostic (1.73e-1)"	"prognostic unfavorable (1.69e-4)"	"prognostic unfavorable (2.94e-4)"	"unprognostic (1.16e-1)"	"unprognostic (2.73e-1)"	"unprognostic (1.41e-3)"	45.9	32.0	11.4	31.8	14.2	13.1	20.9	18.3	16.8	36.2	31.4	40.0	57.7	42.7	19.9	34.1	21.5	32.1	46.9	13.3	18.9	23.1	80.8	20.2	21.0	13.8	14.0	33.9	12.0	8.1	10.5	27.1	15.3	34.0	34.2	38.5	10.5	52.6	54.2	12.8	52.6	90.5	7.6	20.5	16.8	23.5	12.7	18.9	17.9	58.5	22.0	40.7	17.9	15.4	52.1	90.8	76.9	74.7	161.3	173.0	25.9	195.1	176.4	135.2	166.8	93.2	44.2	12.6	46.9	279.6	54.9	41.2	99.6	86.3	208.6	39.6	36.9	21.8	67.7	347.3	122.4	35.9	31.3	134.0	48.8	91.6	73.7	114.6	130.8	26.9	15.6	30.1	125.8	47.5	32.9	16.9	18.4	81.7	91.3	44.0	111.8	19.1	84.7	75.6	8.5	20.5	132.8	43.0	51.8	68.6	51.5	12.4	138.4	75.0	57.8	110.8	52.0	27.0	36.6	56.0	50.3	31.4	70.2	70.5	34.3	38.6	26.6	29.3	38.4	23.6	33.1	34.9	31.1	21.1	34.9	28.0	29.5	42.1	27.3	26.7	38.1	31.4	11.4	14.2	18.3	16.8	13.3	18.9	13.8	14.0	15.3	7.6	12.7	15.4	35.4	16.0	26.9	34.9	30.5	25.9	33.5	15.5	15.4	39.7	11.8	10.3	54.6	15.7	18.8	31.3	68.8	16.0	36.0	87.0	7.9	9.8	13.4	11.3	42.8	41.1	24.5	6.1	48.3	5.6	43.7	55.0	26.5	18.8	27.9	56.9	118.9	133.6	25.6	30.3	51.1	31.6	12.2	36.4	32.3	18.6	74.9	24.3	24.9	48.7	25.6	19.4	32.0	34.2	44.3	17.8	34.1	71.5	38.5	37.5	88.6	32.8	10.1	58.7	39.5	27.6	51.4	18.0	15.5	15.7	24.0	24.8	32.3	31.0	30.2	56.5
SELENOM	"SELM, SEPM"	ENSG00000198832	"Selenoprotein M"	Q8WWX9	22	31104772-31120069	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Breast glandular cells: 373.6;Breast myoepithelial cells: 436.2;Collecting duct cells: 309.0;Distal tubular cells: 309.1;Endometrial stromal cells: 349.5;Exocrine glandular cells: 586.6;Smooth muscle cells: 225.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Group enriched"	"Detected in all"	5	"B-cells: 154.8;T-cells: 233.0"	"Cell line enhanced"	"Detected in many"		"BJ: 152.2;BJ hTERT+: 143.8;HHSteC: 183.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB008667, HPA019601"	Approved		Approved	Nucleoplasm,Cytosol	"Intracellular and membrane"	NA	NA		170000	"Cluster 20: T-cells - T-cell receptor"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 7: Non-specific - Mitochondria"	"Nucleoplasm, Cytosol"		"CAB008667: AB_1622762, HPA019601: AB_1856666"	"unprognostic (5.29e-3)"	"unprognostic (1.68e-1)"	"unprognostic (7.61e-2)"	"unprognostic (1.32e-1)"	"unprognostic (2.93e-2)"	"unprognostic (1.02e-1)"	"unprognostic (2.59e-3)"	"unprognostic (1.45e-1)"	"unprognostic (1.60e-2)"	"unprognostic (1.60e-1)"	"unprognostic (3.51e-3)"	"unprognostic (8.31e-2)"	"prognostic unfavorable (2.55e-6)"	"unprognostic (1.32e-2)"	"unprognostic (3.80e-1)"	"unprognostic (5.20e-2)"	"unprognostic (3.19e-2)"	241.8	95.4	126.7	55.7	126.7	2.9	239.8	127.3	170.7	458.8	189.9	575.4	37.2	600.2	14.8	86.1	437.8	28.6	227.2	130.0	149.3	162.5	36.7	157.5	25.9	137.1	138.6	262.4	154.3	94.7	241.1	32.2	131.0	339.6	16.4	8.1	198.8	140.1	109.9	114.8	193.9	85.3	139.6	97.6	285.6	42.1	142.1	10.2	225.8	18.6	15.3	462.3	290.7	132.3	12.8	25.7	7.4	42.7	68.8	80.5	82.2	152.2	143.8	69.2	50.0	0.8	2.0	1.6	30.9	89.9	31.2	1.2	6.9	9.2	4.7	7.0	25.6	2.7	7.8	13.3	183.7	0.0	13.1	78.5	27.1	33.1	12.6	33.1	9.0	2.2	2.4	14.7	17.9	6.6	0.5	1.4	9.6	11.8	27.3	0.1	0.1	18.1	11.1	0.1	16.2	35.7	47.3	41.6	0.7	2.5	57.5	0.9	30.9	20.8	59.0	77.8	0.1	13.2	6.5	1.0	83.1	0.2	13.8	18.3	10.5	5.1	105.3	19.9	137.9	154.8	174.5	127.0	6.4	129.5	233.0	137.8	8.2	39.1	40.1	2.5	179.0	102.6	126.7	126.7	127.3	170.7	130.0	149.3	137.1	138.6	131.0	139.6	142.1	132.3	168.6	54.5	126.5	0.0	38.8	0.0	0.0	0.0	0.0	0.0	373.6	436.2	0.0	0.0	32.2	309.0	0.0	11.7	23.2	0.0	309.1	101.2	0.0	22.8	349.5	61.8	0.0	0.0	0.0	586.6	149.5	161.3	0.0	18.1	30.3	30.8	0.0	0.0	22.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.9	0.0	0.0	42.9	0.0	0.0	0.0	0.0	166.2	0.0	0.0	22.3	0.0	0.0	152.5	20.4	0.0	0.0	0.0	225.6	0.0	0.0	0.0	0.0	23.4	24.8	30.5	0.0	0.0
SH3D19	"DKFZp434D0215, EBP, Eve-1, EVE1, Kryn, SH3P19"	ENSG00000109686	"SH3 domain containing 19"	Q5HYK7	4	151102751-151325605	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in all"		"Oligodendrocyte precursor cells: 263.9;Oligodendrocytes: 360.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC diff: 190.3;ASC TERT1: 161.0;HSkMC: 129.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA016424, HPA058562"	Enhanced		Supported	Nucleoplasm,Cytosol		NA	NA				"Cluster 46: Fibroblasts - ECM organization"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"	"Nucleoplasm, Cytosol"		"HPA016424: AB_1856814, HPA058562: AB_2683758"	"unprognostic (1.09e-1)"	"unprognostic (6.14e-2)"	"unprognostic (1.24e-3)"	"unprognostic (1.37e-1)"	"unprognostic (1.67e-1)"	"unprognostic (2.84e-2)"	"unprognostic (1.30e-2)"	"unprognostic (5.09e-1)"	"unprognostic (7.37e-2)"	"unprognostic (1.48e-1)"	"unprognostic (6.40e-3)"	"unprognostic (1.86e-1)"	"prognostic favorable (1.38e-5)"	"unprognostic (7.90e-2)"	"unprognostic (1.07e-1)"	"unprognostic (1.62e-1)"	"unprognostic (1.64e-2)"	70.8	15.7	9.8	12.8	14.9	0.2	31.5	6.0	9.6	22.5	104.9	44.2	44.4	23.2	10.7	40.8	23.7	63.7	64.1	6.8	11.6	27.2	49.9	36.2	5.1	8.8	10.3	42.9	15.2	19.9	5.0	27.9	8.8	27.1	48.3	12.8	17.3	40.5	17.7	30.0	49.0	41.4	5.1	7.4	22.6	12.4	11.5	3.9	25.1	33.8	7.9	33.3	20.6	18.6	26.3	19.2	12.1	9.5	190.3	161.0	26.0	31.8	34.0	13.9	14.4	24.9	31.6	0.0	12.5	29.9	22.7	19.2	12.8	36.6	13.5	0.1	10.1	0.0	22.2	26.7	46.0	0.1	0.1	129.1	27.6	20.9	32.0	23.9	81.9	0.0	0.0	0.1	36.9	10.9	0.0	0.4	24.3	40.3	27.6	0.0	0.9	0.4	17.3	18.3	0.9	16.3	22.7	23.0	18.5	24.7	7.5	0.1	59.9	43.6	15.6	19.5	12.9	0.1	0.0	0.1	22.6	0.1	54.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	9.8	14.9	6.0	9.6	6.8	11.6	8.8	10.3	8.8	5.1	11.5	18.6	36.7	22.4	32.5	8.1	2.9	28.6	14.1	12.3	18.8	6.6	20.5	25.0	88.5	34.3	29.2	16.5	14.6	25.9	5.0	103.5	5.9	11.9	4.4	17.6	38.1	29.1	18.6	7.0	55.8	15.4	20.7	77.9	38.7	13.7	21.5	37.5	21.8	46.4	7.4	6.7	30.0	35.6	10.2	4.6	20.2	6.7	62.1	4.8	26.6	74.0	1.2	20.8	5.2	263.9	360.1	21.3	55.9	48.2	3.2	41.5	88.2	27.2	52.4	11.0	13.1	46.0	26.3	2.9	6.0	16.7	38.5	27.2	5.5	20.3	54.0	41.2
SH3RF3	"FLJ00204, POSH2, SH3MD4"	ENSG00000172985	"SH3 domain containing ring finger 3"	Q8TEJ3	2	109129205-109504634	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in many"	7	"Astrocytes: 47.0;Excitatory neurons: 108.3;Inhibitory neurons: 160.9;Microglial cells: 164.9;Oligodendrocyte precursor cells: 42.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HHSteC: 19.8;RPMI-8226: 20.5;TIME: 23.2;U-266/84: 28.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA044822, HPA048444"	Approved		Supported	Nucleoplasm		Yes	No				"Cluster 47: Non-specific - Unknown function"	"Cluster 16: U-266 - Nucleosome"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Nucleoplasm		"HPA044822: AB_2679103, HPA048444: AB_2680396"	"unprognostic (1.97e-1)"	"unprognostic (8.84e-3)"	"unprognostic (8.04e-2)"	"unprognostic (1.91e-1)"	"unprognostic (2.55e-1)"	"unprognostic (1.78e-1)"	"unprognostic (8.00e-2)"	"unprognostic (1.76e-1)"	"unprognostic (2.98e-2)"	"prognostic unfavorable (2.33e-4)"	"unprognostic (4.57e-2)"	"unprognostic (1.95e-1)"	"unprognostic (3.54e-2)"	"unprognostic (4.94e-2)"	"unprognostic (2.72e-1)"	"unprognostic (2.79e-2)"	"unprognostic (1.39e-2)"	6.1	6.7	4.7	3.0	6.1	0.8	4.3	1.3	6.5	5.5	1.6	5.6	1.1	3.7	0.7	2.8	4.8	4.4	6.0	6.3	3.2	6.8	1.1	7.2	2.1	3.0	4.5	3.2	2.0	0.5	1.9	5.2	2.8	4.7	1.4	0.6	1.6	4.4	5.7	3.1	3.3	3.8	3.1	2.1	2.9	4.2	3.9	3.2	2.5	7.3	1.2	5.5	4.2	3.5	0.0	0.1	0.1	2.2	9.0	6.9	0.0	4.2	12.2	3.1	1.1	1.1	0.0	0.0	3.1	3.1	0.7	0.0	0.2	1.8	1.3	0.0	4.2	0.0	0.2	0.0	19.8	0.1	0.0	12.0	2.9	14.1	6.3	1.8	11.4	2.2	0.0	11.7	7.3	0.0	0.0	6.5	1.1	0.0	12.0	2.6	0.0	20.5	0.0	0.0	0.7	2.5	0.0	0.0	0.4	0.1	0.2	0.0	23.2	4.0	12.0	11.5	5.5	4.0	28.6	0.0	0.0	6.3	5.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	4.7	6.1	1.3	6.5	6.3	3.2	3.0	4.5	2.8	3.1	3.9	3.5	5.3	0.0	0.0	47.0	0.2	1.9	0.4	0.2	1.8	0.5	0.6	0.5	10.7	0.0	0.7	0.0	0.0	0.0	1.5	0.1	0.0	1.1	2.6	9.4	9.6	6.7	1.8	0.0	108.3	0.2	0.2	4.8	0.0	1.1	0.0	0.2	7.5	0.0	4.7	10.1	160.9	0.8	0.0	2.5	1.5	5.2	2.1	1.2	5.4	164.9	0.0	1.7	0.0	42.3	1.9	0.1	0.0	3.0	1.6	0.2	0.0	0.6	2.1	0.0	13.1	3.2	6.8	0.7	9.6	0.8	0.9	0.1	0.5	2.3	0.1	0.0
SLC24A3		ENSG00000185052	"Solute carrier family 24 member 3"	Q9HC58	20	19212642-19722926	"Metabolic proteins, Predicted membrane proteins, Transporters"	"Antiport, Calcium transport, Ion transport, Potassium transport, Sodium transport, Symport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 81.7"	"Group enriched"	"Detected in many"	9	"Astrocytes: 134.5;Inhibitory neurons: 327.0;Oligodendrocyte precursor cells: 375.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	39	"basophil: 5.8;eosinophil: 1.8"	"Lineage enriched"	"Detected in single"	58	"granulocytes: 5.8"	"Cell line enriched"	"Detected in some"	4	"HMC-1: 75.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043400, HPA045497"	Uncertain		Approved	"Golgi apparatus,Cytosol"		NA	NA			"Cluster 34: Basophils - Unknown function"	"Cluster 47: Non-specific - Unknown function"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Golgi apparatus"	Cytosol	"HPA043400: AB_2678462, HPA045497: AB_2679349"	"unprognostic (8.74e-2)"	"unprognostic (1.13e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.41e-1)"	"unprognostic (7.40e-2)"	"unprognostic (2.09e-1)"	"unprognostic (2.40e-1)"	"unprognostic (7.62e-2)"	"unprognostic (3.04e-2)"	"unprognostic (3.25e-2)"	"unprognostic (1.05e-1)"	"unprognostic (5.40e-2)"	"unprognostic (1.21e-3)"	"unprognostic (3.85e-2)"	"unprognostic (1.89e-1)"	"prognostic unfavorable (6.08e-4)"	"unprognostic (7.36e-3)"	10.4	3.1	16.2	4.0	11.7	1.4	4.9	13.3	56.1	17.8	2.7	10.8	3.8	28.3	24.3	20.6	20.0	13.0	1.1	81.7	18.6	1.1	0.7	5.5	1.0	13.6	19.2	14.6	0.7	7.5	1.2	3.0	9.1	10.9	5.4	7.3	4.7	17.5	40.9	7.0	5.0	29.1	10.3	2.4	3.8	1.5	34.8	1.9	3.0	16.9	2.7	8.6	8.9	5.4	0.0	0.0	0.0	0.0	0.3	0.8	0.0	0.8	13.3	0.4	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.2	0.4	0.0	0.0	18.2	0.0	0.0	0.7	0.0	75.7	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.1	8.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.6	0.0	0.0	9.0	0.0	0.6	17.0	0.2	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	5.8	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	16.2	11.7	13.3	56.1	81.7	18.6	13.6	19.2	9.1	10.3	34.8	5.4	0.2	3.2	1.1	134.5	0.1	1.1	1.1	0.4	0.0	19.1	5.0	2.3	0.4	0.0	1.3	1.8	0.0	8.5	0.1	0.3	0.0	0.1	17.0	1.2	29.8	0.4	7.7	3.4	11.8	0.0	0.3	1.9	0.0	1.6	26.6	0.1	0.4	0.0	0.6	1.7	327.0	4.1	0.0	0.0	0.7	18.3	3.7	1.1	0.0	12.2	0.0	3.1	0.0	375.5	2.4	0.2	2.8	4.1	0.4	0.8	0.4	0.0	0.0	2.2	0.0	2.7	3.0	0.5	0.8	2.9	4.1	3.4	0.4	0.1	0.7	3.8
SORT1	"Gp95, NT3"	ENSG00000134243	"Sortilin 1"	Q99523	1	109309568-109397918	"Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Differentiation, Endocytosis, Osteogenesis, Transport"	"Developmental protein, Receptor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 285.6"	"Cell type enriched"	"Detected in many"	4	"Oligodendrocytes: 447.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"intermediate monocyte: 9.2;non-classical monocyte: 10.8"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006889, CAB011498"	Enhanced		Supported	"Golgi apparatus,Plasma membrane,Cytosol"		NA	NA	7170000	110000	"Cluster 51: Monocytes - Innate immune response"	"Cluster 70: Brain - Nervous system development"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	"Golgi apparatus, Cytosol"	"Plasma membrane"	"CAB011498: AB_2192606, HPA006889: AB_1080056"	"unprognostic (2.10e-2)"	"unprognostic (7.46e-2)"	"prognostic favorable (7.74e-6)"	"unprognostic (4.12e-1)"	"unprognostic (9.41e-2)"	"unprognostic (1.40e-1)"	"prognostic unfavorable (1.23e-4)"	"unprognostic (3.34e-3)"	"unprognostic (4.27e-2)"	"unprognostic (9.44e-2)"	"unprognostic (2.42e-2)"	"unprognostic (1.28e-2)"	"unprognostic (1.23e-3)"	"unprognostic (1.45e-2)"	"unprognostic (2.15e-1)"	"unprognostic (3.95e-1)"	"unprognostic (4.46e-3)"	48.2	11.3	71.0	12.0	168.3	21.4	25.1	124.3	114.2	17.7	21.5	29.5	22.1	24.7	139.8	41.5	27.5	17.8	64.7	131.8	90.0	38.7	6.5	37.4	2.8	151.9	133.8	6.1	17.5	46.5	11.3	44.8	153.1	18.3	26.9	40.0	25.2	44.0	85.0	19.0	21.9	27.8	102.8	10.2	18.2	43.5	118.0	6.4	42.7	71.8	10.3	16.9	18.0	285.6	38.8	15.3	37.5	45.8	107.0	21.2	107.3	28.2	44.9	27.2	29.0	39.8	14.0	0.3	35.2	11.9	19.9	9.4	44.7	22.3	38.9	1.1	21.2	10.7	23.5	43.1	41.8	0.2	33.5	53.2	3.6	33.3	7.3	72.6	4.2	31.7	81.3	4.0	38.7	41.1	27.9	0.8	14.1	17.5	6.3	30.7	87.9	18.9	52.0	27.8	38.3	21.8	16.6	109.3	120.6	53.1	46.1	6.7	1.1	5.8	21.7	1.0	47.6	37.0	32.2	0.3	9.8	0.3	24.3	0.0	7.1	2.5	0.0	9.2	0.0	0.0	0.0	0.0	4.5	0.0	0.0	0.0	1.8	0.4	10.8	1.6	0.0	2.0	71.0	168.3	124.3	114.2	131.8	90.0	151.9	133.8	153.1	102.8	118.0	285.6	10.6	38.5	47.9	54.5	1.9	1.3	4.7	6.7	1.2	14.9	27.5	14.2	98.9	27.1	20.3	75.4	35.5	30.6	3.2	70.2	5.9	23.9	65.1	33.2	5.2	15.9	16.8	4.0	87.9	23.7	30.2	9.8	16.8	34.9	7.6	10.4	7.9	22.1	30.1	13.5	56.7	27.7	6.1	38.7	9.9	79.7	8.7	34.6	21.4	78.7	37.7	21.7	0.0	48.7	447.8	25.6	23.2	49.7	1.5	7.1	64.0	13.1	29.6	50.7	32.9	25.1	53.6	46.3	21.6	9.3	1.8	36.8	2.1	1.8	28.3	10.8
STBD1	"FLJ41801, GENX-3414"	ENSG00000118804	"Starch binding domain 1"	O95210	4	76306733-76311130	"Plasma proteins, Predicted intracellular proteins, Transporters"	"Autophagy, Carbohydrate metabolism, Glycogen metabolism"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 130.3;skeletal muscle: 248.5;tongue: 154.7"	"Cell type enhanced"	"Detected in some"		"Distal enterocytes: 9.1;Ductal cells: 7.9;Glandular and luminal cells: 5.1;Plasma cells: 7.0;Proximal enterocytes: 19.5;Respiratory ciliated cells: 6.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"Karpas-707: 140.7;U-266/70: 62.8"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA011952, HPA012849"	Enhanced		Approved	"Endoplasmic reticulum"		NA	NA			"Cluster 22: NK-cells - Unknown function"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 45: Enterocytes - Digestion"	"Endoplasmic reticulum"		"HPA011952: AB_1847461, HPA012849: AB_1847460"	"unprognostic (1.46e-1)"	"unprognostic (1.02e-3)"	"unprognostic (4.29e-2)"	"unprognostic (1.95e-1)"	"unprognostic (2.57e-1)"	"unprognostic (4.72e-2)"	"unprognostic (1.35e-2)"	"unprognostic (6.84e-2)"	"unprognostic (3.06e-1)"	"unprognostic (1.03e-1)"	"unprognostic (4.96e-3)"	"unprognostic (4.42e-2)"	"unprognostic (3.52e-2)"	"unprognostic (2.93e-1)"	"unprognostic (2.00e-1)"	"unprognostic (2.84e-1)"	"unprognostic (5.74e-2)"	109.7	5.3	4.3	7.3	4.0	19.9	11.8	3.5	6.3	7.0	2.9	29.0	9.6	9.3	3.2	15.1	13.7	12.8	52.7	4.0	7.0	10.0	130.3	14.1	1.3	6.7	5.4	10.0	12.0	7.9	1.7	16.8	6.2	20.7	26.4	4.0	4.7	13.9	248.5	1.5	26.1	28.0	5.6	2.2	15.5	9.7	5.6	1.3	2.6	154.7	2.1	22.1	4.5	5.6	15.9	9.9	2.0	10.0	46.3	13.9	12.7	21.9	21.6	12.0	12.6	12.6	17.9	0.0	13.1	25.8	26.2	9.2	9.6	6.1	7.4	52.4	3.6	1.7	18.2	16.5	4.8	9.5	10.5	7.1	24.0	10.2	8.2	32.4	0.9	0.0	0.6	140.7	23.7	13.0	0.6	7.4	2.5	24.1	7.2	0.0	3.8	9.9	8.0	17.2	2.6	17.7	12.9	20.2	0.3	5.0	4.9	3.7	3.9	11.6	5.9	29.4	12.5	62.8	17.1	0.0	19.6	7.5	5.4	0.1	2.6	5.7	2.0	3.1	1.1	0.1	2.4	2.4	2.5	0.0	0.5	0.9	0.3	4.4	1.2	0.3	0.8	1.3	4.3	4.0	3.5	6.3	4.0	7.0	6.7	5.4	6.2	5.6	5.6	5.6	0.0	0.0	0.5	0.0	0.1	0.0	1.1	0.0	0.0	0.0	0.5	0.4	0.0	0.0	0.0	0.0	0.0	0.6	0.2	9.1	0.0	7.9	0.0	2.8	1.5	0.1	0.0	0.4	0.0	3.9	1.4	1.0	2.6	5.1	0.0	0.3	0.0	1.5	0.2	0.0	0.0	3.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.6	0.0	1.0	0.0	0.0	3.3	2.9	0.0	7.0	0.5	19.5	0.3	6.6	0.0	0.0	1.1	3.0	0.2	0.0	1.1	0.0	0.8	0.3	0.3	1.4	0.9
TCEAL1	"p21, pp21, SIIR, WEX9"	ENSG00000172465	"Transcription elongation factor A like 1"	Q15170	X	103628704-103630953	"Predicted intracellular proteins"	"Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"Leydig cells: 283.6;Peritubular cells: 387.8;Sertoli cells: 151.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA057345, HPA060384, HPA076762"	Approved		Enhanced	Nucleoplasm		No	No			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 18: U-2197 - ECM organization"	"Cluster 48: Smooth muscle cells - ECM organization"	Nucleoplasm		"HPA057345: , HPA060384: AB_2732648, HPA076762: "	"unprognostic (1.98e-2)"	"unprognostic (2.53e-2)"	"unprognostic (1.50e-1)"	"unprognostic (1.20e-1)"	"unprognostic (1.99e-1)"	"unprognostic (5.30e-2)"	"unprognostic (1.38e-1)"	"unprognostic (5.60e-3)"	"unprognostic (6.09e-2)"	"unprognostic (2.03e-2)"	"unprognostic (9.85e-3)"	"unprognostic (6.54e-2)"	"unprognostic (4.80e-2)"	"unprognostic (2.62e-1)"	"unprognostic (2.56e-1)"	"unprognostic (5.56e-2)"	"unprognostic (8.76e-2)"	34.9	54.7	33.9	13.8	35.6	9.9	39.4	33.6	47.1	107.9	32.6	61.1	15.2	140.8	40.3	37.8	114.3	34.8	32.2	36.0	37.8	25.1	19.0	30.5	14.1	31.7	31.4	174.8	20.3	31.9	33.9	17.8	35.2	63.3	16.8	14.7	16.1	79.3	55.1	17.3	29.2	95.0	31.4	26.2	40.3	20.1	35.8	12.2	31.9	33.6	9.8	97.9	58.3	33.6	21.8	20.6	11.4	15.8	48.2	33.2	15.2	30.2	30.3	28.9	31.2	9.1	21.1	10.0	30.4	39.3	43.9	21.2	19.2	16.0	21.4	0.0	23.9	13.6	27.2	17.8	21.7	0.1	19.7	40.9	30.4	22.4	12.3	47.7	30.1	11.4	5.1	5.5	58.7	24.1	12.1	0.3	3.8	19.3	32.9	12.4	36.8	0.1	40.4	21.3	15.7	13.2	30.6	14.4	35.4	8.3	13.5	12.7	24.0	20.9	7.7	49.3	15.7	5.4	18.6	0.3	27.4	0.1	21.3	26.8	13.2	0.8	15.3	9.4	22.5	31.9	13.7	12.9	26.4	24.9	18.2	20.8	1.4	22.6	4.0	20.9	13.2	12.8	33.9	35.6	33.6	47.1	36.0	37.8	31.7	31.4	35.2	31.4	35.8	33.6	26.5	16.0	31.2	9.4	10.4	29.7	52.7	38.4	24.5	21.8	47.3	42.8	32.9	28.6	37.2	25.8	2.1	30.0	8.9	6.2	56.7	22.9	2.5	27.5	50.0	32.2	27.6	9.1	22.1	24.6	29.8	37.4	7.7	21.9	26.6	22.7	46.1	19.7	34.7	21.9	20.4	13.2	30.5	21.0	23.1	11.7	283.6	16.5	19.6	6.5	19.7	38.6	19.6	16.6	10.3	11.7	17.5	387.8	5.1	18.4	15.0	52.8	48.0	12.3	151.2	32.6	45.3	6.0	8.5	15.5	21.3	7.3	11.3	32.5	19.4	17.6
TCEAL4	"FLJ21174, WEX7"	ENSG00000133142	"Transcription elongation factor A like 4"	Q96EI5	X	103576231-103587729	"Predicted intracellular proteins"	"Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Leydig cells: 1524.1;Peritubular cells: 1785.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"																	NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 52: Non-specific - Transcription"				"unprognostic (2.21e-1)"	"unprognostic (2.21e-1)"	"unprognostic (6.17e-3)"	"unprognostic (1.47e-1)"	"unprognostic (1.14e-1)"	"prognostic unfavorable (3.11e-5)"	"unprognostic (1.08e-1)"	"prognostic favorable (2.75e-4)"	"unprognostic (1.37e-1)"	"unprognostic (1.63e-2)"	"unprognostic (5.36e-2)"	"unprognostic (4.16e-1)"	"unprognostic (2.02e-2)"	"unprognostic (7.49e-2)"	"unprognostic (3.35e-2)"	"unprognostic (5.46e-2)"	"unprognostic (7.63e-2)"	167.6	213.2	157.9	44.3	159.0	28.1	156.1	154.5	204.9	517.9	206.4	204.4	32.4	712.6	251.4	113.8	428.0	86.9	179.3	154.9	166.8	144.3	111.4	167.2	30.5	164.6	160.6	855.8	98.1	134.6	180.4	112.1	163.8	318.4	49.5	77.5	88.9	262.6	95.9	146.6	111.8	277.5	157.1	125.7	159.3	118.9	158.0	30.7	134.9	81.5	30.3	423.5	278.9	170.0	153.8	115.2	96.1	85.7	330.5	196.1	96.4	165.0	165.3	101.5	118.2	49.6	112.0	37.9	178.5	181.5	242.6	96.8	107.3	120.2	122.9	0.6	72.4	51.7	179.9	65.0	291.9	0.4	41.2	262.6	182.4	84.5	193.7	253.3	149.2	52.7	0.7	39.9	303.9	376.5	56.5	2.8	87.6	3.6	136.8	55.5	162.8	7.5	155.3	186.4	97.3	95.6	265.4	64.1	224.0	112.0	102.3	25.1	185.3	100.6	39.8	257.3	68.9	11.7	71.7	1.7	138.7	0.7	104.6	12.3	28.5	1.0	12.8	15.3	18.4	36.4	17.5	13.7	37.7	22.8	15.9	16.8	1.1	24.7	11.9	11.8	57.0	13.6	157.9	159.0	154.5	204.9	154.9	166.8	164.6	160.6	163.8	157.1	158.0	170.0	131.6	112.2	159.1	20.9	28.8	130.0	305.9	170.2	117.3	88.5	169.2	191.4	278.7	114.4	130.8	198.6	14.6	222.8	11.7	19.6	385.4	156.6	11.7	117.0	459.5	143.2	104.2	28.6	19.5	95.2	331.5	202.4	46.4	178.9	116.9	167.0	231.0	218.6	148.4	90.9	21.1	44.9	91.6	61.7	80.5	65.2	1524.1	69.9	104.9	11.2	82.3	201.9	4.1	26.2	31.9	68.7	33.7	1785.5	23.3	195.5	7.6	297.2	81.0	60.5	361.6	120.3	192.8	34.8	58.5	91.1	104.3	94.3	29.7	144.7	39.4	135.8
TEAD1	"AA, TCF13, TEF-1"	ENSG00000187079	"TEA domain transcription factor 1"	P28347	11	12674421-12944737	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 230.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA057339, HPA062471"			Enhanced	Nucleoplasm		NA	NA				"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 44: Endometrium - Transcription"	Nucleoplasm		"HPA057339: AB_2683413, HPA062471: AB_2684773"	"unprognostic (1.00e-1)"	"unprognostic (2.53e-2)"	"unprognostic (8.84e-2)"	"unprognostic (9.93e-3)"	"unprognostic (2.05e-2)"	"unprognostic (4.50e-1)"	"unprognostic (1.50e-1)"	"unprognostic (1.75e-1)"	"unprognostic (1.43e-1)"	"unprognostic (4.40e-3)"	"unprognostic (8.39e-2)"	"unprognostic (4.76e-2)"	"unprognostic (1.41e-2)"	"unprognostic (7.08e-3)"	"unprognostic (2.52e-1)"	"unprognostic (3.14e-1)"	"unprognostic (2.18e-2)"	29.5	12.1	11.1	8.2	11.6	0.0	17.8	8.6	8.5	23.4	30.6	36.1	7.7	26.4	7.1	29.8	19.2	18.5	31.3	14.5	14.8	17.2	13.6	15.9	4.2	15.1	12.3	21.9	15.2	27.1	14.4	33.3	10.5	18.8	13.0	10.5	10.2	20.1	67.5	13.2	11.9	27.2	13.3	7.3	16.4	8.6	15.6	4.2	17.8	72.6	5.6	33.9	14.7	12.9	62.8	52.1	43.9	58.7	59.9	62.1	65.4	89.2	76.2	71.6	69.7	53.8	54.5	0.4	23.0	120.9	32.3	37.0	53.7	35.9	115.5	0.2	17.6	0.0	107.3	18.1	55.8	0.0	4.7	51.8	18.3	50.4	68.2	58.6	15.2	3.9	26.0	0.2	111.2	13.1	0.1	0.6	17.2	14.5	23.5	0.3	64.8	33.2	48.2	37.2	26.9	31.2	90.9	43.1	59.0	63.8	20.0	4.4	32.0	107.8	76.2	84.9	59.5	8.6	17.3	12.0	41.6	0.2	69.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.1	11.6	8.6	8.5	14.5	14.8	15.1	12.3	10.5	13.3	15.6	12.9	37.9	89.8	21.7	230.8	0.4	99.3	32.2	19.3	39.9	12.9	16.4	20.2	75.0	31.5	33.1	49.7	12.5	24.1	0.2	11.0	1.9	16.6	6.5	80.8	97.4	33.3	46.7	0.0	101.8	12.8	52.4	46.5	18.8	142.9	0.0	57.7	25.7	39.8	3.7	1.7	108.4	13.5	10.2	1.9	16.0	7.2	23.6	1.9	24.9	91.8	0.0	31.2	0.0	121.2	69.7	34.8	8.1	24.0	1.4	69.4	6.7	29.8	53.8	17.5	6.6	73.5	46.7	3.0	22.3	29.9	54.8	12.3	2.0	45.5	10.4	54.6
TENM3	"KIAA1455, ODZ3, Ten-M3, TEN3"	ENSG00000218336	"Teneurin transmembrane protein 3"	Q9P273	4	182143987-182803024	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion, Differentiation"		"Disease variant, Microphthalmia"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 21.8;placenta: 13.1"	"Cell type enriched"	"Detected in many"	4	"Inhibitory neurons: 635.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AF22: 66.3;BEWO: 63.3;HDLM-2: 90.0;T-47d: 86.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA047043	Approved		Approved	Nucleoplasm		NA	NA				"Cluster 10: Brain - Neuronal signaling"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Nucleoplasm		"HPA047043: AB_2679914"	"unprognostic (5.79e-2)"	"unprognostic (3.01e-2)"	"unprognostic (6.62e-2)"	"unprognostic (4.43e-2)"	"unprognostic (1.46e-2)"	"unprognostic (1.08e-1)"	"unprognostic (8.28e-2)"	"unprognostic (8.68e-3)"	"unprognostic (1.82e-1)"	"unprognostic (2.31e-2)"	"unprognostic (4.85e-2)"	"unprognostic (2.54e-1)"	"unprognostic (4.10e-2)"	"unprognostic (1.47e-3)"	"unprognostic (8.59e-2)"	"unprognostic (1.07e-2)"	"unprognostic (5.25e-4)"	5.0	5.1	12.0	1.6	18.4	0.0	2.0	0.0	12.3	1.5	0.0	4.3	0.8	2.9	0.6	0.8	1.0	2.4	1.4	21.8	8.1	0.9	0.3	0.8	0.8	2.8	7.3	3.8	1.2	5.1	4.5	13.1	0.0	3.7	0.8	3.9	0.6	3.6	2.1	0.4	0.9	2.3	0.8	2.2	0.7	2.1	7.4	2.8	6.1	4.3	1.2	1.6	1.4	2.0	0.3	2.6	66.3	0.4	13.2	23.5	63.3	7.8	2.7	6.9	6.1	33.9	17.6	0.0	0.9	52.6	28.6	3.3	16.0	3.4	6.8	90.0	26.7	0.0	0.0	0.0	1.3	0.0	0.0	31.2	1.2	21.5	15.0	15.4	9.6	0.0	0.0	0.4	10.6	2.3	0.1	0.1	21.4	0.0	2.8	0.0	17.1	0.2	0.1	0.1	27.2	25.2	4.0	0.5	0.1	35.8	86.0	3.4	21.2	53.7	38.2	0.2	39.6	0.0	0.0	0.0	28.2	0.0	40.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.0	18.4	0.0	12.3	21.8	8.1	2.8	7.3	0.0	0.8	7.4	2.0	0.1	0.0	0.0	23.8	0.0	0.4	0.2	0.7	1.8	50.8	1.6	2.2	3.9	0.0	0.1	3.7	4.2	112.7	0.0	0.0	1.9	0.1	12.4	0.1	4.5	0.7	5.3	0.0	115.6	1.8	54.6	4.1	0.0	0.6	0.0	7.7	1.1	0.7	10.4	5.0	635.6	0.0	0.0	0.0	0.7	3.2	8.4	0.0	1.8	8.4	0.0	10.6	0.0	12.1	24.4	0.4	0.0	2.6	0.0	0.4	0.0	0.3	0.0	3.1	0.0	4.8	3.2	3.8	7.2	1.8	0.0	133.4	0.1	4.1	0.1	0.1
TMOD1	"D9S57E, ETMOD, TMOD"	ENSG00000136842	"Tropomodulin 1"	P28289	9	97501180-97601743	"Predicted intracellular proteins"		Actin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 250.0;tongue: 255.8"	"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 60.0;Erythroid cells: 138.9;Horizontal cells: 102.6"	"Group enriched"	"Detected in many"	4	"glioma: 21.6;ovarian cancer: 17.1"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"EFO-21: 38.0;HDLM-2: 155.7;K-562: 53.3;SH-SY5Y: 157.4"	"Low region specificity"	"Detected in all"							HPA051202	Enhanced					NA	NA		9400	"Cluster 40: NK-cells - Unknown function"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 6: Erythroid cells - Oxygen transport"			"HPA051202: AB_2681387"	"unprognostic (8.54e-2)"	"unprognostic (2.26e-2)"	"unprognostic (1.44e-3)"	"unprognostic (1.95e-1)"	"unprognostic (1.08e-1)"	"unprognostic (2.62e-3)"	"unprognostic (2.82e-1)"	"unprognostic (3.09e-1)"	"unprognostic (2.09e-1)"	"unprognostic (2.91e-1)"	"unprognostic (1.40e-2)"	"unprognostic (3.48e-1)"	"unprognostic (1.72e-2)"	"unprognostic (1.04e-2)"	"unprognostic (1.42e-1)"	"unprognostic (2.02e-1)"	"unprognostic (4.88e-5)"	18.8	65.1	16.8	4.5	19.9	24.2	15.8	25.0	22.0	46.4	16.3	34.8	4.2	54.3	5.6	17.4	27.4	7.4	144.2	18.0	25.7	9.2	28.5	15.5	2.6	20.1	12.1	51.3	23.0	13.9	31.6	2.6	17.3	17.1	6.3	9.2	10.4	9.1	250.0	7.5	12.2	36.3	17.8	3.5	18.4	2.8	12.6	1.0	21.9	255.8	2.4	38.3	25.4	22.6	5.4	1.4	0.0	0.7	6.3	0.6	1.9	1.0	9.1	0.1	0.2	1.2	1.6	0.1	38.0	0.1	8.5	0.4	1.6	0.0	0.0	155.7	5.6	7.4	8.8	0.6	0.2	0.1	12.5	0.5	0.0	0.4	0.0	0.1	0.7	0.2	53.3	0.1	0.1	2.3	0.0	1.0	2.0	1.5	0.6	0.0	5.1	0.1	0.0	1.1	0.6	157.4	4.8	0.1	2.7	2.1	2.0	7.7	0.8	0.0	5.7	4.3	1.1	19.1	4.1	0.2	7.0	5.1	8.4	0.8	0.3	0.5	1.2	0.3	1.1	1.2	1.0	0.7	0.5	2.0	0.6	0.7	0.0	0.7	0.4	0.1	2.2	1.1	16.8	19.9	25.0	22.0	18.0	25.7	20.1	12.1	17.3	17.8	12.6	22.6	4.7	6.4	4.2	2.3	1.9	2.3	1.0	0.0	0.0	1.1	1.6	1.3	60.0	4.3	0.0	0.0	6.2	0.2	1.1	0.0	0.0	0.3	0.8	10.2	14.5	13.0	3.0	138.9	27.6	6.5	0.4	12.8	4.6	27.7	10.8	0.1	27.5	20.2	0.9	102.6	19.3	0.4	0.0	13.7	4.2	0.6	10.2	6.5	17.8	6.5	0.1	2.2	0.0	31.2	5.9	4.7	0.0	6.8	0.4	2.1	0.0	0.2	0.0	1.3	19.7	8.8	23.9	2.6	6.8	0.2	1.0	0.1	3.2	0.1	0.1	0.9
TSPAN18	TSPAN	ENSG00000157570	"Tetraspanin 18"	Q96SJ8	11	44726465-44932423	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 83.5"	"Group enriched"	"Detected in many"	6	"Adipocytes: 72.2;Cardiomyocytes: 22.3;Early spermatids: 29.7;Endothelial cells: 51.8;Hepatic stellate cells: 70.3;Proximal tubular cells: 20.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"AF22: 36.7;CAPAN-2: 61.5;GAMG: 35.2;HDLM-2: 48.7;NTERA-2: 33.0;RH-30: 38.4;SCLC-21H: 31.9;SH-SY5Y: 36.2;SuSa: 99.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 46: Fibroblasts - ECM organization"	"Cluster 12: NES - Nervous system development"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"				"unprognostic (1.09e-1)"	"unprognostic (1.97e-1)"	"unprognostic (8.53e-3)"	"unprognostic (3.48e-2)"	"unprognostic (6.30e-2)"	"unprognostic (8.64e-2)"	"unprognostic (7.17e-2)"	"unprognostic (2.91e-2)"	"unprognostic (8.75e-2)"	"unprognostic (1.07e-1)"	"unprognostic (1.19e-1)"	"unprognostic (2.29e-1)"	"unprognostic (1.04e-3)"	"unprognostic (6.78e-3)"	"unprognostic (3.22e-1)"	"unprognostic (2.19e-1)"	"unprognostic (5.59e-2)"	22.2	46.1	5.8	10.4	4.3	1.2	10.0	30.5	8.2	14.4	3.6	47.9	6.7	46.7	3.6	21.0	20.8	13.3	83.5	26.1	4.6	14.5	4.9	22.4	7.7	5.1	10.4	7.4	1.6	3.9	5.4	30.2	4.9	15.8	9.9	1.0	3.3	41.4	14.7	6.3	16.4	46.6	8.9	14.1	16.6	4.0	10.8	4.0	14.8	19.9	4.2	23.1	10.2	2.3	0.0	0.6	36.7	0.5	0.0	0.0	0.0	0.6	0.5	2.3	0.1	7.3	61.5	0.0	16.4	1.0	35.2	0.0	6.6	0.2	0.6	48.7	2.4	0.2	5.0	0.0	0.0	0.2	0.1	0.7	0.0	0.1	0.0	0.0	14.3	0.2	1.1	0.0	0.1	0.0	0.0	0.1	33.0	0.1	1.0	0.1	38.4	0.2	0.0	0.0	31.9	36.2	0.4	0.1	0.1	99.8	0.2	0.1	1.4	0.0	0.1	0.2	0.0	0.0	0.2	0.0	0.0	1.6	1.0	0.0	0.0	1.6	0.1	0.0	0.8	0.2	1.1	0.5	0.0	0.0	1.3	0.2	0.3	0.5	0.0	0.0	0.3	1.7	5.8	4.3	30.5	8.2	26.1	4.6	5.1	10.4	4.9	8.9	10.8	2.3	72.2	0.0	3.7	5.5	1.5	1.7	0.1	0.0	0.6	1.8	1.0	0.3	22.3	0.0	0.0	7.3	0.0	0.1	1.1	0.0	0.0	0.4	29.7	0.7	0.9	51.8	0.0	3.6	2.7	0.2	0.2	6.8	0.5	1.4	1.3	0.0	70.3	1.0	0.4	1.7	4.1	0.0	0.0	2.5	2.6	5.6	2.8	3.4	7.2	2.8	0.2	0.1	0.0	4.0	1.3	0.7	0.0	1.5	0.6	0.2	0.0	20.2	0.0	0.5	0.0	4.9	2.0	0.6	1.0	0.0	1.1	0.3	3.0	3.2	0.0	0.1
TTC23	"FLJ12572, HCC-8"	ENSG00000103852	"Tetratricopeptide repeat domain 23"	Q5W5X9	15	99136323-99251223	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 27.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"basophil: 1.8"	"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039806, HPA040369"	Uncertain		Approved	Cytosol		NA	NA			"Cluster 34: Basophils - Unknown function"	"Cluster 12: Smooth muscle tissue - Mixed function"	"Cluster 38: EFO-21 - Unknown function"	"Cluster 52: Non-specific - Transcription"	Cytosol		"HPA039806: AB_10793921, HPA040369: AB_10795381"	"prognostic favorable (3.17e-4)"	"unprognostic (5.41e-2)"	"unprognostic (1.45e-1)"	"prognostic favorable (1.07e-4)"	"unprognostic (1.40e-2)"	"unprognostic (6.53e-2)"	"unprognostic (9.25e-3)"	"unprognostic (2.56e-1)"	"unprognostic (6.18e-2)"	"unprognostic (1.76e-3)"	"unprognostic (1.88e-1)"	"unprognostic (3.24e-1)"	"unprognostic (3.21e-2)"	"unprognostic (1.11e-2)"	"unprognostic (4.31e-1)"	"unprognostic (7.99e-2)"	"unprognostic (1.23e-1)"	8.3	10.1	5.3	4.3	6.6	1.1	8.0	5.1	6.3	11.6	6.6	17.1	3.5	11.2	6.9	9.8	10.0	8.8	10.6	4.5	6.2	8.9	8.1	6.6	3.1	6.7	5.8	14.9	8.0	8.9	5.3	9.4	6.5	10.7	7.8	7.2	6.7	9.2	8.1	8.4	6.8	10.0	5.7	5.2	9.1	13.0	6.0	3.7	12.7	7.6	3.3	13.2	10.1	8.1	9.9	9.8	15.3	17.8	18.0	20.2	6.4	12.0	14.8	12.6	14.2	8.8	17.0	2.4	23.7	13.7	11.4	19.0	5.0	12.0	13.7	3.3	16.3	10.7	17.1	7.0	10.4	2.4	0.7	14.5	10.5	9.9	9.5	13.7	21.6	4.8	8.3	1.4	11.8	6.0	8.6	2.7	8.4	2.7	7.0	2.7	19.9	3.8	10.0	13.2	6.7	3.0	15.8	6.4	14.7	15.4	10.7	10.9	14.3	16.0	9.4	10.7	15.5	8.1	12.4	3.3	14.3	0.8	9.6	1.8	0.1	0.1	0.0	0.3	0.1	0.1	0.1	0.1	0.7	0.1	0.0	0.0	0.5	0.5	0.1	0.5	0.1	0.0	5.3	6.6	5.1	6.3	4.5	6.2	6.7	5.8	6.5	5.7	6.0	8.1	5.9	3.2	7.0	27.1	0.6	2.4	4.6	4.4	4.6	1.7	4.6	4.3	9.5	4.3	5.2	5.5	0.0	4.6	0.1	4.3	5.9	6.0	12.5	3.3	10.6	7.0	0.0	0.8	3.3	6.2	4.6	7.4	10.2	4.5	1.3	13.5	9.3	5.3	4.0	8.4	3.5	5.7	6.1	3.8	1.7	8.5	9.0	2.5	1.8	15.9	0.6	11.5	0.0	6.6	13.2	3.9	2.6	10.1	0.1	3.1	3.8	5.5	4.0	5.4	6.6	6.5	5.5	18.0	9.2	7.9	4.0	1.9	0.4	10.9	6.7	2.6
TTC7B	TTC7L1	ENSG00000165914	"Tetratricopeptide repeat domain 7B"	Q86TV6	14	90524564-90816479	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 88.8;Excitatory neurons: 116.7;Inhibitory neurons: 132.8;Oligodendrocyte precursor cells: 69.9;Oligodendrocytes: 70.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	7	"basophil: 5.6;eosinophil: 8.0"	"Lineage enriched"	"Detected in single"	9	"granulocytes: 8.0"	"Cell line enhanced"	"Detected in many"		"HMC-1: 72.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA058363, HPA059577"	Enhanced		Supported	"Plasma membrane"		NA	NA			"Cluster 10: Basophils - Unknown function"	"Cluster 47: Non-specific - Unknown function"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Plasma membrane"		"HPA058363: AB_2683692, HPA059577: AB_2684069"	"unprognostic (9.37e-2)"	"unprognostic (4.20e-2)"	"unprognostic (1.01e-2)"	"unprognostic (2.41e-2)"	"unprognostic (2.58e-1)"	"unprognostic (2.67e-4)"	"unprognostic (9.42e-2)"	"unprognostic (2.17e-1)"	"unprognostic (5.38e-2)"	"unprognostic (7.60e-2)"	"unprognostic (2.75e-3)"	"unprognostic (2.87e-2)"	"prognostic favorable (3.20e-6)"	"unprognostic (2.74e-2)"	"unprognostic (7.41e-2)"	"unprognostic (4.48e-2)"	"unprognostic (1.07e-2)"	23.7	11.6	42.9	9.1	43.4	10.2	18.1	47.1	57.2	20.1	0.7	37.9	5.0	24.2	6.1	15.5	18.0	9.2	33.2	51.0	18.7	16.9	17.6	18.5	4.1	35.7	32.2	15.8	24.7	15.7	18.2	18.4	38.7	16.1	4.4	14.4	12.8	13.9	60.9	9.3	11.0	17.6	14.6	15.4	22.4	4.2	45.2	3.5	9.5	27.9	2.7	25.4	13.1	39.6	19.4	17.2	20.0	14.8	18.2	21.5	65.5	15.5	13.2	20.2	21.7	4.5	5.1	0.2	23.6	17.4	23.9	0.4	13.1	10.8	19.6	35.3	14.1	43.6	8.9	4.1	18.3	1.0	72.8	16.1	7.1	10.9	13.2	18.5	29.4	16.9	24.7	35.3	19.7	20.5	0.5	17.2	11.4	1.1	14.8	37.8	33.0	6.6	6.6	14.4	30.5	20.9	15.4	6.3	33.3	12.7	9.0	13.3	33.7	20.6	16.1	15.2	25.4	12.0	6.3	0.2	29.6	4.1	20.6	5.6	0.2	8.0	0.1	0.5	0.2	0.1	0.1	0.1	0.3	0.1	0.1	0.1	1.0	0.3	0.1	0.5	0.9	0.5	42.9	43.4	47.1	57.2	51.0	18.7	35.7	32.2	38.7	14.6	45.2	39.6	13.1	3.2	1.1	88.8	0.5	2.8	2.1	1.1	0.6	13.4	2.7	2.8	21.6	2.8	0.4	5.5	16.7	13.1	0.6	0.1	1.9	2.3	5.9	1.3	5.2	7.9	1.2	2.5	116.7	2.4	7.4	7.3	0.5	2.0	7.6	20.0	10.8	9.9	8.1	30.3	132.8	0.1	4.1	5.6	4.3	3.2	6.8	7.2	12.4	36.5	2.7	6.0	0.0	69.9	70.7	0.8	0.1	7.2	0.4	3.0	0.3	4.0	5.5	17.8	26.3	9.9	9.2	1.7	1.6	0.7	2.0	30.1	1.1	2.1	0.0	1.2
TXNRD1	"GRIM-12, Trxr1, TXNR"	ENSG00000198431	"Thioredoxin reductase 1"	Q16881	12	104215779-104350307	"Cancer-related genes, Enzymes, FDA approved drug targets, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Electron transport, Transport"	Oxidoreductase	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Basal prostatic cells: 459.7;Prostatic glandular cells: 557.4;Urothelial cells: 488.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"fHDF/TERT166: 1452.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001395, CAB004607, CAB015834, HPA043871"	Approved		Supported	Nucleoplasm		NA	NA		6100000	"Cluster 46: Basophils - DNA binding"	"Cluster 12: Smooth muscle tissue - Mixed function"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 22: Epithelial cell types - Mixed function"	Nucleoplasm		"CAB004607: AB_628405, CAB015834: , HPA001395: AB_1858377, HPA043871: AB_2678709"	"unprognostic (2.52e-2)"	"unprognostic (1.16e-1)"	"unprognostic (5.48e-2)"	"unprognostic (1.01e-1)"	"unprognostic (3.15e-1)"	"unprognostic (1.94e-2)"	"prognostic unfavorable (1.12e-5)"	"unprognostic (5.55e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.08e-1)"	"unprognostic (6.42e-2)"	"unprognostic (2.21e-1)"	"prognostic unfavorable (1.20e-5)"	"unprognostic (2.13e-1)"	"unprognostic (1.27e-1)"	"unprognostic (1.18e-2)"	"unprognostic (8.80e-2)"	47.1	148.1	22.5	40.6	21.1	64.7	28.0	20.9	22.6	28.0	37.3	50.9	58.4	47.9	21.0	30.7	39.0	55.9	65.8	21.1	29.8	37.9	46.5	63.0	34.4	55.2	26.7	34.1	19.0	33.8	21.2	39.1	33.3	41.0	45.6	20.1	20.8	60.6	67.8	12.4	39.4	51.6	22.9	27.8	52.1	37.8	24.6	42.8	30.4	64.0	34.1	141.6	30.1	25.7	228.4	1032.6	118.1	111.3	553.5	308.0	409.8	412.4	259.3	182.7	186.8	110.5	329.4	169.3	187.0	1452.6	682.1	77.7	235.7	158.6	214.1	82.7	101.8	143.1	765.8	468.0	885.7	226.3	149.9	176.9	159.8	403.7	128.1	557.1	634.0	227.9	200.5	77.5	276.8	109.1	233.4	102.7	114.4	453.0	1053.1	227.3	82.1	146.5	211.2	123.1	182.6	110.6	333.3	519.1	325.2	222.6	123.2	131.4	854.5	89.3	183.7	201.3	341.2	84.8	179.9	254.5	186.8	122.5	538.0	109.4	29.9	69.7	23.6	39.0	26.9	21.3	21.6	23.9	39.5	14.5	19.1	16.7	102.6	24.4	48.4	25.2	19.8	27.6	22.5	21.1	20.9	22.6	21.1	29.8	55.2	26.7	33.3	22.9	24.6	25.7	26.0	64.1	67.5	50.3	27.6	104.0	459.7	41.3	40.9	28.1	19.4	16.3	66.2	32.9	79.3	16.5	22.9	26.1	40.4	93.4	41.1	79.6	45.0	100.9	36.8	116.2	20.4	46.3	48.2	80.7	34.3	90.1	69.8	119.6	53.2	35.2	49.2	68.2	42.0	28.6	56.7	18.8	44.7	43.5	100.5	19.1	68.0	62.2	19.6	49.6	51.9	24.8	26.8	29.1	55.3	197.7	40.5	29.3	28.4	557.4	24.6	37.5	105.5	20.9	0.0	43.4	84.0	14.4	33.8	24.3	72.9	51.3	28.5	98.4	33.0	488.0
VASP		ENSG00000125753	"Vasodilator stimulated phosphoprotein"	P50552	19	45506579-45526983	"Plasma proteins, Predicted intracellular proteins"		Actin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Extravillous trophoblasts: 443.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"eosinophil: 52.7"	"Group enriched"	"Detected in all"	7	"granulocytes: 52.7;monocytes: 22.7"	"Cell line enhanced"	"Detected in all"		"HMC-1: 270.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004612, HPA005724"	Enhanced		Supported	"Plasma membrane,Cell Junctions,Focal adhesion sites"		NA	NA		32000000	"Cluster 52: Eosinophils - Transcription"	"Cluster 14: B-cells - Humoral immune response"	"Cluster 15: RT4 - Unknown function"	"Cluster 38: Extravillous trophoblasts - Unknown function"	"Plasma membrane, Cell Junctions, Focal adhesion sites"		"CAB004612: AB_2213431, HPA005724: AB_1858721"	"unprognostic (3.07e-2)"	"unprognostic (1.07e-2)"	"unprognostic (4.70e-2)"	"unprognostic (7.85e-3)"	"unprognostic (8.31e-2)"	"unprognostic (1.90e-2)"	"prognostic unfavorable (3.49e-5)"	"unprognostic (1.66e-3)"	"unprognostic (1.58e-1)"	"unprognostic (1.30e-2)"	"unprognostic (3.64e-3)"	"unprognostic (4.39e-1)"	"prognostic unfavorable (5.91e-7)"	"unprognostic (1.15e-1)"	"unprognostic (1.15e-1)"	"unprognostic (1.69e-1)"	"unprognostic (1.08e-2)"	54.5	24.6	9.3	75.2	8.3	94.0	42.5	9.2	12.6	37.7	11.0	88.9	61.9	89.1	6.0	37.5	54.4	27.0	36.4	8.1	9.4	39.1	27.3	58.2	48.7	13.0	10.9	22.5	20.6	10.7	17.1	31.5	13.8	43.8	20.4	1.9	30.7	39.1	12.5	32.8	63.6	36.5	11.7	107.0	70.5	14.7	15.0	24.9	27.6	8.5	32.0	71.6	39.0	12.0	68.9	66.3	20.6	35.6	10.2	17.4	50.5	70.2	52.8	47.4	40.9	30.1	142.0	31.2	55.7	56.4	31.3	60.6	6.2	69.5	15.9	87.0	14.8	183.7	32.3	55.4	56.6	68.1	270.1	26.8	38.2	44.5	28.5	38.3	71.1	25.8	112.1	67.5	29.4	53.7	30.3	58.7	36.0	65.1	44.5	21.6	12.6	12.2	40.9	216.2	23.0	16.3	83.6	41.7	48.2	13.0	45.7	115.2	107.0	74.7	74.4	24.7	112.4	32.8	43.3	54.7	52.4	82.3	92.3	13.3	8.5	52.7	4.1	13.9	2.8	3.4	3.3	3.9	5.5	3.3	2.1	2.5	34.5	4.0	22.7	2.1	2.6	5.8	9.3	8.3	9.2	12.6	8.1	9.4	13.0	10.9	13.8	11.7	15.0	12.0	80.9	16.0	19.5	2.9	99.4	98.3	95.6	48.8	37.0	6.9	53.5	57.0	19.0	48.6	41.5	33.1	27.1	67.1	85.9	202.3	17.6	138.6	3.2	33.9	30.5	77.0	114.7	20.0	2.6	98.2	443.6	26.7	81.6	58.1	83.1	17.4	48.5	15.8	160.1	6.7	3.4	159.3	44.7	132.5	232.0	3.8	26.1	192.9	49.8	10.3	162.9	13.2	185.3	2.0	2.3	212.5	245.5	49.2	38.2	73.4	134.6	20.4	18.6	14.7	131.5	46.5	89.4	18.9	15.5	38.7	77.7	140.9	95.7	21.0	129.5	144.8
ZHX3	"KIAA0395, TIX1"	ENSG00000174306	"Zinc fingers and homeoboxes 3"	Q9H4I2	20	41178448-41317672	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Differentiation, Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 370.5;Early spermatids: 106.3;Excitatory neurons: 99.0;Inhibitory neurons: 96.5;Oligodendrocyte precursor cells: 139.7;Oligodendrocytes: 142.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA046498			Supported	Nucleoplasm		NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 78: Testis - Spermatogenesis"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 64: Astrocytes - Nervous system maintenance"	Nucleoplasm		"HPA046498: AB_2679676"	"unprognostic (6.26e-2)"	"unprognostic (1.41e-2)"	"unprognostic (2.10e-1)"	"prognostic unfavorable (1.62e-4)"	"unprognostic (3.40e-2)"	"unprognostic (4.50e-2)"	"unprognostic (2.29e-1)"	"unprognostic (3.88e-1)"	"unprognostic (3.42e-1)"	"unprognostic (7.25e-3)"	"unprognostic (1.50e-2)"	"unprognostic (1.06e-1)"	"prognostic favorable (2.53e-5)"	"unprognostic (3.06e-1)"	"unprognostic (2.74e-1)"	"prognostic unfavorable (7.52e-4)"	"prognostic unfavorable (1.84e-5)"	14.4	15.4	33.8	6.5	32.8	3.4	13.3	31.6	27.4	11.6	16.4	19.8	8.6	15.8	5.7	13.6	15.7	8.4	12.2	30.2	27.7	26.4	17.2	11.6	4.5	37.6	32.1	16.3	11.9	15.4	7.8	4.9	29.9	10.6	8.0	10.8	5.7	11.9	28.5	11.0	11.4	12.1	29.4	4.3	15.5	35.0	36.0	7.0	19.0	20.1	4.8	18.1	11.0	28.6	22.5	6.3	6.6	14.2	52.6	56.3	7.6	31.0	35.4	28.3	19.1	11.4	2.9	15.6	14.7	58.5	7.6	7.0	7.9	39.2	30.0	4.3	7.1	6.6	8.6	8.8	21.6	7.6	7.9	34.6	18.7	21.3	27.3	19.2	12.3	11.7	6.2	10.6	38.3	45.0	11.9	4.5	2.9	10.4	23.0	5.8	18.6	6.2	38.6	6.7	23.0	8.3	20.7	12.0	7.4	5.7	11.6	10.5	19.9	70.2	10.8	25.0	15.5	12.2	8.0	6.9	28.9	11.0	11.4	0.1	0.1	0.4	0.2	0.1	0.4	0.6	0.2	0.1	0.2	0.6	0.4	0.3	0.1	0.6	0.2	0.1	0.2	0.1	33.8	32.8	31.6	27.4	30.2	27.7	37.6	32.1	29.9	29.4	36.0	28.6	29.8	19.2	16.4	370.5	4.7	2.9	3.9	2.6	2.8	19.5	6.3	4.7	12.7	17.2	5.8	22.0	4.2	0.6	3.8	5.5	11.7	3.7	106.3	12.3	33.2	15.1	14.9	3.8	99.0	2.7	2.7	20.5	6.6	26.3	1.3	3.7	16.4	31.6	3.0	40.4	96.5	5.6	4.1	3.5	1.7	32.3	18.6	3.5	1.8	52.5	1.9	28.6	1.0	139.7	142.4	4.6	1.3	24.5	2.7	2.6	12.6	27.0	3.2	7.1	26.3	41.2	10.9	11.0	5.2	6.3	3.7	0.4	2.7	19.7	4.7	2.3
ZYX		ENSG00000159840	Zyxin	Q15942	7	143381295-143391111	"Plasma proteins, Predicted intracellular proteins"	"Cell adhesion, Host-virus interaction"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"endometrium 1: 596.6"	"Cell type enhanced"	"Detected in many"		"Macrophages: 207.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"neutrophil: 163.3"	"Group enriched"	"Detected in all"	4	"dendritic cells: 58.4;granulocytes: 163.3;monocytes: 83.6"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004835, CAB009321, HPA073497, CAB075747"	Enhanced		Supported	"Plasma membrane,Actin filaments,Focal adhesion sites"		NA	NA		180000000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 51: Myeloid cells - Hemostasis"	"Focal adhesion sites"	"Plasma membrane, Actin filaments"	"CAB009321: AB_2221290, CAB075747: AB_2665753, HPA004835: AB_1080771, HPA073497: AB_2686611"	"unprognostic (1.96e-2)"	"unprognostic (5.35e-2)"	"unprognostic (2.36e-2)"	"unprognostic (1.25e-1)"	"unprognostic (1.44e-2)"	"unprognostic (1.18e-1)"	"unprognostic (2.21e-3)"	"unprognostic (1.66e-3)"	"unprognostic (2.60e-1)"	"unprognostic (4.22e-1)"	"unprognostic (1.98e-1)"	"unprognostic (2.43e-1)"	"prognostic unfavorable (7.92e-5)"	"unprognostic (1.39e-1)"	"unprognostic (8.12e-2)"	"unprognostic (1.95e-1)"	"unprognostic (6.72e-2)"	211.5	75.4	21.6	82.5	24.3	106.3	191.0	24.4	33.5	275.7	24.8	382.6	28.1	596.6	16.5	136.7	294.9	57.0	152.0	21.9	21.9	99.4	89.9	316.8	53.9	27.5	24.7	168.7	78.5	84.3	52.4	38.4	27.5	171.9	20.2	5.2	108.1	75.3	113.3	130.7	148.7	127.7	23.8	213.6	154.0	98.9	28.8	27.6	89.0	19.1	31.1	301.6	185.9	26.8	73.9	39.3	50.6	70.5	93.9	208.2	63.4	152.1	158.9	146.5	122.7	135.4	42.6	4.6	57.5	168.5	84.1	55.8	31.7	138.0	67.8	81.6	18.7	105.9	45.7	46.9	163.8	86.4	162.6	222.9	60.5	160.1	54.0	90.5	187.9	9.1	28.0	42.8	159.6	73.4	1.3	165.9	110.0	25.4	273.1	16.3	28.0	6.4	112.2	34.6	2.8	39.5	112.3	99.2	57.0	45.9	12.1	80.5	343.7	176.5	74.1	187.9	152.4	15.6	20.4	11.7	154.6	87.4	119.8	18.9	70.8	48.2	20.2	70.4	16.2	3.1	19.4	23.3	58.4	2.0	11.7	13.8	163.3	14.7	83.6	14.5	19.1	44.1	21.6	24.3	24.4	33.5	21.9	21.9	27.5	24.7	27.5	23.8	28.8	26.8	51.6	6.4	6.4	8.1	26.7	33.8	174.0	78.4	26.7	3.7	40.2	85.3	11.6	25.8	45.4	35.0	0.0	40.6	51.7	40.1	7.9	100.3	1.5	23.4	172.6	58.2	38.2	19.3	36.9	94.1	95.8	66.6	44.9	42.0	36.8	13.7	55.3	32.0	164.6	0.0	18.3	26.7	24.4	195.7	95.1	6.8	28.6	207.1	14.2	7.5	171.9	15.1	40.2	7.5	5.2	169.8	48.2	55.3	20.3	61.3	19.8	19.6	9.9	3.0	85.5	48.7	103.9	7.3	9.9	46.3	20.2	28.0	91.9	8.8	28.6	106.4